
<html lang="en"     class="pb-page"  data-request-id="f4c06cde-fda7-4e91-97e2-332fcc2a8e87"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm800109e;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1" /></meta><meta name="dc.Creator" content="Nassima  Oumata" /></meta><meta name="dc.Creator" content="Karima  Bettayeb" /></meta><meta name="dc.Creator" content="Yoan  Ferandin" /></meta><meta name="dc.Creator" content="Luc  Demange" /></meta><meta name="dc.Creator" content="Angela  Lopez-Giral" /></meta><meta name="dc.Creator" content="Marie-Lorène  Goddard" /></meta><meta name="dc.Creator" content="Vassilios  Myrianthopoulos" /></meta><meta name="dc.Creator" content="Emmanuel  Mikros" /></meta><meta name="dc.Creator" content="Marc  Flajolet" /></meta><meta name="dc.Creator" content="Paul  Greengard" /></meta><meta name="dc.Creator" content="Laurent  Meijer" /></meta><meta name="dc.Creator" content="Hervé  Galons" /></meta><meta name="dc.Description" content="Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer’s disease, production of amyloid-β peptides (extracellular plaques) and hyper-..." /></meta><meta name="Description" content="Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer’s disease, production of amyloid-β peptides (extracellular plaques) and hyper-..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 13, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800109e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800109e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800109e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800109e" /></link>
        
    
    

<title>Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800109e" /></meta><meta property="og:title" content="Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0001.jpeg" /></meta><meta property="og:description" content=" Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer’s disease, production of amyloid-β peptides (extracellular plaques) and hyper-phosphorylation of Tau (intracellular neurofibrillary tangles). A series of 2,6,9-trisubstituted purines, structurally related to the CDK inhibitor roscovitine, have been synthesized. They mainly differ by the substituent on the C-6 position. These compounds were screened for kinase inhibitory activities and antiproliferative effects. Several biaryl derivatives displayed potent inhibition of both CDKs and CK1. In particular, derivative 13a was a potent inhibitor of CDK1/cyclin B (IC50: 220 nM), CDK5/p25 (IC50: 80 nM), and CK1 (IC50: 14 nM). Modeling of these molecules into the ATP-binding pocket of CK1δ provided a rationale for the increased selectivity toward this kinase. 13a was able to prevent the CK1-dependent production of amyloid-β in a cell model. CDK/CK1 dual-specificity inhibitors may have important applications in Alzheimer’s disease and cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800109e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800109e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800109e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800109e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800109e&amp;href=/doi/10.1021/jm800109e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 5229-5242</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8004306" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800318d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nassima++Oumata">Nassima Oumata</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karima++Bettayeb">Karima Bettayeb</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoan++Ferandin">Yoan Ferandin</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luc++Demange">Luc Demange</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Lopez-Giral">Angela Lopez-Giral</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-Lor%C3%A8ne++Goddard">Marie-Lorène Goddard</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vassilios++Myrianthopoulos">Vassilios Myrianthopoulos</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel++Mikros">Emmanuel Mikros</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Flajolet">Marc Flajolet</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Greengard">Paul Greengard</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Meijer">Laurent Meijer</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herv%C3%A9++Galons">Hervé Galons</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. For biochemistry: L.M. phone +33.(0)2.98.29.23.39; fax, +33.(0)2.98.29.25.26; E-mail, <a href="/cdn-cgi/l/email-protection#4a272f23202f380a39286738253929252c2c642c38"><span class="__cf_email__" data-cfemail="cba6aea2a1aeb98bb8a9e6b9a4b8a8a4adade5adb9">[email protected]</span></a>. For chemistry: H.G., phone +33.(0)1.53.73.96.84; fax, +33.(0)1.43.29.05.92; E-mail, <a href="/cdn-cgi/l/email-protection#a6cec3d4d0c388c1c7cac9c8d5e6d3c8cfd08bd6c7d4cfd59388c0d4"><span class="__cf_email__" data-cfemail="2e464b5c584b00494f4241405d6e5b404758035e4f5c475d1b00485c">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes.</div><div class="corresp-fn" id="afn2">‡CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique.</div><div class="corresp-fn" id="afn3">§Department of Pharmacy, University of Athens.</div><div class="corresp-fn" id="afn4">∥Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800109e&amp;href=/doi/10.1021%2Fjm800109e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 5229–5242</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 13, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 February 2008</li><li><span class="item_label"><b>Published</b> online</span>13 August 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 September 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800109e" title="DOI URL">https://doi.org/10.1021/jm800109e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5229%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNassima%2BOumata%252C%2BKarima%2BBettayeb%252C%2BYoan%2BFerandin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D17%26contentID%3Djm800109e%26title%3DRoscovitine-Derived%252C%2BDual-Specificity%2BInhibitors%2Bof%2BCyclin-Dependent%2BKinases%2Band%2BCasein%2BKinases%2B1%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5242%26publicationDate%3DSeptember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800109e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3167</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">93</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800109e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nassima&quot;,&quot;last_name&quot;:&quot;Oumata&quot;},{&quot;first_name&quot;:&quot;Karima&quot;,&quot;last_name&quot;:&quot;Bettayeb&quot;},{&quot;first_name&quot;:&quot;Yoan&quot;,&quot;last_name&quot;:&quot;Ferandin&quot;},{&quot;first_name&quot;:&quot;Luc&quot;,&quot;last_name&quot;:&quot;Demange&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Lopez-Giral&quot;},{&quot;first_name&quot;:&quot;Marie-Lorène&quot;,&quot;last_name&quot;:&quot;Goddard&quot;},{&quot;first_name&quot;:&quot;Vassilios&quot;,&quot;last_name&quot;:&quot;Myrianthopoulos&quot;},{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;Mikros&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Flajolet&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Greengard&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Meijer&quot;},{&quot;first_name&quot;:&quot;Hervé&quot;,&quot;last_name&quot;:&quot;Galons&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;5229-5242&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800109e&quot;},&quot;abstract&quot;:&quot;Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer’s disease, production of amyloid-β peptides (extracellular plaques) and hyper-phosphorylation of Tau (intracellular neurofibrillary tangles). A series of 2,6,9-trisubstituted purines, structurally related to the CDK inhibitor roscovitine, have been synthesized. They mainly differ by the substituent on the C-6 position. These compounds were screened for kinase inhibitory activities and antiproliferative effects. Several biaryl derivatives displayed potent inhibition of both CDKs and CK1. In particular, derivative 13a was a potent inhibitor of CDK1/cyclin B (IC50: 220 nM), CDK5/p25 (IC50: 80 nM), and CK1 (IC50: 14 nM). Modeling of these molecules into the ATP-binding pocket of CK1δ provided a rationale for the increased selectivity toward this kinase. 13a was able to prevent the CK1-dependent production of amyloid-β in a cell model. CDK/CK1 dual-specificity inhibitors may have important applica&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800109e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800109e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800109e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800109e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800109e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800109e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800109e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800109e&amp;href=/doi/10.1021/jm800109e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800109e" /></input><a href="/doi/pdf/10.1021/jm800109e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800109e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800109e%26sid%3Dliteratum%253Aachs%26pmid%3D18698753%26genre%3Darticle%26aulast%3DOumata%26date%3D2008%26atitle%3DRoscovitine-Derived%252C%2BDual-Specificity%2BInhibitors%2Bof%2BCyclin-Dependent%2BKinases%2Band%2BCasein%2BKinases%2B1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D17%26spage%3D5229%26epage%3D5242%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer’s disease, production of amyloid-β peptides (extracellular plaques) and hyper-phosphorylation of Tau (intracellular neurofibrillary tangles). A series of 2,6,9-trisubstituted purines, structurally related to the CDK inhibitor roscovitine, have been synthesized. They mainly differ by the substituent on the C-6 position. These compounds were screened for kinase inhibitory activities and antiproliferative effects. Several biaryl derivatives displayed potent inhibition of both CDKs and CK1. In particular, derivative <b>13a</b> was a potent inhibitor of CDK1/cyclin B (IC<sub>50</sub>: 220 nM), CDK5/p25 (IC<sub>50</sub>: 80 nM), and CK1 (IC<sub>50</sub>: 14 nM). Modeling of these molecules into the ATP-binding pocket of CK1δ provided a rationale for the increased selectivity toward this kinase. <b>13a</b> was able to prevent the CK1-dependent production of amyloid-β in a cell model. CDK/CK1 dual-specificity inhibitors may have important applications in Alzheimer’s disease and cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein phosphorylation is catalyzed by protein kinases. The human kinome comprises 518 kinase genes: 40 atypical and 478 classical protein kinases. These latter consist of 338 serine/threonine kinases, 90 tyrosine kinases, and 50 sequences that lack a functional catalytic site.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Abnormalities in protein phosphorylation have been observed in numerous major human diseases, strongly encouraging the search for pharmacological inhibitors of protein kinases.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a></div><div class="NLM_p">Our laboratory has focused its efforts on the search for, optimization, and characterization of inhibitors of several disease-relevant kinases, such as cyclin-dependent kinases (CDKs), glycogen synthase kinases-3 (GSK-3),<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: Aβ, amyloid β peptide; β-APP, β-amyloid precursor protein; CDK, cyclin-dependent kinase; CK1, casein kinase 1; FCS, fetal calf serum; GSK-3, glycogen synthase kinase-3; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i> -tetrazolium.</p></div>  and casein kinases 1 (CK1). Inhibitors of CDKs have a great potential in the treatment of pathological conditions such as solid tumors, leukemia, neurodegenerative disorders (Alzheimer’s and Parkinson’s diseases, stroke, traumatic brain injury), renal diseases (polycystic kidney disease, glomerulonephritis), pain, inflammation, diabetes, and some viral diseases (reviewed in refs  <a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">8,9</a>). Inhibitors of GSK-3 are being studied for their potential use in Alzheimer’s disease, manic depression, diabetes, etc., (reviewed in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>). CK1s are less studied as therapeutic targets, but their implication in multiple physiological events and some human diseases (reviewed in ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>) provides a growing impetus for the discovery of selective CK1 inhibitors.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Purines represent a large family of biologically active molecules and constitute the scaffold of a wide variety of promising drugs, including kinase inhibitors (reviewed in refs <a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">13–15</a>). Among the large diversity of purines that have been synthesized, 2,6,9-trisubstituted purines have generated considerable interest as protein kinase inhibitors (reviewed in ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>). The most advanced molecule, roscovitine (or CYC202 or Seliciclib),<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(-17-19)</a> developed by Cyclacel Pharmaceuticals, is currently in phase 2b clinical trials against non-small cell lung cancer, in phase 2 against nasopharyngeal cancer, in phase 1 against various renal diseases (glomerulonephritis), and in preclinical evaluation against polycystic kidney disease,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Alzheimer’s disease (in preparation), stroke,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and inflammation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The metabolism of roscovitine, which is orally available, is well established. The main metabolic pathways are the oxidation of the alcohol of the C-2 side chain into a carboxylate group, the conjugation of a glucose or glucuronic acid residue on this alcohol, and the loss of the isopropyl group on N9.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Interestingly, the benzyl group has not been reported to be affected by metabolism. Although frequently considered as rather selective for some CDKs (CDK1, CDK2, CDK5, CDK7, CDK9), roscovitine interacts with several other targets, although with a lower affinity (DYRK1A, CK1, pyridoxal kinase).<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a></div><div class="NLM_p">All of this information first suggests that the trisubstituted purine motive of roscovitine remains an attractive scaffold to develop new derivatives with reasonable chances of generating useful bioactivity associated with moderate toxicity. Inhibitors should be selected more on the basis of their inhibitory profile on several key relevant kinases implicated in a particular pathology rather than on potent inhibition of a single target. For instance, in Alzheimer’s disease, hyperphosphorylation of Tau is carried out by a small set of kinases, CDK5, GSK3, and CK1 being the most important ones (reviewed in refs <a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">29,30</a>). In addition, amyloid-β formation from its β-amyloid precursor protein (β-APP) also involves CDK5,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> GSK-3,<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> and CK1.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus CDK1,<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> CDK5,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> GSK-3,<a onclick="showRef(event, 'ref32 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref32 ref40 ref41 ref42">(32, 40-42)</a> and CK1<a onclick="showRef(event, 'ref34 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref34 ref43 ref44 ref45">(34, 43-45)</a> all appear to be involved in the two diagnostic features of Alzheimer’s disease, amyloid-β production (responsible for formation of amyloid plaques) and Tau hyperphosphorylation (responsible for the formation of neurofibrillary tangles of paired helical filaments). Multitarget inhibitors acting on this selection of kinases could therefore become of great therapeutic value.</div><div class="NLM_p last">The aim of the present study was to synthesize and evaluate a series of trisubstituted purines that mainly differed by the C-6 substituent. The prepared compounds were evaluated on the four main kinases involved in Alzheimer’s disease, CDK1, CDK5, GSK-3, and CK1. This study uncovered CDK/CK1 dual specificity inhibitors, which should be evaluated for their potential therapeutic applications, especially in the Alzheimer’s disease field.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Most of the trisubstituted purine derivatives described herein were obtained following a three steps synthetic route outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Starting from commercially available 2,6-dichloropurine <b>1</b>, alkylation of N9 with 2-bromopropane provided 2,6-dichloro-9-isopropylpurine <b>2</b>. Displacement of the 6-chloro was accomplished either by Suzuki cross-coupling or by nucleophilic substitution with appropriate amines. In the last step, nucleophilic substitution of the 2-chlorine afforded the expected molecules. However, we failed to achieve the nucleophilic substitution of the 6-chlorine with anilines bearing a pyridyl group (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reaction of intermediate <b>2</b> with 4-bromoaniline afforded the corresponding amine <b>9</b>. Suzuki coupling of boronic ester with bromoderivative <b>9</b> did not lead to the expected biaryl but to compound <b>12</b>. Reaction of boranylanilines with <b>2</b> afforded the corresponding amines <b>10</b>, which subsequently reacted with bromopyridines to afford the expected biaryls <b>11</b>. Finally, reaction with amino-alcohols afforded the trisubstituted purines <b>13</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0006.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-bromopropane, K<sub>2</sub>CO<sub>3</sub>, DMSO 15−18 °C; (b) boronate, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (c) ArNH<sub>2</sub> or ArCH<sub>2</sub>NH<sub>2</sub>, NEt<sub>3</sub>, BuOH 100 °C; (d) RNH<sub>2</sub>, NBu<sub>3</sub>, DMSO, 165 °C.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0007.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArNH<sub>2</sub>, NEt<sub>3</sub>, BuOH 100 °C; (b) boronate, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (c) ArBr, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (d) RNH<sub>2</sub>, NBu<sub>3</sub>, DMSO 165 °C.</p></p></figure><div class="NLM_p last">The synthesis of a large number of 2,6,9-trisubstituted purines, including combinatorial methods, has been previously described.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46-50)</a> Generally, the synthesis of 2,6,9-trisubstituted purines start from commercially available 2,6-dichloropurine <b>1</b> and most authors start with the substitution on C6-position. We found easier to achieve first the preparation of the key intermediate <b>2</b>. Regiospecific N9 alkylation was achieved by precise control of the reaction temperature.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Biological Evaluation: Purified Protein Kinases</h3><div class="NLM_p">All synthesized compounds were evaluated for their potential inhibitory effects on purified kinases (CDK1/cyclin B, CDK5/p25, GSK-3α/β, CK1δ/ε) as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values were determined from dose−response curves and compared to those of the reference molecules, (<i>R</i>)-roscovitine <b>8a</b> and (<i>S</i>)-roscovitine <b>8b</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Purines <b>6a</b>−<b>8h</b> on Four Protein Kinases and on the Survival of SH-SY5Y and HEK293 Cells<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0008.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">Ar</th><th align="center" valign="middle">R</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK5</th><th align="center" valign="middle">GSK-3α/β</th><th align="center" valign="middle">CK1</th><th align="center" valign="middle">SH-SY5Y</th><th align="center" valign="middle">HEK293</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>6a</b></td><td align="left" valign="top">phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>50</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td></tr><tr valign="top"><td align="left" valign="top"><b>6b</b></td><td align="left" valign="top">3-pyridyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>50</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td></tr><tr valign="top"><td align="left" valign="top"><b>6c</b></td><td align="left" valign="top">4-pyridyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td><td align="left" valign="top">>10</td><td align="left" valign="top">>100</td><td align="left" valign="top">>100</td></tr><tr valign="top"><td align="left" valign="top"><b>7a</b></td><td align="left" valign="top">phenyl-2 -phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">29</td><td align="left" valign="top">17</td><td align="left" valign="top">>100</td><td align="left" valign="top">>50</td><td align="left" valign="top">29</td><td align="left" valign="top">6.6</td></tr><tr valign="top"><td align="left" valign="top"><b>7b</b></td><td align="left" valign="top">phenyl-3-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">1.1</td><td align="left" valign="top">0.4</td><td align="left" valign="top">>100</td><td align="left" valign="top">0.05</td><td align="left" valign="top">37.6</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>7c</b></td><td align="left" valign="top">phenyl-4-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="left" valign="top">0.23</td><td align="left" valign="top">0.1</td><td align="left" valign="top">90</td><td align="left" valign="top">0.08</td><td align="left" valign="top">26.8</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>7d</b></td><td align="left" valign="top">phenyl-3-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0.02</td><td align="left" valign="top">>100</td><td align="left" valign="top">0.6</td><td align="left" valign="top">11</td><td align="left" valign="top">15.6</td></tr><tr valign="top"><td align="left" valign="top"><b>7e</b></td><td align="left" valign="top">phenyl-4-phenyl</td><td align="left" valign="top">1-hydroxy-2-methylprop-2-yl</td><td align="left" valign="top">0.28</td><td align="left" valign="top">0.08</td><td align="left" valign="top">50</td><td align="left" valign="top">0.048</td><td align="left" valign="top">28.6</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>7f</b></td><td align="left" valign="top">phenyl-3-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.09</td><td align="left" valign="top">0.05</td><td align="left" valign="top">>10</td><td align="left" valign="top">0.6</td><td align="left" valign="top">11.6</td><td align="left" valign="top">16.8</td></tr><tr valign="top"><td align="left" valign="top"><b>8a</b></td><td align="left" valign="top">phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.35</td><td align="left" valign="top">0.20</td><td align="left" valign="top">>10</td><td align="left" valign="top">2.3</td><td align="left" valign="top">17.5</td><td align="left" valign="top">46.7</td></tr><tr valign="top"><td align="left" valign="top"><b>8b</b></td><td align="left" valign="top">phenyl</td><td align="left" valign="top">(<i>S</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.55</td><td align="left" valign="top">0.25</td><td align="left" valign="top">−</td><td align="left" valign="top">6.0</td><td align="left" valign="top">−</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>8c</b></td><td align="left" valign="top">2-pyridyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.74</td><td align="left" valign="top">1.00</td><td align="left" valign="top">14.5</td><td align="left" valign="top">7</td><td align="left" valign="top">165.1</td><td align="left" valign="top">190</td></tr><tr valign="top"><td align="left" valign="top"><b>8d</b></td><td align="left" valign="top">2-pyridyl</td><td align="left" valign="top">(<i>S</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">1.15</td><td align="left" valign="top">1.70</td><td align="left" valign="top">>33</td><td align="left" valign="top">13</td><td align="left" valign="top">−</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>8e</b></td><td align="left" valign="top">3-pyridyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.13</td><td align="left" valign="top">0.16</td><td align="left" valign="top">>10</td><td align="left" valign="top">2.2</td><td align="left" valign="top">7.7</td><td align="left" valign="top">20.5</td></tr><tr valign="top"><td align="left" valign="top"><b>8f</b></td><td align="left" valign="top">3-pyridyl</td><td align="left" valign="top">(<i>S</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.13</td><td align="left" valign="top">0.14</td><td align="left" valign="top">>10</td><td align="left" valign="top">4.1</td><td align="left" valign="top">−</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>8g</b></td><td align="left" valign="top">4-pyridyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.33</td><td align="left" valign="top">0.23</td><td align="left" valign="top">>10</td><td align="left" valign="top">2.0</td><td align="left" valign="top">64.8</td><td align="left" valign="top">73.7</td></tr><tr valign="top"><td align="left" valign="top"><b>8h</b></td><td align="left" valign="top">4-pyridyl</td><td align="left" valign="top">(<i>S</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.39</td><td align="left" valign="top">0.41</td><td align="left" valign="top">>10</td><td align="left" valign="top">2.2</td><td align="left" valign="top">−</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>8i</b></td><td align="left" valign="top">phenyl-3-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">3.2</td><td align="left" valign="top">2.60</td><td align="left" valign="top">>100</td><td align="left" valign="top">1.1</td><td align="left" valign="top">2.4</td><td align="left" valign="top">2.5</td></tr><tr valign="top"><td align="left" valign="top"><b>8j</b></td><td align="left" valign="top">phenyl-3-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.25</td><td align="left" valign="top">0.2</td><td align="left" valign="top">3.3</td><td align="left" valign="top">0.9</td><td align="left" valign="top">3.3</td><td align="left" valign="top">2.8.</td></tr><tr valign="top"><td align="left" valign="top"><b>8k</b></td><td align="left" valign="top">phenyl-3-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.12</td><td align="left" valign="top">0.08</td><td align="left" valign="top">>10</td><td align="left" valign="top">0.9</td><td align="left" valign="top">7.4</td><td align="left" valign="top">5.2</td></tr><tr valign="top"><td align="left" valign="top"><b>8l</b></td><td align="left" valign="top">phenyl-3-(4-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">1.6</td><td align="left" valign="top">1.6</td><td align="left" valign="top">58</td><td align="left" valign="top">1.2</td><td align="left" valign="top">6.5</td><td align="left" valign="top">20</td></tr><tr valign="top"><td align="left" valign="top"><b>8m</b></td><td align="left" valign="top">phenyl-4-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">0.13</td><td align="left" valign="top">0.13</td><td align="left" valign="top">12</td><td align="left" valign="top">0.6</td><td align="left" valign="top">0.43</td><td align="left" valign="top">0.56</td></tr><tr valign="top"><td align="left" valign="top"><b>8n</b></td><td align="left" valign="top">phenyl-4-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="left" valign="top">0.08</td><td align="left" valign="top">0.08</td><td align="left" valign="top">10</td><td align="left" valign="top">0.6</td><td align="left" valign="top">0.76</td><td align="left" valign="top">0.90</td></tr><tr valign="top"><td align="left" valign="top"><b>8o</b></td><td align="left" valign="top">phenyl-4-(2-pyridyl)</td><td align="left" valign="top">1-hydroxy-2-methylprop-2-yl</td><td align="left" valign="top">0.21</td><td align="left" valign="top">0.21</td><td align="left" valign="top">16</td><td align="left" valign="top">0.68</td><td align="left" valign="top">0.94</td><td align="left" valign="top">−</td></tr><tr valign="top"><td align="left" valign="top"><b>8p</b></td><td align="left" valign="top">phenyl-4-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">1.9</td><td align="left" valign="top">2.0</td><td align="left" valign="top">84</td><td align="left" valign="top">0.73</td><td align="left" valign="top">1.25</td><td align="left" valign="top">2.2</td></tr><tr valign="top"><td align="left" valign="top"><b>8q</b></td><td align="left" valign="top">phenyl-4-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="left" valign="top">0.9</td><td align="left" valign="top">0.9</td><td align="left" valign="top">6</td><td align="left" valign="top">0.7</td><td align="left" valign="top">0.74</td><td align="left" valign="top">0.76</td></tr><tr valign="top"><td align="left" valign="top"><b>8r</b></td><td align="left" valign="top">phenyl-4-(4-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">2.3</td><td align="left" valign="top">2.2</td><td align="left" valign="top">35.5</td><td align="left" valign="top">1.1</td><td align="left" valign="top">1.69</td><td align="left" valign="top">1.54</td></tr><tr valign="top"><td align="left" valign="top"><b>8s</b></td><td align="left" valign="top">phenyl-4-phenyl</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="left" valign="top">3.0</td><td align="left" valign="top">2.52</td><td align="left" valign="top">>100</td><td align="left" valign="top">0.8</td><td align="left" valign="top">0.75</td><td align="left" valign="top">1.33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Purines were tested at various concentrations on CDK1/cyclin B, CDK5/p25, GSK-3α/β, and CK1δ/ε, as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. The compounds were tested at various concentrations for their effects on SH-SY5Y and HEK293 cell survival after 48 h incubation as estimated using the MTS reduction assay. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. −: not tested. When IC<sub>50</sub> values are reported as >10, 33, or 100 μM, this indicates that the compound did not display any inhibitory activity at the highest concentration tested (10, 33, or 100 μM). Some compounds were essentially inactive at 10 μM (indicated as >10 μM), they were not tested at higher concentrations. Some displayed a small but significant inhibition at this concentration and were thus tested up to 100 μM, when solubility was not an issue. <b>8a</b>, (<i>R</i>)-roscovitine; <b>8b</b>, (<i>S</i>)-roscovitine; <b>8m</b>, (<i>R</i>)-C&R8.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Purines <b>12</b> on Four Protein Kinases and on the Survival of SH-SY5Y and HEK293 Cells<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0009.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">Ar</th><th align="center" valign="middle" char=".">CDK1</th><th align="center" valign="middle" char=".">CDK5</th><th align="center" valign="middle" char=".">GSK-3α/β</th><th align="center" valign="middle" char=".">CK1</th><th align="center" valign="middle" char=".">SH-SY5Y</th><th align="center" valign="middle" char=".">HEK293</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>12a</b></td><td align="left" valign="top">3-pyridyl</td><td align="char" valign="top" char=".">0.41</td><td align="char" valign="top" char=".">0.73</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">0.091</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">−</td></tr><tr valign="top"><td align="left" valign="top"><b>12b</b></td><td align="left" valign="top">4-pyridyl</td><td align="char" valign="top" char=".">0.59</td><td align="char" valign="top" char=".">0.6</td><td align="char" valign="top" char=".">>100</td><td align="char" valign="top" char=".">0.083</td><td align="char" valign="top" char=".">60</td><td align="char" valign="top" char=".">−</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Purines were tested at various concentrations on CDK1/cyclin B, CDK5/p25, GSK-3α/β, and CK1δ/ε, as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. The compounds were tested at various concentrations for their effects on SH-SY5Y and HEK293 cell survival after 48 h incubation as estimated using the MTS reduction assay. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. −: not tested. When IC<sub>50</sub> values are reported as >10, 33, or 100 μM, this indicates that the compound did not display any inhibitory activity at the highest concentration tested (10, 33, or 100 μM). Some compounds were essentially inactive at 10 μM (indicated as >10 μM), they were not tested at higher concentrations. Some displayed a small but significant inhibition at this concentration and were thus tested up to 100 μM, when solubility was not an issue.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Purines <b>13</b> on Four Protein Kinases and on the Survival of SH-SY5Y and HEK293 Cells<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0010.gif" alt="" id="gr6" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">Ar</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">CDK1</th><th align="center" valign="middle" char=".">CDK5</th><th align="center" valign="middle" char=".">GSK-3α/β</th><th align="center" valign="middle" char=".">CK1</th><th align="center" valign="middle" char=".">SH-SY5Y</th><th align="center" valign="middle">HEK293</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>13a</b></td><td align="left" valign="top">phenyl-3-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)- 1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.22</td><td align="char" valign="top" char=".">0.08</td><td align="char" valign="top" char=".">4.1</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">17.2</td><td align="left" valign="top">–</td></tr><tr valign="top"><td align="left" valign="top"><b>13b</b></td><td align="left" valign="top">phenyl-3-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="char" valign="top" char=".">0.18</td><td align="char" valign="top" char=".">0.08</td><td align="char" valign="top" char=".">5.1</td><td align="char" valign="top" char=".">0.031</td><td align="char" valign="top" char=".">16.8</td><td align="left" valign="top">–</td></tr><tr valign="top"><td align="left" valign="top"><b>13c</b></td><td align="left" valign="top">phenyl-3-(2-pyridyl)</td><td align="left" valign="top">1-hydroxy-2-methylprop-2-yl</td><td align="char" valign="top" char=".">0.48</td><td align="char" valign="top" char=".">0.16</td><td align="char" valign="top" char=".">4.9</td><td align="char" valign="top" char=".">0.020</td><td align="char" valign="top" char=".">16.0</td><td align="left" valign="top">–</td></tr><tr valign="top"><td align="left" valign="top"><b>13d</b></td><td align="left" valign="top">phenyl-3-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.18</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">60</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">15.4</td><td align="left" valign="top">–</td></tr><tr valign="top"><td align="left" valign="top"><b>13e</b></td><td align="left" valign="top">phenyl-3-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">0.01</td><td align="char" valign="top" char=".">13</td><td align="char" valign="top" char=".">0.08</td><td align="char" valign="top" char=".">7.5</td><td align="left" valign="top">9.2</td></tr><tr valign="top"><td align="left" valign="top"><b>13f</b></td><td align="left" valign="top">phenyl-3-(4-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.18</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">20</td><td align="char" valign="top" char=".">0.11</td><td align="char" valign="top" char=".">15.8</td><td align="left" valign="top">11.6</td></tr><tr valign="top"><td align="left" valign="top"><b>13g</b></td><td align="left" valign="top">phenyl-4-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">0.03</td><td align="char" valign="top" char=".">40</td><td align="char" valign="top" char=".">0.13</td><td align="char" valign="top" char=".">10</td><td align="left" valign="top">10.4</td></tr><tr valign="top"><td align="left" valign="top"><b>13h</b></td><td align="left" valign="top">phenyl-4-(2-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="char" valign="top" char=".">0.06</td><td align="char" valign="top" char=".">0.05</td><td align="char" valign="top" char=".">90</td><td align="char" valign="top" char=".">0.4</td><td align="char" valign="top" char=".">17.5</td><td align="left" valign="top">14.6</td></tr><tr valign="top"><td align="left" valign="top"><b>13i</b></td><td align="left" valign="top">phenyl-4-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.18</td><td align="char" valign="top" char=".">0.02</td><td align="char" valign="top" char=".">7.5</td><td align="char" valign="top" char=".">0.22</td><td align="char" valign="top" char=".">6.5</td><td align="left" valign="top">7.4</td></tr><tr valign="top"><td align="left" valign="top"><b>13j</b></td><td align="left" valign="top">phenyl-4-(3-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="char" valign="top" char=".">0.18</td><td align="char" valign="top" char=".">0.02</td><td align="char" valign="top" char=".">8.0</td><td align="char" valign="top" char=".">0.63</td><td align="char" valign="top" char=".">8.9</td><td align="left" valign="top">8.3</td></tr><tr valign="top"><td align="left" valign="top"><b>13k</b></td><td align="left" valign="top">phenyl-4-(4-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-but-2-yl</td><td align="char" valign="top" char=".">0.02</td><td align="char" valign="top" char=".">0.02</td><td align="char" valign="top" char=".">1.9</td><td align="char" valign="top" char=".">0.23</td><td align="char" valign="top" char=".">7</td><td align="left" valign="top">8</td></tr><tr valign="top"><td align="left" valign="top"><b>13l</b></td><td align="left" valign="top">phenyl-4-(4-pyridyl)</td><td align="left" valign="top">(<i>R</i>)-1-hydroxy-3-methylbut-2-yl</td><td align="char" valign="top" char=".">0.03</td><td align="char" valign="top" char=".">0.02</td><td align="char" valign="top" char=".">12</td><td align="char" valign="top" char=".">1.2</td><td align="char" valign="top" char=".">6.6</td><td align="left" valign="top">6.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Purines were tested at various concentrations on CDK1/cyclin B, CDK5/p25, GSK-3α/β, and CK1δ/ε, as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. The compounds were tested at various concentrations for their effects on SH-SY5Y and HEK293 cell survival after 48 h incubation as estimated using the MTS reduction assay. IC<sub>50</sub> values, calculated from the dose−response curves, are reported in μM. −: not tested. When IC<sub>50</sub> values are reported as >10, 33, or 100 μM, this indicates that the compound did not display any inhibitory activity at the highest concentration tested (10, 33, or 100 μM). Some compounds were essentially inactive at 10 μM (indicated as >10 μM), they were not tested at higher concentrations. Some displayed a small but significant inhibition at this concentration and were thus tested up to 100 μM, when solubility was not an issue.</p></div></div></div><div class="NLM_p">All three 6-aryl-substituted purines (<b>6a</b>, <b>6b</b>, <b>6c</b>) were completely inactive, confirming the essential hydrogen bond donating N6 present in all active purines.<a onclick="showRef(event, 'ref18 ref19 ref52'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref52">(18, 19, 52)</a> All other compounds showed submicromolar activities on CDK1 and CDK5. The substituent in C2-position had generally limited influence. The most potent inhibitors were the biarylanilines series <b>13</b> with the pyridine nucleus meta to the amine. In contrast, all roscovitine analogues remained either inactive or poorly active on GSK-3 (IC<sub>50</sub> in the 2−50 μM range), despite the observation that many CDK inhibitors are also excellent GSK-3 inhibitors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> IC<sub>50</sub> values for CDK1 and CDK5 were very similar, a likely consequence of the close similarity of both kinases, especially in their ATP-binding site.</div><div class="NLM_p last">Results showed the appearance of significant CK1 inhibitory activity among many derivatives or analogues of roscovitine (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), especially compounds <b>13a</b>−<b>13f</b>. The most potent CK1 inhibitors shared a biaryl substituent on N6. (<i>R</i>)-DRF053 (<b>13a</b>) was the most potent inhibitor of CK1 (IC<sub>50</sub>: 0.014 μM), compared to (<i>R</i>)-roscovitine (<b>8a</b>) (IC<sub>50</sub>: 2.3 μM). In fact, <b>13a</b> appears to be one of the most potent known inhibitor of CK1.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Modeling of the CK1/Purine Interactions</h3><div class="NLM_p">The conversion of (<i>R</i>)-roscovitine (<b>8a</b>) to C&R8 (<b>8m</b>) and then to DRF053 (<b>13a</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) showed a gradual improvement of biological activity toward CK1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Enhanced affinity of <b>13a</b> was also demonstrated for CDK1 and CDK5, however to a lesser degree. To provide a structural rationale for this biological data, we tried to locate and evaluate differences in the interaction mode of these analogues with the two groups of kinases. A sequence alignment of CDK1, CDK2, CDK5, and various isoforms of CK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) showed that there are several important variations of residues located in the vicinity of the ATP binding pocket between the CDKs and the CK1 isoforms. These variations are located either at the ribose binding site or at the glycine loop. More specifically, at the ribose site Asp86<sup>CDK2</sup>, an important residue that in many cases interacts directly either with the natural substrate (ATP-CDK2; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1B38">1B38</a>) or with inhibitors (roscovitine-CDK5; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNL">1UNL</a>) is replaced by a serine (Ser88<sup>CK1-δ</sup>). Moreover, Lys89<sup>CDK2</sup> is replaced by an aspartate in the CK1 isoforms (Asp91<sup>CK1-δ</sup>). Two additional residue variations appear at the glycine loop: Glu8<sup>CDK2</sup> is replaced by a basic residue, arginine in CK1-α, -δ (Arg13<sup>CK1-δ</sup>), and -ε isoforms and lysine in CK1-γ1, -γ2, and -γ3 isoforms. Lys20<sup>CDK2</sup> is replaced by a leucine in CK1 (Leu25<sup>CK1-δ</sup>).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and DRF053 (<b>13a</b>). IC<sub>50</sub> values for CDK5/p25 and CK1 are indicated under each structure in μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. An alignment of the sequences of CDK1, 2, and 5 and five isoforms of CK1. Identical residues are enclosed in red-filled boxes and similar residues in blue-bordered boxes. The red arrow indicates Arg13<sup>CK1-δ</sup>. This position is occupied by a basic residue, arginine or lysine, in all CK1 isoforms, while in the CDKs, it is a glutamate. A favorable interaction between this residue and the pyridinyl ring of C&R8 (<b>8m</b>) and <b>13a</b> in CK1, and its absence in the CDKs could account for the specificity gain of the latter two analogues with respect to roscovitine for CK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Docking of <b>13a</b> in CK1-δ resulted in two distinct binding modes. In both of them, the usually observed adenine type interaction between the ligand and the receptor was sustained with purine N6 donating and N7 receiving a hydrogen bond from the receptor backbone of the binding cavity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A−B). However, two possible orientations of the 3-pyridinylphenylamino moiety were obtained. The first binding mode is characterized by a mixed hydrogen bond stacking interaction of pyridine with the side chain of Arg16 of the glycine loop. The pyridine nitrogen forms a hydrogen bond with the guanidine moiety, while the phenyl ring is oriented parallel to Arg guanidinium, stabilized through a π−π interaction (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). In the second binding mode, the phenylamino N6−C1′ bond demonstrates a ∼60° rotation, which orients the 3-pyridinylphenylamino group toward the C-terminal lobe where it forms hybrophobic interactions with Pro87<sup>CK1-δ</sup> and stacking with Phe95<sup>CK1-δ</sup>. Docking of <b>8m</b> in CK1-δ (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C) resulted in two binding poses that were similar to the structures, which resulted in the case of <b>13a-</b>CK1-δ complex.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Overall structure of CK1-δ complexed with analogue <b>13a</b> (magenta). The kinase is depicted as a ribbon and colored according to its secondary structure (red: α helix; cyan: beta-sheet; gray: random coil). (B) Analogue <b>13a</b> docked in the ATP-binding pocket of CK1-δ. The hydrogen bonds formed between the ligand and the kinase backbone as well as with the side chain of Arg13 are depicted as yellow dashed lines. The gatekeeper residue Met82 near the hydrophobic cavity of the pocket is also visible. (C) Analogue <b>8m</b> docked in the ATP-binding pocket of CK1-δ. Same representation as in (B). (D) (<i>R</i>)-Roscovitine <b>8a</b> docked in the ATP-binding pocket of CK1-δ. While the two hydrogen bonds formed with the receptor backbone are present, Arg13 does not interact with the ligand and adopts a different orientation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The favorable interaction of pyridine with Arg13<sup>CK1-δ</sup> proposed by the first binding mode of both <b>13a</b> and <b>8m</b>, which does not exist in the case of roscovitine <b>8a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D), could provide an explanation of the improved affinity of 3- and 4-pyridinyl substituted analogues with respect to CK1. In the case of CDKs, the corresponding residue of Arg13<sup>CK1-δ</sup> is a conserved acidic residue (Glu8<sup>CDK1, 2, 5</sup>) with no capacity to act either as a hydrogen bond donor or as a stacking partner for pyridine. A 2-aromatic substituted pyridine (calculated p<i>K</i><sub>a</sub> 4.25) can accommodate mainly π−π aromatic stacking and cation−π interactions or hydrogen bonds where pyridine nitrogen serves as hydrogen bond acceptor (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B−C). The absence of an interaction in the CDKs similar to that between pyridine and Arg13<sup>CK1-δ</sup> in CK1 explains the fact that <b>8m</b> does not demonstrate an improved affinity for CDK1 and CDK5. However, the increased binding affinity of <b>13a</b> toward both CK1 and CDKs with respect to <b>8m</b> could not be interpreted by docking calculations but only by considering the alteration of N6 stereoelectronic properties. The conversion of the 4-pyridinylbenzyl substitution of <b>8m</b> N6 to a 3-pyridinylphenyl in <b>13a</b> increases the hydrogen bonding potential of N6. This is caused by the increased polarization of the N−H bond resulting from the enhancement of the sp2 character of the N6 of <b>13a</b>, which carries two aromatic substitutions compared to analogue <b>8m</b>. An ab initio single-point energy calculation of <b>13a</b> and <b>8m</b> at the B3LYP/6-31+G* level validated the aforementioned hypothesis. The gap between the negative partial charge of nitrogen and the positive charge of hydrogen is 1.14e for <b>13a</b> and 0.58e for <b>8m</b>. The stronger hydrogen bonding potential of <b>13a</b> N6H is consistent with experimental data showing that <i>N</i>-methylaniline exhibits half of the hydrogen bond acidity compared to diphenylamine.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> To reproduce this experimental result theoretically in our system and further examine the influence of substitutions on the hydrogen bonding potential of secondary amines, we have performed ab initio interaction energy calculations. The second-order Møller−Plesset perturbation theory method was chosen in order to include electron correlation effects and obtain accurate results. Interaction energy calculations of the complexes of diphenylamine−CK1 and <i>N</i>-methylaniline−CK1 were performed. The results obtained at the MP2/6-31+G* level showed that the interaction energy was 1.07 kcal/mol more favorable in the case of the diphenylamine−receptor complex. The experimental ΔΔ<i>G</i> between <b>13a</b> and <b>8m</b>, which is in the range of 1.45−1.97 kcal/mol, is in very good agreement with the above calculated values, considering the approximations for the ab initio calculations (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). These results suggest that the improved affinity of <b>13a</b>, where N6 carries two aromatic substituents, compared to that of <b>8a</b>, with only one aromatic substituent, could be mainly attributed to the enthalpic gain offered by the hydrogen bond formed between N6 and the protein backbone carbonyl.</div><div class="NLM_p last">The dual CDK−CK1 specificity character gained by analogues <b>13a</b> and <b>8m</b> with respect to roscovitine can be considered as a combined result of the favorable interactions provided by the 3- or 4-pyridinyl substitution toward CK1 and the enhanced hydrogen bonding potential of N6 carrying two aromatic substituents toward both CDK and CK1 receptors.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Evaluation: Cell Proliferation Assays</h3><div class="NLM_p">All compounds were tested for their antiproliferative effects. Human neuroblastoma SH-SY5Y and human embryonic kidney cells were exposed for 48 h to various concentrations of each compound. Viability was then estimated by the MTS reduction assay as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The three 6-aryl-substituted purines (<b>6a</b>, <b>6b</b>, <b>6c</b>) and compounds <b>8c</b> and <b>12a</b> were completely inactive. All other compounds displayed significant cell death inducing activity, the IC<sub>50</sub> values ranging from 0.43 to 65 μM.</div><div class="NLM_p">Structure−activity relationships based on CDKs and CK1 inhibition were difficult to correlate with the antiproliferative effects determined on both cell lines. For example, biarylmethyamines compounds (e.g., compounds <b>8m</b> and <b>8n</b>), which displayed the highest antiproliferative effects (on SH-SY5Y cell line, IC<sub>50</sub> values were 0.43 and 0.76 μM, respectively), were far from being the most potent kinase inhibitors. Further, another interesting aspect of the SAR studies was the observation that the replacement of an heterobiaryl moiety in <b>8m</b> and <b>8n</b> by a biphenyl in <b>8s</b> reduced the inhibitory potency on CDK1 and CDK2 (IC<sub>50</sub> >2 μM). Nevertheless, a potent antiproliferative effect was observed with this compound.</div><div class="NLM_p">Altogether, the synthesized compounds can be divided in three groups in terms of biological activity (kinase and cell survival):</div><div class="NLM_p">(1) Inactive on both kinases and cell proliferation: compounds <b>6a</b>−<b>6c</b>.</div><div class="NLM_p">(2) Active on both kinases and cell proliferation: the biarylmethylamine series (compounds <b>8i</b>−<b>8s</b>) demonstrated high antiproliferative action, which contrasted with variable enzyme inhibition. No clear correlation could be established between kinase inhibition and antiproliferative effects. Different cellular properties (cell permeability, intracellular stability, intracellular distribution, or targets) may account for this lack of direct correlation. The <b>8i</b>−<b>8s</b> series of molecules could be developed as potential anticancer agents. As an illustration, we have investigated in detail the cellular effects of the most active compound, <b>8m</b> (C&R8)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a>.</div><div class="NLM_p last">(3) Active on kinases but poor antiproliferative activity: the biarylamine type compounds (series <b>13</b>) were highly potent CDK/CK1 inhibitors but displayed low antiproliferative effect. As a general rule, CK1 inhibition inversely correlated with antiproliferative activity. This series of molecules could be developed as protective agents, especially against neurodegenerative diseases, as illustrated below with compound <b>13a</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Biological Evaluation: Inhibition of Amyloid-β Production</h3><div class="NLM_p">Recently, CK1 was demonstrated to regulate the production of amyloid-β (Aβ) formation and CK1 inhibitors to prevent Aβ production.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To test whether our molecules could act as CK1 inhibitors in a cellular system, we exposed N2A cells stably expressing amyloid-β precursor protein (APP) (N2A-APP<sub>695</sub> cells) to various concentrations of the selection of three compounds, (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and (<i>R</i>)-DRF053 (<b>13a</b>), for a 3 h period. Cell supernatants were then collected and A-β40 levels measured by an ELISA assay. Results show a dose-dependent inhibitory effect on A-β40 production for the three compounds, (<i>R</i>)-DRF053 (<b>13a</b>) being the most efficient (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Although these results might suggest that the three compounds are able to inhibit CK1 in a cellular context, leading to reduced production of amyloid-β from the amyloid-β precursor protein, this needs to be formally demonstrated and there are alternative explanations, including an effect through other targets (kinases and non-kinases). The use of chemically different CK1 inhibitors, specific siRNAs, and compounds that do not affect other kinases than CK1, will shed some light on the link between CK1 and amyloid-β production.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent inhibition of amyloid-β production in N2A-APP<sub>695</sub> cells by (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and (<i>R</i>)-DRF053 (<b>13a</b>). N2A cells stably expressing APP-695 were incubated in the absence or presence of various concentrations of (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and (<i>R</i>)-DRF053 (<b>13a</b>). Cell supernatants were collected after 3 h of incubation and subjected to Aβ40 ELISA assays. Data from at least three experiments (mean ± SEM) were compared (GraphPad Prism v4.0) with the control conditions (DMSO). (*: <i>P</i> < 0.05; **: <i>P</i> < 0.01; ***: <i>P</i> < 0.001; one-tailed Student’s <i>t</i> test, 95% significance level).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, the introduction of a biarylamine or a biarylmethylamine on the 6 position of the purine system led to potent inhibitors of CDKs. Unexpectedly, some compounds displayed potent inhibition of CK1 as well. Docking calculations suggested that potency enhancement toward the CDKs and CK1 result from interactions between the protein binding pocket and two separate parts of the inhibitor molecule. Introducing a substituent at purine position 6 that can interact favorably with an arginine (or alternatively a lysine) located in the glycine loop of CK1α, γ, δ, and ε isoforms takes advantage of the conserved variation of this residue in the CDKs and inhibitors like <b>8m</b> gain 1 order of magnitude in potency with respect to CK1 compared to roscovitine. Further improvement of potency but in a common trend in both families of kinases is achieved by the transformation of the biarylmethylamine substituent of purine position 6 to a biarylamine. The amine group attached at position 6 acts as a hydrogen bond donor that stabilizes the protein−inhibitor complex. The bond formed in the case of the biarylamines is stronger than that formed in the case of the biarylmethylamine analogues. The stronger bonding potential of biarylamines like <b>13a</b> was confirmed with a high level ab initio interaction energy calculation.</div><div class="NLM_p last">As both CK1 and CDK families of kinases are involved in the development of Alzheimer’s disease, these modifications on the 2,6,9-trisubstituted purines deserve to be further explored in terms of both pharmacological tools for the study of neurodegeneration pathways in cellular and animal models and possibly for potential therapeutic applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Methods</h4><div class="NLM_p last">Melting points were determined on a Kofler hot-stage (Reichert) and are uncorrected. NMR spectra were recorded on Bruker Avance 400 MHz (100 MHz for <sup>13</sup>C NMR). Chemical shifts are given in ppm downfield of tetramethylsilane (TMS) used as an internal standard. Infrared spectra were recorded on a FTIR Schimadzu 8300. Reactions were monitored by TLC using Merk silica gel 60F-254 thin layer plates. Column chromatography was carried out on SDS Chromagel 60 ACC, 40−63 μm. The HPLC analyses were carried out on a system consisting of a Waters 600 system controller, a Jones Chromatography heater−chiller oven, and a Waters 994 photodiode array detector. Microanalysis (C, H, N) of compounds <b>6</b>, <b>7</b>, <b>8</b>, and <b>13</b> agreed (±0.4) with calculated values. Biarylamines were prepared by Suzuki−Myaura coupling.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Results of compounds microanalysis are presented in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2,6-Dichloro-9-iso-propylpurine (<b>2</b>)</h4><div class="NLM_p last">To a solution of 2,6-dichloro-9<i>H</i>-purine <b>1</b> (9.00 g, 47.6 mmol) in DMSO (50 mL) at 15 °C was added K<sub>2</sub>CO<sub>3</sub> (19.74 g, 142.8 mmol) and 2-bromopropane (21.85 mL, 238 mmol). After 8 h stirring at 15−18 °C, water was added and the solution was extracted with AcOEt. The organic layers were assembled, washed with H<sub>2</sub>O (3 × 20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and chromatographed on a silica gel column (Cyclohexane/AcOEt 1:9) to yield a white solid (7.80 g, 71%); mp 149−152 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.65 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.91 (hept, 1H, <i>J</i> = 6.8 Hz, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 8.17 (s, 1H, H-8).</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Synthesis of 6-Aryl-2-chloropurines (<b>3</b>)</h3><div class="NLM_p">To solution of <b>2</b> (2.31 g, 10 mmol) in 40 mL dioxane under argon were added Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub> (0.575 g, 0.5 mmol). After 5 min stirring under N<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3</sub> aqueous solution (20 mL) and pinacolboronate derivatives (11 mmol) were added. The reaction mixture was refluxed under N<sub>2</sub> for 6 h and then cooled to room temperature. The mixture was concentrated in vacuo to half of its initial volume and extracted with AcOEt (3 × 15 mL). The combined organic extracts were washed with H<sub>2</sub>O and brine and then dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed in vacuo. Compounds <b>3</b> crystallized upon trituration with cyclohexane.</div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-Chloro-6-phenyl-9-iso-propylpurine (<b>3a</b>)</h4><div class="NLM_p last">Yield 87%, mp 112−113 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.66 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.97 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.54−7.67 (m, 3H, H<sub>phenyl</sub>), 7. 75−7.90 (m, 2H, H<sub>phenyl</sub>), 8.17 (s, 1H, H-8).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-Chloro-6-(3-pyridyl)-9-iso-propylpurine (<b>3b</b>)</h4><div class="NLM_p last">Yield 53%, mp 163−164 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.66 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.97 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.30 (m, 1H, H<sub>pyridyl</sub>), 7.90 (m, 2H, H<sub>pyridyl</sub>), 8.22 (s, 1H, H-8), 8.65 (d, 1H, H<sub>pyridyl</sub>).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-Chloro-6-(4-pyridyl)-9-iso-propylpurine (<b>3c</b>)</h4><div class="NLM_p last">Yield 76%, mp 145−148 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.66 (d, 6H, <i>J</i> = 6.8 Hz, CH(CH<sub>3</sub>)<sub>2</sub>), 4.97 (hept, 1H, CH(CH<sub>3</sub>)<sub>2</sub>), 8.22 (s, 1H, H-8), 8.63 (bd, 2H, <i>J</i> = 5.5 Hz, H<sub>pyridyl</sub>), 8.82 (bd, 2H, H<sub>pyridyl</sub>).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Synthesis of 6-Amino-2-chloropurines (Preparation of Compounds <b>4</b>, <b>5</b>, <b>9</b>, <b>10</b>)</h3><div class="NLM_p">To a solution of <b>2</b> (2.31 g, 10 mM) in 15 mL <i>n</i>-BuOH was added the primary amine (12 mM) and NEt<sub>3</sub> (2.20 mL, 16 mM). After 2 h heating at 100 °C, <i>n</i>-BuOH was evaporated in vacuo. To the residue, 10 mL water were added and this mixture was extracted with AcOEt (3 × 20 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent was removed in vacuo. The residue was chromatographied on a silica gel column using (CH<sub>2</sub>Cl<sub>2</sub>/AcOEt, various ratio) as eluent.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-Chloro-6-(2-phenylphenylamino)-9-iso-propylpurine (<b>4a</b>)</h4><div class="NLM_p last">Yield 56%, mp 68 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.66 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.97 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 6.90−7.47(m, 10H, H<sub>phenyl</sub>), 8.22(s, 1H, H-8).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-Chloro-6-(3-phenylphenylamino)-9-iso-propylpurine (<b>4b</b>)</h4><div class="NLM_p last">Yield 75%, mp 117−119 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.66 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.97 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 6.90−7.35 (m, 10H, H<sub>phenyl</sub>), 8.22 (s, 1H, H-8).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Chloro-6-(4-phenylphenylamino)-9-iso-propylpurine (<b>4c</b>)</h4><div class="NLM_p last">Yield 65%, mp 123−126 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.54 (d, 6H, <i>J</i> = 6 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.82 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.25−7.82(m, 10H, H<sub>phenyl</sub>), 8.10(s, 1H, H-8).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-Chloro-6-[(2-pyridyl)methylamino]-9-iso-propylpurine (<b>5a</b>)</h4><div class="NLM_p last">Yield 45%, mp 67−69 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.49 (d, 6H, <i>J</i> = 6.6 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.55 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.88 (bs, 2H, NHC<i>H</i><sub><i>2</i></sub>), 6.53(bs, 1H, N<i>H</i>), 7.10 (dd, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 5.0 Hz, H<sub>pyridyl</sub>), 7.29 (d, 1H, H<sub>pyridyl</sub>), 7.47 (s, 1H, H-8), 7.54 (td, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 1.8 Hz, H<sub>pyridyl</sub>), 8.48 (dd, 1H, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Chloro-6-[(3-pyridyl)methylamino]-9-iso-propylpurine (<b>5b</b>)</h4><div class="NLM_p last">Yield 56%, mp 184−186 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.58 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.83 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.85−4.90 (m, 2H, NHC<i>H</i><sub><i>2</i></sub>), 6.22 (bs, 1H, N<i>H</i>), 7.24−7.29 (m, 1H, H<sub>pyridyl</sub>) 7.73 (m, 1H, H<sub>pyridyl</sub>), 7.78 (s, 1H, H-8), 8.54 (m, 1H, H<sub>pyridyl</sub>), 8.66 (bs, 1H, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Chloro-6-[(4-pyridyl)methylamino]-9-iso-propylpurine (<b>5c</b>)</h4><div class="NLM_p last">Yield 77%, mp 120−122 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.58 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.84 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.85−4.91 (m, 2H, NHC<i>H</i><sub>2</sub>), 6.25 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.29 (d, 2H, H<sub>pyridyl</sub>), 7.80 (s, 1H, H-8), 8.56 (d, 2H, <i>J</i> = 5.6 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Chloro-6-[3-(phenyl)phenylmethylamino]-9-iso-propylpurine (<b>5d</b>)</h4><div class="NLM_p last">Yield 45%, mp 105−107 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.35 (d, 6H, <i>J</i> = 6.7 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.80 (bs, 2H, NHC<i>H</i><sub><i>2</i></sub>), 7.26−7.49 (m, 10H, H<sub>phenyl</sub>), 7.82 (s, 1H, H-8).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Chloro-6-[4-(phenyl)phenylmethylamino]-9-iso-propylpurine (<b>5e</b>)</h4><div class="NLM_p last">Yield 32%, mp 98−101 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.57 (d, 6H, <i>J</i> = 6.7 Hz, CH(CH<sub>3</sub>)<sub>2</sub>) 4.64 (hept, 1H, <i>J</i> = 6.8 Hz, CH(CH<sub>3</sub>)<sub>2</sub>), 4.82 (bs, 2H, NHCH<sub>2</sub>), 6.65 (brs, 1H, NH); 7.30−7.34 (m, 1H, H<sub>phenyl</sub>), 7.44 (t, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.52−7.63 (m, 5H, H<sub>phenyl</sub> + H-8), 7.81−7.84 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Chloro-6-[3-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5f</b>)</h4><div class="NLM_p last">Yield 44%, mp 120−122 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.34 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.78 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>); 4.86 (bs, 2H, NHC<i>H</i><sub><i>2</i></sub>), 5.80 (brs, 1H, NH); 7.23 (m, 2H, H<sub>pyridyl</sub>), 7.80 (dd, 1H, H<sub>pyridyl</sub>), 7.38−7.65 (m, 5H, H<sub>phenyl</sub> + H-8), 8.63 (d, 1H, <i>J =</i> 2.5 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Chloro-6-[3-(3-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5g</b>)</h4><div class="NLM_p last">Yield 65%, mp 115−117 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.55 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.81 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.90 (d, 2H, NHC<i>H</i><sub>2</sub>), 6.66 (bs, 1H, N<i>H</i>), 7.30 (dd, 1H, <i>J</i> = 2.8, 8 Hz, H<sub>pyridyl</sub>), 7.41−7.52 (m, 3H, H<sub>phenyl</sub>), 7.61 (s, 1H, H-8), 7.69 (s, 1H, H<sub>phenyl</sub>), 7.86 (dd, 1H, <i>J</i> = 1.6 and <i>J</i>′ = 8 Hz, H<sub>pyridyl</sub>), 8.59 (dd, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 4.8 Hz, H<sub>pyridy<i>l</i></sub>), 8.85 (d, 1H, <i>J</i> = 2.4 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Chloro-6-[3-(4-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5h</b>)</h4><div class="NLM_p last">Yield 48%, mp 145−148 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.58 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.79 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.85 (bs, 2H, NHC<i>H</i><sub>2</sub>), 6.59 (bs, 1H, N<i>H</i>), 7.20−7.49 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>) 7.65(dd, 2H, pyridyl), 7.76 (s, 1H, 8-H), 7.98 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.79(dd, 2H, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Chloro-6-[4-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5i</b>)</h4><div class="NLM_p last">Yield 56%, mp 176−179 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.58 (d, 6H, <i>J</i> = 6.8 Hz, CH(<i>CH</i><sub><i>3</i></sub>)<sub>2</sub>), 4.79 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.85 (bs, 2H, NHC<i>H</i><sub>2</sub>), 6.59 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.20−7.23 (m, 1H, H<sub>pyridyl</sub>), 7.49 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.73−7.71 (m, 2H, H<sub>pyridyl</sub>), 7.79 (s, 1H, H-8), 7.98 (d, 2H, <i>H</i><sub>pheny<i>l</i></sub>), 8.71 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Chloro-6-[4-(3-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5j</b>)</h4><div class="NLM_p last">Yield 68%, mp 158−160 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.56 (d, 6H, <i>J</i> = 7.2 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.84 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.88 (bs, 2H, NHC<i>H</i><sub>2</sub>), 7.37 (dd, 1H, <i>J</i> = 2.8 Hz and <i>J</i>′ = 7.6 Hz, H<sub>pyridyl</sub>), 7.52 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.57 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.80 (s, 1H, H-8), 7.82 (dt, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 8.4 Hz, H<sub>pyridyl</sub>), 8.60 (d, 1H, <i>J</i> = 3.6 Hz, H<sub>pyridyl</sub>), 8.84 (d, 1H, <i>J</i> = 1.6, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Chloro-6-[4-(4-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>5k</b>)</h4><div class="NLM_p last">Yield 56%, mp 127−132 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.53 (d, 6H, <i>J</i> = 7 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.84 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.88 (bs, 2H, NHC<i>H</i><sub>2</sub>), 7.52 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.57 (d, 2H, H<sub>phenyl</sub>), 7.80 (s, 1H, H-8), 7.62 (dd, 2H, H<sub>pyridyl</sub>), 8.82 (dd, 2H, H<sub>pyridyl</sub>).</div></div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Amination by Nucleophilic Substitution of the 2 Chlorine. Preparation of <b>6</b>, <b>7</b>, <b>8</b>, and <b>13</b></h3><div class="NLM_p">A mixture of compound <b>3</b>, <b>4</b>, <b>5</b>, or <b>11</b>, (2 mmol), NBu<sub>3</sub> (10 mmol), amino-alcohol (10 mmol), and DMSO 0.5 mL was heated at 165 °C for 3 h. After cooling to rt, 5 mL of H<sub>2</sub>O was added and the mixture was extracted with AcOEt (3 × 10 mL). The residue was chromatographied using AcOEt-EtOH-NEt<sub>3</sub> as eluent.</div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-phenyl-9-iso-propylpurine (<b>6a</b>)</h4><div class="NLM_p last">Yield 56%, mp 100−104 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.01 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.53 (d, 6H, <i>J</i> = 6.6 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.71 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.62 (dd, 1H, <i>J</i> = 10,3 Hz and <i>J</i>′ = 7.5 Hz, C<i>H</i><sub><i>2</i></sub>OH), 3.75 (dd, 1H, <i>J</i> = 10.3 Hz and <i>J</i>′ = 2.4 Hz, C<i>H</i><sub>2</sub>OH), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.48−7.66(m, 3H, H<sub>phenyl</sub>), 7. 75−7.92 (m, 2H, H<sub>phenyl</sub>), 8.22 (s, 1H, H-8).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-(3-pyridyl)-9-iso-propylpurine (<b>6b</b>)</h4><div class="NLM_p last">Yield 42%, mp 98−100 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>CH<sub>2</sub>), 1.54 (d, 6H, <i>J</i> = 6.9 Hz, CH(CH<sub>3</sub>)<sub>2</sub>), 1.72 (m, 2H, CH<sub>3</sub>CH<sub>2</sub>), 3.66 (dd, 1H, <i>J</i> = 6.6 Hz and J′ = 10.8 Hz, CH<sub>2</sub>OH), 3.83 (dd, 1H, <i>J</i> = 3.2 Hz and J′ = 10.8 Hz, CH<sub>2</sub>OH), 4.02 (m, 1H, CHNH), 4.66 (hept, 1H, CH(CH<sub>3</sub>)<sub>2</sub>), 5.20 (d, 1H, <i>J</i> = 6.5 Hz, CHNH), 7.35 (dd, 1H, <i>J</i> = 4.8 Hz and J′ = 8.1 Hz, H<sub>pyridyl</sub>), 7.78 (s, 1H, H-8), 8.64 (d, 1H, <i>J</i> = 4.5 Hz, H<sub>pyridyl</sub>), 8.88 (d, 1H, <i>J</i> = 7.8 Hz, H<sub>pyridyl</sub>), 9.73 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 9.8, 21.3, 21.4, 23.9, 45.7, 54.8, 65.6, 122.3, 124.8, 130.8, 135.8, 138.5, 149.6, 150, 152, 152.8, 158.4.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-(4-pyridyl)-9-iso-propylpurine (<b>6c</b>)</h4><div class="NLM_p last">Yield 58%, mp 136−138 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.54 (d, 6H, <i>J</i> = 6.8 Hz, CH(<i>CH</i><sub>3</sub>)<sub>2</sub>), 1.77−1.31 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.70 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.83 (dd, 1H, <i>J</i> = 3.4 Hz and <i>J′</i> = 10.9 Hz, C<i>H</i><sub>2</sub>OH), 3.99−4.09 (m, 1H, C<i>H</i>NH), 4.68 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.20 (d, 1H, <i>J</i> = 3.4 Hz, CHN<i>H</i>), 7.81 (s, 1H, H-8), 8.43 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>), 8.70 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 9.8, 21.3, 21.4, 23.8, 45.8, 54.8, 65.5, 122.2 (2×), 125.3, 138.9, 142.2, 149.2 (2×), 151.6, 153.3, 158.4.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[2-(phenyl)-phenylamino]-9-iso-propylpurine (<b>7a</b>)</h4><div class="NLM_p last">Yield 65%, mp 134−138 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.43 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.48−1.60 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.54 (dd, 1H, <i>J</i> = 3.2 Hz and <i>J′</i> = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 3.71 (dd, 1H, <i>J</i> = 2.4 and <i>J′</i> = 10 Hz, C<i>H</i><sub>2</sub>OH), 3.81−3.85 (m, 1H, C<i>H</i>NH), 4.51 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.1 (d, 1H, <i>J</i> = 6 Hz, CHN<i>H</i>), 7.10 (t, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.23−7.40 (m, 8H, H-8 + H<sub>phenyl</sub>), 7.54 (s, 1H, N<i>H</i><sub>phenyl</sub>), 8.25 (d, 1H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>). <sup>13</sup>C NMR: δ 10.9, 22.4, 22.5, 24.8, 46.5, 56.0, 67.4, 115.1, 123.0, 123.9, 127.7, 127.8, 128.8 (×2), 129.3, 130.4, 133.6, 135.1 (×2), 135.4, 138.4, 150.5, 152.6, 159.6.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[3-(phenyl)phenylamino)-9-iso-propylpurine (<b>7b</b>)</h4><div class="NLM_p last">Yield 78%, mp 100−105 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.02 (t, 3H, <i>J</i> = 7.6 Hz, C<i>H</i><sub>3</sub>-CH<sub>2</sub>), 1.56 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.59−1.69 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.65 (dd, 1H, <i>J</i> = 7.2 Hz and <i>J′</i> = 10 Hz, C<i>H</i><sub>2</sub>OH), 3.85 (d, 1H, <i>J</i> = 10 Hz, C<i>H</i><sub>2</sub>OH), 3.95−4.03 (m, 1H, C<i>H</i>-NH), 4.63 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.98 (d, 1H, <i>J</i> = 6.4 Hz, CHN<i>H</i>), 7.14−7.75 (m, 10H, H<sub>phenyl</sub> + H-8). <sup>13</sup>C NMR: δ 10.9, 22.5, 24.9, 46.7, 56.1, 67.5, 115.1, 118.8, 121.9, 127.2, 127.4, 128.7, 129.2, 135.2, 139.4, 141.1, 142.0, 152.4 (×2), 159.7.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[3-(phenyl)phenylamino]-9-iso-propylpurine (<b>7c</b>)</h4><div class="NLM_p last">Yield 56%, mp 90−105 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.01 (d, 6H, <i>J</i> = 6.4 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.56 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 2.00 (hept, 1H, <i>J</i> = 6.4 Hz, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 3.71 (dd, 1H, <i>J</i> = 7.2 Hz and <i>J′</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 3.87 (d, 1H, <i>J</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 4.09−4.24 (m, 1H, C<i>H</i>NH), 4.64 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.01 (d, 1H, <i>J</i> = 6.4 Hz, CHN<i>H</i>), 7.14−7.75 (m, 10H, H<sub>phenyl</sub>). <sup>13</sup>C NMR: δ 18.7, 19.5, 22.5 (×2), 30.0, 46.5, 59.8, 65.8, 115.2, 118.8, 121.8, 127.2 (×2), 127.4 (×3), 128.7, 129.2, 135.1, 139.5, 141.1, 141.9, 152.3 (×2), 160.0.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[4-(phenyl)phenylamino]-9-iso-propylpurine (<b>7d</b>)</h4><div class="NLM_p last">Yield 45%, mp 115−118 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.05 (d, 6H, <i>J</i> = 6.8 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.57 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 2.00−2.10 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 3.72−3.77 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.87−3.93 (m, 2H, C<i>H</i><sub>2</sub>OH and C<i>H</i>NH), 4.64 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.01 (d, 1H, <i>J</i> = 5.1 Hz, CHN<i>H</i>), 7.30−7.34 (m, 1H, H<sub>phenyl</sub>), 7.44 (t, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.59−7.61 (m, 5H, 8-H + H<sub>phenyl</sub>), 7.67 (s, 1H, N<i>H</i><sub>phenyl</sub>), 7.81−7.84 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>).</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(1-Hydroxy-2-methylprop-2-ylamino)-6-[3-(phenyl)-phenylamino]-9-iso-propylpurine (<b>7e</b>)</h4><div class="NLM_p last">Yield 27%, mp 80−85 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.40 (s, 6H, (HOCH<sub>2</sub>CC<i>H</i><sub>3</sub>)<sub>2</sub>), 1.59 (d, 6H, <i>J</i> = 6.8 Hz, NHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 3.72 (d, 2H, <i>J</i> = 6 Hz, C<i>H</i><sub><i>2</i></sub>OH), 4.61 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.14−7.75 (m, 10H, H<sub>phenyl</sub>). <sup>13</sup>C NMR: δ 22.4 (×2), 25.1 (×2), 46.9, 55.4, 72.3, 115.0, 119.2, 119.5, 122.3, 127.2 (×2), 127.3 (×2), 128.6, 129.2, 135.2, 139.0, 141.0, 142.0, 149.6, 152.6, 158.4.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[4-(phenyl)-phenylamino]-9-iso-propylpurine (<b>7f</b>)</h4><div class="NLM_p last">Yield 42%, mp 76−79 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.06 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.57 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.62−1.72 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.69−3.72 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.83−3.89 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.93−4.00 (m, 1H, C<i>H</i>NH), 4.64 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.00 (bs, 1H, CHN<i>H</i>), 7.30−7.34 (m, 1H, H<sub>phenyl</sub>), 7.42−7.46 (m, 2H, H<sub>phenyl</sub>), 7.59−7.75 (m, 5H, 8-H + H<sub>phenyl</sub>), 7.81−7.84 (m, 2H, H<sub>phenyl</sub>). <sup>13</sup>C NMR: δ 10.9, 22.5, 22.6, 24.9, 46.7, 56.2, 67.7, 115.3, 120.2 (×2), 126.8 (×2), 126.9, 127.5 (×2), 128.7 (×2), 135.2, 135.8, 138.3, 140.7, 152.3, 153.3, 159.7.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[(2-pyridyl)-methylamino]-9-iso-propylpurine (<b>8c</b>)</h4><div class="NLM_p last">Yield 44%, mp 109−113 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94 (t, 3H, <i>J</i> = 7.3 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.6 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.55 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.60 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 7.1 Hz, C<i>H</i><sub>2</sub>OH), 3.75 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 3.0 Hz, C<i>H</i><sub>2</sub>OH), 3.85 (m, 1H, C<i>H</i>NH), 4.55 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.83 (bs, 2H, NHC<i>H</i><sub>2</sub>), 5.08 (d, 1H, <i>J</i> = 6.3 Hz, CHN<i>H</i>), 7.10 (dd, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 5.0 Hz, H<sub>pyridyl</sub>), 7.25 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.29 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.47 (s, 1H, 8-H), 7.54 (td, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 1.8 Hz, H<sub>pyridyl</sub>), 8.46 (dd, 1H, <i>J</i> = 5.0 Hz and <i>J</i>′ = 1.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.9, 22.4, 22.5, 24.8, 45.5, 46.3, 55.9, 67.2, 114.5, 121.6, 122.0, 134.5, 136.6, 148.9, 154.7, 158.2, 159.9.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-2(1-Hydroxybut-2-ylamino)-6-[(2-pyridyl)methylamino]-9-iso-propylpurine (<b>8d</b>)</h4><div class="NLM_p last">Yield 54%, mp 117−120 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.95 (t, 3H, <i>J</i> = 7.3 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.6 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.57 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.58 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 7.1 Hz, C<i>H</i><sub>2</sub>OH), 3.75 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 3.0 Hz, C<i>H</i><sub>2</sub>OH), 3.85 (m, 1H, C<i>H</i>NH), 4.55 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.83 (bs, 2H, NHC<i>H</i><sub>2</sub>), 5.08 (d, 1H, <i>J</i> = 6.3 Hz, CHN<i>H</i>), 7.10 (dd, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 5.0 Hz, H<sub>pyridyl</sub>), 7.25 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.29 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.47 (s, 1H, 8-H), 7.54 (td, 1H, <i>J</i> = 7.6 Hz and <i>J′</i> = 1.8 Hz, H<sub>pyridyl</sub>), 8.48 (dd, 1H, <i>J</i> = 5.0 Hz and <i>J</i>′ = 1.8 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[(3-pyridyl)methylamino]-9-iso-propylpurine (<b>8e</b>)</h4><div class="NLM_p last">Yield 55%, mp 117−120 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (t, 3H, <i>J</i> = 7.5 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.61 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.60 (dd, 1H, <i>J</i> = 10.6 Hz and <i>J</i>′ = 7.3 Hz, C<i>H</i><sub>2</sub>OH), 3.77 (dd, 1H, <i>J</i> = 10.7 Hz and <i>J</i>′ = 2.9 Hz, C<i>H</i><sub>2</sub>OH), 3.88 (m, 1H, C<i>H</i>NH), 4.59 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.73 (m, 2H, NHC<i>H</i><sub>2</sub>), 4.96 (d, 1H, <i>J</i> = 6.6 Hz, CHN<i>H</i>), 6.65 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7,21 (dd, 1H, <i>J</i> = 7.8 Hz and <i>J′</i> = 4.8 Hz, H<sub>pyridyl</sub>), 7.46 (s, 1H, 8-H), 7.66 (m, 1H, H<sub>pyridyl</sub>), 8.47 (dd, 1H, <i>J</i> = 4.8 Hz and <i>J</i>′ = 1.5 Hz, H<sub>pyridyl</sub>) 8.60 (d, 1H, <i>J</i> = 1.8 Hz, H<sub>pyridyl</sub>)<sub>.</sub><sup>13</sup>C NMR: δ 11.1, 22.6, 22.7, 25.4, 42.4, 47.9, 55.8, 65.3, 114.6, 125.2, 136.6, 137.5, 137.9, 148.5, 149.4, 152.0, 155.9, 161.0.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>S</i>)-2-(1-Hydroxybut-2-ylamino)-6-[(3-pyridyl)methylamino]-9-iso-propylpurine (<b>8f</b>)</h4><div class="NLM_p last">Yield 70%, mp 115−116 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (t, 3H, <i>J</i> = 7.5 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.50 (d, 6H, <i>J</i> = 6.5 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.64 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.62 (dd, 1H, <i>J</i> = 10.0 Hz and <i>J</i>′ = 7.3 Hz, C<i>H</i><sub>2</sub>OH), 3.77 (dd, 1H, <i>J</i> = 10.0 Hz and <i>J</i>′ = 2.9 Hz, C<i>H</i><sub>2</sub>OH), 3.92 (m, 1H, C<i>H</i>NH), 4.59 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.75 (m, 2H, NHC<i>H</i><sub>2</sub>), 5.21 (d, 1H, <i>J</i> = 6.6 Hz, CHN<i>H</i>), 6.63 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7,22 (dd, 1H, <i>J</i> = 7.8 Hz and <i>J′</i> = 4.8 Hz, H<sub>pyridyl</sub>), 7.41 (s, 1H, 8-H), 7.63 (m, 1H, H<sub>pyridyl</sub>), 8.45 (dd, 1H, <i>J</i> = 4.8 Hz and <i>J</i>′ = 1.5 Hz, H<sub>pyridyl</sub>) 8.61 (d, 1H, <i>J</i> = 1.8 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[(4-pyridyl)methylamino]-9-iso-propylpurine (<b>8g</b>)</h4><div class="NLM_p last">Yield 67%, mp 130−132 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.53 (d, 6H, <i>J</i> = 6.7 Hz, -CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.61 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.60 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 7.5 Hz, -C<i>H</i><sub>2</sub>OH), 3.78 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 2.4 Hz, C<i>H</i><sub>2</sub>OH), 3.85 (m, 1H, C<i>H</i>NH), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.77 (m, 2H, NHC<i>H</i><sub>2</sub>), 4.92 (d, 1H, <i>J</i> = 6.1 Hz, CHN<i>H</i>), 6.55 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.26 (d, 2H, <i>J</i> = 5.8 Hz, H<sub>pyridyl</sub>), 7.51 (s, 1H, 8-H), 8.51 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.5, 22.0, 22.1, 24.5, 42.7, 46.1, 55.7, 67.5, 114.1, 121.8 (×2), 134.5, 148.1, 149.5 (×2), 154.3 (×2), 159.4.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-2-(1-Hydroxybut-2-ylamino)-6-[(4-pyridyl)methylamino]-9-iso-propylpurine (<b>8h</b>)</h4><div class="NLM_p last">Yield 55%, mp 128−130 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.53 (d, 6H, <i>J</i> = 6.7 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.61 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.60 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 7.5 Hz, C<i>H</i><sub>2</sub>OH), 3.78 (dd, 1H, <i>J</i> = 10.8 Hz and <i>J</i>′ = 2.4 Hz, C<i>H</i><sub>2</sub>OH), 3.85 (m, 1H, C<i>H</i>NH), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.77 (m, 2H, NHC<i>H</i><sub>2</sub>), 4.92 (d, 1H, <i>J</i> = 6.1 Hz, CHN<i>H</i>), 6.55 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.26 (d, 2H, <i>J</i> = 5.8 Hz, H<sub>pyridyl</sub>), 7.51 (s, 1H, 8-H), 8.51 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[3-(phenyl)phenylmethylamino]-9-iso-propylpurine (<b>8i</b>)</h4><div class="NLM_p last">Yield 42%, mp 100−102 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.91 (t, 3H, <i>J</i> = 7.3 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.40 (d, 6H, <i>J</i> = 6.7 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.45−1.56 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.54 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.78 (d, 1H, <i>J</i> = 10.6 Hz, C<i>H</i><sub>2</sub>OH), 3.79−3.82 (m, 1H, C<i>H</i>NH), 4.50 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.74 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.87 (d, 1H, <i>J</i> = 5,7 Hz, CHN<i>H</i>), 6.48 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.23−7.52 (m, 10H, H-8). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 10.2, 21.4, 21.5, 23.9, 43,4, 45.4, 55.2, 67.2, 113.6, 118.5, 125.1, 125.6, 126.1 (2×), 126.3, 127.7 (2×), 128, 133.5 (2×), 138.5, 139.9, 140.5, 153.9, 159.</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[3-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8j</b>)</h4><div class="NLM_p last">Yield 32%, mp 163−165 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.91 (t, 3H, <i>J</i> = 7.3 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.40 (d, 6H, <i>J</i> = 6.7 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.45−1.56 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.54 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.78 (d, 1H, <i>J</i> = 10.6 Hz, C<i>H</i><sub>2</sub>OH), 3.79−3.82 (m, 1H, C<i>H</i>NH), 4.50 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.74 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.87 (brs, 1H, NH) 6.48 (bs, 1H, N<i>H</i>), 7.32−7.62 (m, 6H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>); 7.76 (s, 1H, 8-H), 8.66 (d, 1H, <i>J</i> = 4.5 Hz, H<sub>pyridyl</sub>), 8.85 (d, 1H <i>J</i> = 2.8 Hz H<sub>pyridyl</sub>).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[3-(3-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8k</b>)</h4><div class="NLM_p last">Yield 67%, mp 123−126 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (t, 3H, <i>J</i> = 6.8 Hz, <i>CH</i><sub>3</sub>CH<sub>2</sub>), 1.60 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.90−2.00 (m, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>)<sub>2</sub>, 3.67 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J</i>′ = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 3.78−3.87 (m, 2H, C<i>H</i>NH and C<i>H</i><sub>2</sub>OH), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.83 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.99 (d, 1H, N<i>H</i>CH), 6.25 (bs, 1H, N<i>H</i>), 7.36 (dd, 1H, <i>J</i> = 3.2 Hz and <i>J</i>′ = 7.4 Hz, H<sub>pyridyl</sub>), 7.48 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.50 (s, 1H, 8-H), 7.53 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.86 (dt, 1H, <i>J</i> = 2 Hz and <i>J</i>′ = 7.6 Hz, H<sub>pyridyl</sub>), 8.58 (dd, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 8.6 Hz, H<sub>pyridyl</sub>), 8.82 (d, 1H, <i>J</i> = 2 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[3-(4-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8l</b>)</h4><div class="NLM_p last">Yield 78%, mp 144−146 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.98 (t, 3H, <i>J</i> = 6.8 Hz, <i>CH</i><sub>3</sub>CH<sub>2</sub>), 1.60 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.90−2.00 (m, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.70 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J</i>′ = 10.0 Hz, C<i>H</i><sub>2</sub>OH), 3.75−3.85 (m, 2H, C<i>H</i>NH + C<i>H</i><sub>2</sub>OH), 4.62 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.80 (bs, 2H, NHC<i>H</i><sub>2</sub>), 5.15 (d, 1H, N<i>H</i>CH), 6.22 (bs, 1H, N<i>H</i>),7.45−7.63(m, 5H, H<sub>phenyl</sub> + 8-H), 8.45 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>), 8.68 (d, 2H, <i>J</i> = 2.8 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[4-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8m</b>)</h4><div class="NLM_p last">Yield 66%, mp 89−93 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.95 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.50−1.60 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.56 (dd, 1H, <i>J</i> = 2.8 Hz and <i>J′</i> = 10.8 Hz, C<i>H</i><sub><i>2</i></sub>OH), 3.75 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J′</i> = 10.8 Hz, C<i>H</i><sub>2</sub>OH), 3.79−3.85 (m, 1H, C<i>H</i>NH), 4.54 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.76 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.90 (bs, 1H, CHN<i>H</i>), 6.10 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.16 (td, 1H, <i>J</i> = 1.6 and <i>J</i>′ = 5.4 Hz, H<sub>pyridyl</sub>), 7.41 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.45 (s, 1H, 8-H), 7.63−7.70 (m, 2H, H<sub>pyridyl</sub>), 7.89 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.62 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 10.5, 22.3, 22.4, 24.1, 38.0, 45.9, 55.0, 66.8, 113.6, 120.0, 120.9, 125.5, 126.8 (×2), 127.7, 130.0, 134.1, 135.9, 137.7, 140.0, 149.1, 154.1, 156.8, 159.1.</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-yl)-6-[4-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8n</b>)</h4><div class="NLM_p last">Yield 76%, mp 128−135 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94 (d, 6H, <i>J</i> = 6.8 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.67−1.80 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 3.60−3.65 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.76−3.79 (m, 2H, C<i>H</i>NH and C<i>H</i><sub>2</sub>OH), 4.55 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.78 (bs, 2H, NHC<i>H</i><sub>2</sub>), 6.10 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.14−7.18 (m, 1H, H<sub>pyridyl</sub>), 7.41 (d, 2H, <i>J</i> = 8.2 Hz, H<sub>phenyl</sub>), 7.48 (s, 1H, H-8), 7.63−7.70 (m, 2H, H<sub>pyridyl</sub>), 7.89 (d, 2H, <i>J</i> = 8.2 Hz, H<sub>phenyl</sub>), 8.61 (d, 1H, <i>J</i> = 5.2 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 15.2, 18.9, 19.4, 22.5, 22.6, 30.1, 46.4, 59.9, 65.8, 114.6, 120.4, 122.0, 127,1 (×2), 128.0 (×2), 134.5 (×2), 134.7, 138.4, 139.7, 149.6, 154.8, 157.1, 160.2.</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(1-Hydroxy-2-methylprop-2-yl)-6-[4-(2-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8o</b>)</h4><div class="NLM_p last">Yield 65%, mp 110−112 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.42 (s, 6H, C(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.56 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 2.5 (bs, 1H, CH<sub>2</sub>O<i>H</i>), 3.74 (s, 2H, C<i>H</i><sub>2</sub>OH), 4.59 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.81 (bs, 2H, NHC<i>H</i><sub>2</sub>), 6.15 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.14−7.18 (m, 1H, H<sub>pyridyl</sub>), 7.40 (d, 2H, <i>J</i> = 8.0 Hz, H<sub>phenyl</sub>), 7.52 (s, 1H, 8-H), 7.65−7.72 (m, 2H, H<sub>pyridyl</sub>), 7.93 (d, 2H, <i>J</i> = 8.0 Hz, H<sub>phenyl</sub>), 8.65 (d, 1H, <i>J</i> = 5.0 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>R</i>)- 2-(1-Hydroxybut-2-ylamino)-6-[4-(3-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8p</b>)</h4><div class="NLM_p last">Yield 62%, mp 104−106 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97(t, 3H, <i>J</i> = 7.5 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.48 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.61 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.62 (dd, 1H, <i>J</i> = 10.6 Hz and <i>J</i>′ = 7.3 Hz, C<i>H</i><sub>2</sub>OH), 3.77 (dd, 1H, <i>J</i> = 10.7 Hz and <i>J</i>′ = 2.9 Hz, C<i>H</i><sub>2</sub>OH) 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.80 (bs, 2H, NHCH<sub>2</sub>), 5.03 (brt, 1H, <i>J</i> = 6.8 Hz, N<i>H</i>CH<sub>2</sub>), 7.36 (dd, 1H, <i>J</i> = 3.2 and <i>J</i> = 7.4 Hz, H<sub>pyridyl</sub>), 7.48 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.50 (s, 1H, 8-H), 7.53 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.86 (dt, 1H, <i>J</i> = 2 Hz and <i>J</i>′ = 7.6 Hz, H<sub>pyridyl</sub>), 8.58 (dd, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 4.6 Hz, H<sub>pyridyl</sub>), 8.85 (d, 1H, <i>J</i> = 2 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[4-(3-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8q</b>)</h4><div class="NLM_p last">Yield 89%, mp 83−85 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (d, 6H, <i>J</i> = 6.8 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.60 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.90−2.00 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 3.67 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J</i>′ = 10.4 Hz, -C<i>H</i><sub>2</sub>OH), 3.78−3.87 (m, 2H, C<i>H</i>NH + C<i>H</i><sub>2</sub>OH), 4.60 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.83 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.99 (d, 1H, <i>J</i> = 6.8 Hz, N<i>H</i>CH), 6.25 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.36 (dd, 1H, <i>J</i> = 3.2 Hz and <i>J</i>′ = 7.4 Hz, H<sub>pyridyl</sub>), 7.48 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.50 (s, 1H, 8-H), 7.53 (d, 2H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.86 (dt, 1H, <i>J</i> = 2 Hz and <i>J</i>′ = 7.6 Hz, H<sub>pyridyl</sub>), 8.58 (dd, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 8.6 Hz, H<sub>pyridyl</sub>), 8.82 (d, 1H, <i>J</i> = 2 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[4-(4-pyridyl)phenylmethylamino]-9-iso-propylpurine (<b>8r</b>)</h4><div class="NLM_p last">Yield 56%, mp 70−72 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, 3H, <i>J</i> = 7.5 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.49 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.61 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 1.55−1.71 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.57 (dd, 1H, <i>J</i> = 7.8 Hz and <i>J′</i> = 10.7 Hz, C<i>H</i><sub>2</sub>OH), 3.75 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J′</i> = 10.7 Hz, C<i>H</i><sub><i>2</i></sub>OH), 3.79−3.82 (m, 1H, C<i>H</i>NH), 4.56 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.71 (bs, 2H, NHC<i>H</i><sub>2</sub>), 7.41 (d, 2H, <i>J</i> = 6 Hz, H<sub>pyridyl</sub>), 7.48−7.75 (m 5H, H<sub>phenyl</sub> + H-8), 8.60 (d, 2H, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[4-(phenyl)phenylmethylamino]-9-iso-propylpurine (<b>8s</b>)</h4><div class="NLM_p last">Yield 67%, mp 117−120 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, 3H, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.47 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.55−1.71 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.58 (dd, 1H, <i>J</i> = 7.8 Hz and <i>J′</i> = 10.8 Hz, C<i>H</i><sub>2</sub>OH), 3.75 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J′</i> = 10.8 Hz, C<i>H</i><sub>2</sub>OH), 3.79−3.82 (m, 1H, C<i>H</i>NH), 4.55 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.74 (bs, 2H, NHC<i>H</i><sub>2</sub>), 4.82−4.84 (m, 1H, CHN<i>H</i>), 6.04 (bs, 1H, N<i>H</i>CH<sub>2</sub>), 7.24−7.56 (m, 10H, 8-H). <sup>13</sup>C NMR: δ 10.9, 22.5, 22.6, 25.0, 38.7, 46.4, 56.4, 68.6, 113.6, 118.5, 125.1, 125.6 (×2), 127, 127.2, 127.3, 128.1, 128.7, 134.6 (2×), 137.8, 140.3, 140.8, 154.8, 159.9.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-Chloro-6-(4-bromophenylamino)-9-iso-propylpurine (<b>9</b>)</h4><div class="NLM_p last">Yield 71%, mp 172 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.54 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.79 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.42 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>), 7.62 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>), 7.82 (s, 1H, 8-H).</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Chloro-6-[3-(tetramethyldioxaborolanyl)phenylamino]-9-iso-propylpurine (<b>10a</b>)</h4><div class="NLM_p last">Yield 65%, mp 213 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.37 (s, 12 H, (C<i>H</i><sub>3</sub>)<sub>2</sub>COB), 1.61 (d, 6H, <i>J</i> = 7.0 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.85 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.44 (t, 1H, <i>J</i> = 7.3 Hz, H<sub>phenyl</sub>), 7.57 (d, 1H, = 7.3 Hz, H<sub>phenyl</sub>), 7.72 (s, 1H, NH), 7.82 (s, 1H, H<sub>phenyl</sub>), 7.87 (s, 1H, 8-H), 8.27 (d, 1H<sub>,</sub><i>J</i> = 7.3 Hz, H<sub>phenyl</sub>).</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-Chloro-6-[4-(tetramethyldioxaborolanyl)phenylamino]-9-iso-propylpurine (<b>10g</b>)</h4><div class="NLM_p last">Yield = 59%, mp 168 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.34 (s, 12 H, (C<i>H</i><sub>3</sub>)<sub>2</sub>COB), 1.61 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.87 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.78−7.91 (m, 4H, H<sub>phenyl</sub>), 8.07 (s, 1H, H-8).</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-Chloro-6-[3-(2-pyridyl)phenylamino]-9-iso-propylpurine (<b>11a</b>)</h4><div class="NLM_p last">Yield 76%, mp 142−148 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.61 (d, 6H, <i>J</i> = 6.7 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.85 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.53 (t, 1H, <i>J</i> = 7.5 Hz, H<sub>phenyl</sub>), 7.67−7.75 (m, 3H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>), 7.77−7.85 (m, 2H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>), 7.91−7.95 (m, 1H, anilin or pyridin), 8.35 (bs, 1H, H<sub>pyridyl</sub>), 8.69 (d, 1H, <i>J</i> = 4.1 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Chloro-6-[3-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>11d</b>)</h4><div class="NLM_p last">Yield 66%, mp 85−88 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.62 (d, 6H, <i>J</i> = 6.6 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.86 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.36 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.40 (dd, 1H, <i>J</i> = 4.2 Hz and <i>J</i>′ = 7.6 Hz, H<sub>pyridyl</sub>), 7.50 (t, 1H, <i>J</i> = 8.0 Hz, H<sub>phenyl</sub>), 7.79 (d, 1H, <i>J</i> = 8.0 Hz, H<sub>phenyl</sub>), 7.90 (s, 1H, 8-H), 7.95 (d, 1H, <i>J</i> = 8.0 Hz, H<sub>phenyl</sub>), 8.07 (s, 1H, H-8), 8.62 (d, 1H, <i>J</i> = 4.2 Hz, H<sub>pyridyl</sub>), 8.91 (s, 1H, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-Chloro-6-[3-(4-pyridyl)phenylamino]-9-iso-propylpurine (<b>11f</b>)</h4><div class="NLM_p last">Yield 45%, mp 160−165 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.55 (d, 6H, CH(C<i>H</i><sub><i>3</i></sub>)<sub>2</sub>), 4.81 (sept, 1H, <i>J</i> = 6.8 Hz, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.35 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.44 (t, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.52 (d, 2H, <i>J</i> = 4 Hz, H<sub>pyridyl</sub>), 7.74 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.85 (s, 1H, H<sub>phenyl</sub>), 7.99 (s, 1H, 8-H), 8.63 (d, 2H, <i>J</i> = 4 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-Chloro-6-[4-(2-pyridyl)phenylamino]-9-iso-propylpurine (<b>11g</b>)</h4><div class="NLM_p last">Yield 57%, mp 170 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.62 (d, 6H, CH(CH<sub>3</sub>)<sub>2</sub>), 4.86 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.70−7.91 (m, 5H, H<sub>phenyl</sub>, H<sub>pyridyl</sub> and 8-H), 7.92 (d, 1H, <i>J</i> = 8.4 Hz, H<sub>pyridyl</sub>), 8.07 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>), 8.70 (d, 1H, <i>J</i> = 4 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Chloro-6-[4-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>11h</b>)</h4><div class="NLM_p last">Yield 52%, mp 204−207 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.56 (d, 6H, <i>J</i> = 6.4 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.82 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.30 (dd, 1H, <i>J</i> = 4.8 Hz and <i>J</i>′ = 8 Hz, H<sub>pyridyl</sub>), 7.57 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>), 7.82 (dt, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′ = 8 Hz, H<sub>pyridyl</sub>), 7.86 (d, 2H, <i>J</i> = 8.8 Hz, H<sub>phenyl</sub>), 7.94 (s, 1H, 8-H), 8.51 (dd, 1H, <i>J</i> = 1.6 Hz and <i>J</i>′= 4.8 Hz, H<sub>phenyl</sub>), 8.80 (d, 1H, <i>J</i> = 1.6 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-Chloro-6-[4-(4-pyridyl)phenylamino]-9-iso-propylpurine (<b>11k</b>)</h4><div class="NLM_p last">Yield 70%, yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.56 (d, 6H, <i>J</i> = 6.5 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.85 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.10−7.20 (m, 2H, H<sub>phenyl</sub>), 7.40 (d, 2H, <i>J</i> = 7.7 Hz, H<sub>phenyl</sub>), 7.54 (d, 2H, <i>J</i> = 5.0 Hz, H<sub>pyridyl</sub>), 7.75 (s, 1H, 8-H), 8.00 (d, 2H, <i>J</i> = 5.0 Hz, H<sub>pyridyl</sub>).</div></div><div id="sec4_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(3-Pyridyl)-6-(4-bromophenylamino)-9-iso-propylpurine (<b>12a</b>)</h4><div class="NLM_p last">Yield 26%, mp 122−125 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.68 (d, 6H, <i>J</i> = 6.4 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.96 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.37−7.45 (m, 1H, H<sub>pyridyl</sub>), 7.54 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.81 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.94 (s, 1H, 8-H), 8.62−8.75 (m, 2H, H<sub>pyridyl</sub>), 9.70 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 22.5, 47.9, 115.5, 120.1, 127.7, 123.2, 123.4, 132.0, 139.1, 149.9, 144.8, 151.4, 156.2.</div></div><div id="sec4_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(4-Pyridyl)-6-(4-bromophenylamino)-9-iso-propylpurine (<b>12b</b>)</h4><div class="NLM_p last">Yield 20%, mp 200−215 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.63 (d, 6H, <i>J</i> = 6.4 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 4.90 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 7.48 (d, 2H, <i>J</i> = 8.6 Hz, H<sub>phenyl</sub>), 7.75 (d, 2H, <i>J</i> = 8.6 Hz, H<sub>phenyl</sub>), 7.90 (s, 1H, H-8), 8.25 (d, 2H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>), 8.69 (d, 2H, <i>J</i> = 4.8 Hz, H H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 22.6, 47.4, 115.3, 119.6, 120.1, 121.2, 121.8, 128.0, 130.3, 131.7, 137.7, 139.3, 145.4, 149.9, 151.1, 155.9.</div></div><div id="sec4_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[3-(2-pyridyl)phenylamino]-9-isopropylpurine (<b>13a</b>)</h4><div class="NLM_p last">Yield 79%, mp 77−85 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.98 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.49 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.67−1.79 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.64 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.74 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J′</i> = 10,6 Hz, C<i>H</i><sub>2</sub>OH), 3.96−4.07 (m, 1H, C<i>H</i>NH), 4.58 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.94 (m, 1H, CHN<i>H</i>), 7.38 (t, 1H, <i>J</i> = 7.2 Hz, H<sub>phenyl</sub>), 7.50−7.54 (m, 2H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>) 7.68−7.71 (m, 3H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>) 7.86 (s, 1H, H-8), 8.62 (d, 1H, <i>J</i> = 4.3 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.8, 22.5, 22.6, 24.9, 46.4, 55.9, 66.7, 114.9, 118.6, 120.3, 121.0, 121.4, 122.2, 129.1, 135.1, 136.9, 139.8, 140.1, 149.4, 152.2, 157.3, 159.6.</div></div><div id="sec4_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>R</i>)-2(1-Hydroxy-3-methyl-but-2-ylamino)-6-[3-(2-pyridyl)phenylamino]-9-isopropylpurine (<b>13b</b>)</h4><div class="NLM_p last">Yield 50%, mp 95−110 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94 (d, 6H, <i>J</i> = 6.8 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.49 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.95−2.06 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 3.62−3.77 (m, 2H, C<i>H</i><sub>2</sub>OH), 3.91−3.99 (m, 1H, C<i>H</i>NH), 4.58 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.91 (m, 1H, CHN<i>H</i>), 7.36 (t, 1H, <i>J</i> = 7.2 Hz, H<sub>phenyl</sub>), 7.50−7.73 (m, 6H, H<sub>phenyl</sub>, 8-H), 8.62 (d, 1H <i>J</i> = 4.2 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 18.4, 19.7, 22.5, 22.6, 29.5, 46.4, 59.6, 65.2, 115.1, 118.6, 120.3, 121.0, 121.3, 122.3, 129.2, 135.0, 136.9, 139.7, 140.1, 149.5, 152.3, 157.4, 159.9.</div></div><div id="sec4_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(1-Hydroxy-2-methylprop-2-ylamino)-6-[3-(2-pyridyl)phenylamino]-9-iso-propylpurine (<b>13c</b>)</h4><div class="NLM_p last">Yield 48%, mp 103−109 <b>°</b>C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.40 (s, 6H, C(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.56 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 2.54(bs, 1H, CH<sub>2</sub>O<i>H</i>), 3.74 (s, 2H, C<i>H</i><sub>2</sub>OH), 4.59 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 6.81 (bs, 1H, N<i>H</i>), 7.24 (td, 1H, <i>J</i> = 1.6 and <i>J′</i> = 6.8 Hz, H<sub>pyridyl</sub>), 7.45 (t, 1H, <i>J</i> = 8 Hz, H<sub>phenyl</sub>), 7.59 (s, 1H, N<i>H</i>Phenyl), 7.65 (d, 1H, <i>J</i> = 3.2 Hz, H<sub>phenyl</sub>), 7.70−7.77 (m, 2H, H<sub>pyridyl</sub>) 7.90 (d, 1H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.99 (s, 1H, H-8), 8.23 (s, 1H, H<sub>pyridyl</sub>) 8.69 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 22.4 (×2), 25.1, 46.9, 55.4 (×2), 72.1, 115.0, 118.9, 120.7, 120.9, 121.8, 122.2, 129.2, 135.2, 136.7, 139.3, 140.1, 149.5, 149.6, 152.6, 157.1, 158.4.</div></div><div id="sec4_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[3-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>13d</b>)</h4><div class="NLM_p last">Yield 60%, mp 82−89 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94 (t, 3H, <i>J</i> = 6.8 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.49 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.53−1.66 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.61 (dd, 1H, <i>J</i> = 7.2 Hz and <i>J′</i> = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 3.78 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J′</i> = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 3.88−3.98 (m, 1H, C<i>H</i>NH), 4.56 (hept, 1H, <i>J</i> = 6.8 Hz, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.94 (d, 1H, <i>J</i> = 6 Hz, CHN<i>H</i>), 7.29 (dd, 1H, <i>J</i> = 4 Hz and <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.37 (t, 1H, <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.53 (s, 1H, H-8), 7.62−7.70 (m, 2H, H<sub>phenyl</sub> and H<sub>pyridyl</sub>), 7.82 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.99 (s, 1H, H<sub>phenyl</sub>), 8.52 (d, 1H, <i>J</i> = 4 Hz, H<sub>pyridyl</sub>), 8.81 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.8, 22.6, 24.8, 46.7, 56.0, 67.2, 115.1, 118.5, 119.5, 121.6, 123.5, 129.5, 134.5, 135.3, 136.5, 138.5, 139.8, 148.3, 148.5, 152.3, 159.6.</div></div><div id="sec4_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>R</i>)-2(1-Hydroxy-3-methyl-but-2-ylamino)-6-[3-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>13e</b>)</h4><div class="NLM_p last">Yield 51%, mp 90−97 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.93 (d, 6H, <i>J</i> = 6.8 Hz, CH-CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.48 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.95 (hept, 1H, <i>J</i> = 6.8 Hz, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 3.68 (dd, 1H, <i>J</i> = 7.6 Hz, <i>J′</i> = 10,8 Hz, C<i>H</i><sub>2</sub>OH), 3.84 (dd, 1H, <i>J</i> = 2.6 Hz and <i>J′</i> = 10.8 Hz, C<i>H</i><sub>2</sub>OH), 3.84−3.90 (m, 1H, C<i>H</i>NH), 4.55 (hept, 1H, <i>J</i> = 6.8 Hz, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.91 (d, 1H, <i>J</i> = 6.6 Hz, CHN<i>H</i>), 7.30 (dd, 1H, <i>J</i> = 4.8 Hz and <i>J</i> = 7,6 Hz, H<sub>pyridyl</sub>), 7.38 (t, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.53 (s, 1H, 8-H), 7.61−7.70 (m, 2H, H<sub>phenyl</sub>), 7.84 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>pyridyl</sub>), 8.00 (s, 1H, H<sub>phenyl</sub>), 8.53 (d, 1H, <i>J</i> = 4 Hz, H<sub>pyridyl</sub>), 8.82 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 18.8, 19.4, 22.5, 29.9, 46.6, 59.7, 65.6, 115.1, 118.5, 119.5, 121.6, 123.6, 129.6, 134.5, 135.4, 136.6, 138.6, 140.0, 148.3, 148.7, 152.2, 159.9.</div></div><div id="sec4_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[3-(4-pyridyl)phenylamino]-9-iso-propylpurine (<b>13f</b>)</h4><div class="NLM_p last">Yield 88%, mp 85−97 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.96 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.50 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.52−1.66 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.60 (dd, 1H, <i>J</i> = 7.2 Hz, <i>J′</i> = 10.6 Hz, C<i>H</i><sub><i>2</i></sub>OH), 3.79 (dd, 1H, <i>J</i> = 2.4 Hz and <i>J′</i> = 10.6 Hz, C<i>H</i><sub>2</sub>OH), 3.89−3.96 (m, 1H, C<i>H</i>NH), 4.58 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.92 (d, 1H, <i>J</i> = 6.4 Hz, CHN<i>H</i>), 7.26 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.39 (t, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 7.46 (d, 2H, <i>J</i> = 6 Hz, H<sub>pyridyl</sub>), 7.55 (s, 1H, H), 7.69 (s, 1H, H<sub>phenyl</sub>), 7.73 (d, 1H, <i>J</i> = 7.6 Hz, H<sub>phenyl</sub>), 8.60 (d, 2H, <i>J</i> = 6 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.8, 22.3, 25.1, 46.7, 56.3, 67.2, 115.3, 118.5, 120.6, 121.5, 121.6, 129.4, 135.4, 138.8, 140.1, 148.5, 150.0, 152.1, 159.4.</div></div><div id="sec4_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>R</i>)-2-(1-Hydroxy-but-2-ylamino)-6-[4-(2-pyridyl)phenylamino]-9-iso-propylpurine (<b>13g</b>)</h4><div class="NLM_p last">Yield 76%, yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.98 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.46 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.52−1.68 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.63 (dd, 1H, <i>J</i> = 6.8 Hz and <i>J′</i> = 10,8 Hz, C<i>H</i><sub>2</sub>OH), 3.81 (dd, 1H, <i>J</i> = 2.8 Hz, <i>J′</i> = 10,8 Hz, C<i>H</i><sub>2</sub>OH), 3.90−3.98 (m, 1H, C<i>H</i>NH), 4.53 (hept, 1H, <i>J</i> = 6.8 Hz, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.05 (d, 1H, <i>J</i> = 6.8 Hz, CHN<i>H</i>), 7.09−7.14 (m, 1H, H<sub>pyridyl</sub>), 7.51 (s, 1H, H-8), 7.60−7.68 (m, 2H, H<sub>pyridyl</sub>), 7.80 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.90 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.59 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.4, 21.9, 24.5, 45.8, 55.4, 65.8, 114.3, 119.5, 119.6, 121.1, 127.0, 132.7, 134.7, 136.4, 140.1, 148.7, 150.5, 151.4, 159.7, 158.8.</div></div><div id="sec4_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[4-(2-pyridyl)phenylamino]-9-iso-propylpurine (<b>13h</b>)</h4><div class="NLM_p last">Yield 87%, mp 78−82 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.98 (d, 6H, <i>J</i> = 7 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.48 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.97 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 3.68 (dd, 1H, <i>J</i> = 7,6 Hz, <i>J′</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 3.84 (dd, 1H, <i>J</i> = 2.6 Hz and <i>J′</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 3.86−3.88 (m, 1H, C<i>H</i>NH), 4.54 (hept, 1H, <i>J</i> = 6.8 Hz, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.03 (d, 1H, <i>J</i> = 6.8 Hz, CHN<i>H</i>), 7.10−7.15 (m, 1H, H<sub>pyridyl</sub>), 7.53 (s, 1H, 8-H), 7.64−7.68 (m, 2H, H<sub>pyridyl</sub>), 7.80 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 7.93 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.60 (d, 1H, <i>J</i> = 4.6 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 18.7, 19.8, 21.7, 29.5, 46.4, 51.8, 59.4, 114.2, 119.2, 119.6, 121.1, 126.9, 133.0, 134.5, 136.2, 139.5, 148.9, 151.4, 156.2, 159.2.</div></div><div id="sec4_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[4-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>13i</b>)</h4><div class="NLM_p last">Yield 79%, mp 85−105 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.06 (t, 3H, <i>J</i> = 7.2 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.57 (d, 6H, <i>J</i> = 6.8 Hz, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.60−1.70 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.70 (dd, 1H, <i>J</i> = 6.8 Hz and <i>J′</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 3.88 (d, 1H, <i>J</i> = 11 Hz, C<i>H</i><sub>2</sub>OH), 3.96−4.02 (m, 1H, C<i>H</i>NH), 4.65 (hept, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.04 (d, 1H, <i>J</i> = 8 Hz, CHN<i>H</i>), 7.35 (dd, 1H, <i>J</i> = 4.8 Hz, <i>J′</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.56−7.62 (m, 3H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>), 7.68 (s, 1H, 8-H), 7.88 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.57 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>), 8.86 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 10.9, 22.5, 24.9, 46.7, 56.0, 67.3, 115.2, 120.3, 123.6, 127.4, 132.0, 133.8, 135.3, 136.2, 139.3, 148.0, 152.1, 159.7.</div></div><div id="sec4_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[4-(3-pyridyl)phenylamino]-9-iso-propylpurine (<b>13j</b>)</h4><div class="NLM_p last">Yield 84%, mp 116−120 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.05 (d, 6H, <i>J</i> = 6.8 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.57 (d, 6H, <i>J</i> = 6.8 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 2.01 (hept, 1H, <i>J</i> = 7 Hz, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 3.75 (dd, 1H, <i>J</i> = 8.0 Hz and <i>J′</i> = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 3.90 (d, 1H, <i>J</i> = 10.4 Hz, C<i>H</i><sub>2</sub>OH), 4.09−4.17 (m, 1H, C<i>H</i>NH), 4.64 (hept, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.08 (d, 1H, <i>J</i> = 6 Hz, CHN<i>H</i>), 7.35 (dd, 1H, <i>J</i> = 4.8 Hz, <i>J′</i> = 7.6 Hz, H<sub>pyridyl</sub>), 7.56−7.62 (m, 3H, H<sub>phenyl</sub> + H<sub>pyridyl</sub>), 7.68 (s, 1H, 8-H), 7.88 (d, 2H, <i>J</i> = 8.4 Hz, H<sub>phenyl</sub>), 8.57 (d, 1H, <i>J</i> = 4.8 Hz, H<sub>pyridyl</sub>), 8.86 (s, 1H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 19.0, 19.2, 22.3, 30.1, 46.7, 59.7, 65.2, 115.2, 120.1, 123.7, 127.5, 132.2, 133.7, 135.0, 136.3, 139.2, 147.9, 152.0, 159.9.</div></div><div id="sec4_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (<i>R</i>)-2-(1-Hydroxybut-2-ylamino)-6-[4-(4-pyridyl)phenylamino]-9-iso-propylpurine (<b>13k</b>)</h4><div class="NLM_p last">Yield 37%, mp 126−130 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.94−0.99 (m, 3H, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.44−1.52 (m, 6H, CH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.65−1.80 (m, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.66−3.75 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.82−3.90 (m, 1H, C<i>H</i><sub>2</sub>OH), 3.97−4.05 (m, 1H, C<i>H</i>NH), 4.58−4.65 (m, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 5.00−5.05 (m, 1H, CHN<i>H</i>), 7.43−7.47 (m, 2H, H<sub>phenyl</sub>), 7.53−7.65 (m, 3H, H<sub>phenyl</sub> + 8-H), 7.89−7.95 (m, 2H, H<sub>pyridyl</sub>), 8.60−8.65 (m, 2H, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 11.0, 22.8, 25.4, 47.1, 53.5, 56.3, 120.4, 121.5, 127.6, 128.6, 129.4, 132.4, 135.7, 140.6, 148.2, 150.6, 152.2, 159.7.</div></div><div id="sec4_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>R</i>)-2-(1-Hydroxy-3-methylbut-2-ylamino)-6-[4-(4-pyridyl)phenylamino]-9-iso-propylpurine (<b>13l</b>)</h4><div class="NLM_p last">Yield 41%, mp 121−123 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.99 (d, 6H, <i>J</i> = 7.9 Hz, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.51 (d, 6H, <i>J</i> = 7.9 Hz, NCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.97−1.99 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 3.61−3.71 (m, 2H, C<i>H</i><sub>2</sub>OH), 3.82−3.85 (m, 1H, C<i>H</i>NH), 4.55−4.62 (m, 1H, NC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 4.99−5.01 (m, 1H, CHN<i>H</i>), 7.44 (d, 2H, <i>J</i> = 4.1 Hz, H<sub>phenyl</sub>), 7.55 (s, 1H, 8-H), 7.59 (d, 2H, <i>J</i> = 4.1 Hz, H<sub>phenyl</sub>), 7.84 (d, 2H, <i>J</i> = 6.2 Hz, H<sub>pyridyl</sub>), 8.57 (d, 2H, <i>J</i> = 6.2 Hz, H<sub>pyridyl</sub>). <sup>13</sup>C NMR: δ 19.0, 19.5, 22.4, 30.0, 46.6, 59.7, 64.0, 115.1, 119.9, 121.0, 127.3, 131.9, 135.0, 140.3, 147.7, 150.0, 152.0, 160.0.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Docking on CK1</h3><div class="NLM_p last">The multiple sequence alignment of the proteins was created using ClustalW 1.82 (<a href="http://www.ch.embnet.org/software/ClustalW.html" class="extLink">http://www.ch.embnet.org/software/ClustalW.html</a>). The crystal structure of CK1-δ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKJ">1CKJ</a>) with sequence numbering based on SwissProt entry P48730 was used for all CK1 calculations. The ligands were placed in the receptor binding cavity and were minimized with the two hydrogen bonds formed between the receptor backbone and the purine ring constrained at their crystallographic distances and angles.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Then a Monte Carlo local search of 1000 steps as implemented in Macromodel v.9<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> was performed with all residues in a sphere of 6 Å around the ligand free to move and all remaining residues frozen. In all calculations the TNCG minimizer, the AMBER* force field and the GB/SA implicit solvent model were used. Prior to docking, the three ligand molecules were subjected to a 1000-step conformational search. An ab initio single point calculation of the global minimum conformation was performed at the DFT level using B3LYP method and the 6-31+G* basis set of JAGUAR v.4 for partial electrostatic atomic charge calculation. The p<i>K</i><sub>a</sub> calculations were performed with Pallas v.3 software (Pallas 3.1.1.2, CompuDrug Chemistry Ltd.). Alignment depictions were created with ESPript.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> For the interaction energy calculations, the local MP2 method as implemented in JAGUAR v.4<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and the 6-31+G* basis set were used. The LMP2 method is designed to avoid basis set superposition error, so the BSSE was calculated only for the HF energies using the Boys−Bernardi counterpoise method.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Interaction energy calculations were performed by transforming the ligand of the minimized 13a−CK1 complex in diphenylamine or <i>N</i>-methylaniline, subtracting all protein atoms except the backbone carbonyl acting as hydrogen bond acceptor and its amide nitrogen, adding hydrogens to fill valences and performing single point calculations. Experimental ΔΔ<i>G</i> was calculated from IC<sub>50</sub> values using the equation ΔΔ<i>G</i> = Δ<i>G</i><sup>13a</sup><b>−</b> Δ<i>G</i><sup>C&R8</sup><b>=</b><i>RT</i> ln(IC<sub>50</sub><sup>13a</sup>/IC<sub>50</sub><sup>C&R8</sup>), approximating IC<sub>50</sub> ∼ <i>K</i><sub>d</sub>.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Protein Kinase Assays</h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Biochemical Reagents</h4><div class="NLM_p last">Sodium ortho-vanadate, EGTA, EDTA, Mops, β-glycerophosphate, phenylphosphate, sodium fluoride, dithiothreitol (DTT), glutathione-agarose, glutathione, bovine serum albumin (BSA), nitrophenylphosphate, leupeptin, aprotinin, pepstatin, soybean trypsin inhibitor, benzamidine, and histone H1 (type III−S) were obtained from Sigma Chemicals. [γ-<sup>33</sup>P]-ATP was obtained from Amersham. The CK-S peptide (RRKHAAIGpSAYSITA) (pS stands for phosphorylated serine) was purchased from Millegen, and the GS-1 peptide (YRRAAVPPSPSLSRHSSPHQpSEDEEE) was obtained from GenScript Corporation.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Buffers</h4><div class="NLM_p last">Buffer A<i>:</i> 10 mM MgCl<sub>2</sub>, 1 mM EGTA, 1 mM DTT, 25 mM Tris-HCl pH 7.5, 50 μg heparin/mL. Buffer C: 60 mM β-glycerophosphate, 15 mM <i>p</i>-nitrophenylphosphate, 25 mM Mops (pH 7.2), 5 mM EGTA, 15 mM MgCl<sub>2</sub>, 1 mM DTT, 1 mM sodium vanadate, 1 mM phenylphosphate.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Kinase Preparations and Assays</h4><div class="NLM_p">Kinase activities were assayed in buffer A or C, at 30 °C, at a final ATP concentration of 15 μM. Blank values were subtracted and activities expressed in % of the maximal activity, i.e., in the absence of inhibitors. Controls were performed with appropriate dilutions of DMSO.</div><div class="NLM_p last">CDK1/cyclin B (M phase starfish oocytes, native) and CDK5/p25 (human, recombinant) were prepared as previously described.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Their kinase activity was assayed in buffer C, with 1 mg histone H1/mL, in the presence of 15 μM [γ-<sup>33</sup>P] ATP (3000 Ci/mmol; 10 mCi/mL) in a final volume of 30 μL. After 30 min incubation at 30 °C, 25 μL aliquots of supernatant were spotted onto 2.5 cm × 3 cm pieces of Whatman P81 phosphocellulose paper, and, 20 s later, the filters were washed five times (for at least 5 min each time) in a solution of 10 mL of phosphoric acid/liter of water. The wet filters were counted in the presence of 1 mL of ACS (Amersham) scintillation fluid. <i>GSK-</i>3α/β (porcine brain, native) was assayed as described for CDK1 but in buffer A and using GS-1, a GSK-3 specific substrate.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CK1 (porcine brain, native) was assayed as described for CDK1 but using CK-S, a CK1-specific peptide substrate <sup>12</sup>.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Cell Biology</h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Chemicals</h4><div class="NLM_p last">Cell Titer 96 containing the MTS reagent and CytoTox 96 kits were purchased from Promega (Madison, WI). The protease inhibitor cocktail was from Roche (Penzberg, Germany). Unless otherwise stated, the nonlisted reagents were from Sigma.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Cell Lines and Culture Conditions</h4><div class="NLM_p last">SH-SY5Y human neuroblastoma cells were grown in DMEM medium from Invitrogen (Cergy Pontoise, France). The HEK 293 human embryonic kidney cell line was grown in MEM medium from Invitrogen. Both media were supplemented with antibiotics (penicillin-streptomycin) from Lonza and 10% volume of FCS from Invitrogen. Cells were cultured at 37 °C with 5% CO<sub>2</sub>. Drug treatments were performed on exponentially growing cultures at the indicated time and concentrations. Control experiments were carried using appropriate dilutions of DMSO.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Cell Viability Assessment</h4><div class="NLM_p last">Cell viability was determined by measuring the reduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS, Promega (Madison, WI) as previously described.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Measurement of Amyloid β Production in N2A Cells</h4><div class="NLM_p">N2A cells expressing APP (N2A-APP<sub>695</sub> cells) were plated in 12-well dishes at a density of 3 × 10<sup>5</sup> cells per well and grown to 60% confluence. Drugs were added to cell cultures in fresh medium (0.5% fetal bovine serum). Following incubation, cells were recovered with 100 μL of RIPA buffer, incubated for 30 min on ice, and centrifuged at 13000 rpm for 20 min at 4 °C. The supernatants and/or cells were collected and subjected to BCA (Pierce) quantification. Equal amounts of protein samples were subjected to Western blot analysis using appropriate antibodies as described above. For immunoprecipitation assays, media were incubated with antibody 4G8 (Signet) to detect Aβ and full length βAPP.</div><div class="NLM_p last">After immobilization of total Aβ (coated monoclonal antibody specific for the N-terminus of Aβ) from media, Aβ40/42 peptide determinations were made by sandwich ELISA (BioSource International) using rabbit polyclonal antibodies specific for the C-terminus of Aβ40 or Aβ42. Aβ levels were normalized to total protein levels. Aβ40 and Aβ42 standard curves were plotted as a sigmoidal dose response curve (variable slope) using GraphPad Prism v4.0 (GraphPad Software Inc., San Diego, CA). Data presented are the results of at least three independent experiments done in triplicate. Results were analyzed with GraphPad Prism v4.0.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96"><a href="/doi/suppl/10.1021/jm800109e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800109e/suppl_file/jm800109e-file006.pdf">jm800109e-file006.pdf (46.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800109e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Meijer</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff929a96959a8dbf8c9dd28d908c9c909999d1998ddf979a8d899ad1989e9390918cbf8a919689d28f9e8d968ccad1998d"><span class="__cf_email__" data-cfemail="0f626a66656a7d4f7c6d227d607c6c60696921697d">[email protected]</span> <span class="__cf_email__" data-cfemail="6b030e191d0e450c0a070405182b1e05021d461b0a1902185e450d19">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hervé Galons</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#573a323e3d32251724357a25382434383131793125773f322521327930363b3839241722393e217a2736253e2462793125"><span class="__cf_email__" data-cfemail="9ff2faf6f5faeddfecfdb2edf0ecfcf0f9f9b1f9ed">[email protected]</span> <span class="__cf_email__" data-cfemail="7119140307145f16101d1e1f0231041f18075c0110031802445f1703">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nassima Oumata</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karima Bettayeb</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoan Ferandin</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luc Demange</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Lopez-Giral</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Lorène Goddard</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vassilios Myrianthopoulos</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel Mikros</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Flajolet</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Greengard</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Anne Kerleo for her contribution of the initial kinase assays. This research was supported by grants from the EEC (FP6-2002-Life Sciences & Health, PRO-KINASE Research Project) (L.M.), “Cancéropole Grand-Ouest” (L.M.), the “Ligue Nationale contre le Cancer” (L.M.), and “Association France-Alzheimer Finistère”. N.O. and K.B. were supported by a fellowship from, respectively, the “Institut National du Cancer” (INCa) and the “Ministère de la Recherche”. This work was supported by National Institutes of Health Grant AG09464 (PG and MF).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">1912−1916</span><span class="NLM_x">) </span> <span class="NLM_fpage">1933</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1933-1934&issue=1912%E2%88%921916&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26issue%3D1912%25E2%2588%25921916%26spage%3D1933%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kostich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span> </span><span class="NLM_article-title">Human members of the eukaryotic protein kinase family</span> <span class="citation_source-journal">Genome Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">research0043.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">research0043.12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=research0043.1-research0043.12&issue=9&author=M.+Kostichauthor=J.+Englishauthor=V.+Madisonauthor=F.+Gheyasauthor=L.+Wangauthor=P.+Qiuauthor=J.+Greeneauthor=M.+Thomas&title=Human+members+of+the+eukaryotic+protein+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostich%26aufirst%3DM.%26aulast%3DEnglish%26aufirst%3DJ.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DP.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DM.%26atitle%3DHuman%2520members%2520of%2520the%2520eukaryotic%2520protein%2520kinase%2520family%26jtitle%3DGenome%2520Biology%26date%3D2002%26volume%3D3%26issue%3D9%26spage%3Dresearch0043.1%26epage%3Dresearch0043.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="ref3_1"><span><a href="http://www.kinasenet.org/pkr/Welcome.do" class="extLink">http://www.kinasenet.org/pkr/Welcome.do</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.kinasenet.org%2Fpkr%2FWelcome.do."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref3_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Niedner, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzko, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribskov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Protein kinase resource: an integrated environment for phosphorylation research</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=78-86&author=R.+H.+Niednerauthor=O.+V.+Buzkoauthor=N.+M.+Hasteauthor=A.+Taylorauthor=M.+Gribskovauthor=S.+S.+Taylor&title=Protein+kinase+resource%3A+an+integrated+environment+for+phosphorylation+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiedner%26aufirst%3DR.%2BH.%26aulast%3DBuzko%26aufirst%3DO.%2BV.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DGribskov%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DProtein%2520kinase%2520resource%253A%2520an%2520integrated%2520environment%2520for%2520phosphorylation%2520research%26jtitle%3DProteins%26date%3D2006%26volume%3D63%26spage%3D78%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases: the major drug targets of the twenty-first century</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%3A+the+major+drug+targets+of+the+twenty-first+century"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%253A%2520the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F0929867043365062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15180564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlKlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1563-1583&author=P.+M.+Fischer&title=The+design+of+drug+candidate+molecules+as+selective+inhibitors+of+therapeutically+relevant+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases</span></div><div class="casAuthors">Fischer, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1563-1583</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The human genome encompasses some 2000 proteins that utilize ATP in one way or another and some 500 of these are protein-tyrosine and protein-serine/threonine kinases (PTKs & PSTKs).  Substrate phosphorylation by these enzymes is nature's predominant mol. way of organizing cellular signal transduction and regulating biochem. processes in general.  It is not surprising, therefore, that abnormal phosphorylation of cellular proteins is a hallmark of disease and that there was a growing interest in the use of kinase inhibitors as drugs.  In fact the search for such agents has recently culminated in the approval of the 1st kinase inhibitor drugs for medical use.  Although it was demonstrated exhaustively that potent and structurally diverse ATP-antagonistic small mol. kinase inhibitors can be found through mass screening and structure-guided design, the question of biochem., cellular, and in vivo selectivity of such inhibitors remains much less clear.  Here the medicinal chem. of kinase inhibitors is reviewed critically with particular emphasis on target selectivity and specificity.  Approaches based on chem. genomics, combinatorial target-guided ligand assembly, computational chem., and structural biol. techniques, which aim at classifying both inhibitors and kinase targets, are given special emphasis.  The various strategies in which differences in biochem. mechanism of kinase function can be exploited to attain selective inhibition are also discussed.  Furthermore, recent developments in the design of inhibitors to selected individual validated therapeutic kinase targets, including cell cycle kinases and receptor PTKs, etc. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGG4UXoCMRILVg90H21EOLACvtfcHk0lgkL5L6p8UuaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlKlu7c%253D&md5=27aec2f6bdc06f639b3b8eb6b9de8a8f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867043365062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043365062%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DThe%2520design%2520of%2520drug%2520candidate%2520molecules%2520as%2520selective%2520inhibitors%2520of%2520therapeutically%2520relevant%2520protein%2520kinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1563%26epage%3D1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Weinmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metternich, R.</span><span> </span><span class="NLM_article-title">Drug discovery process for kinase inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1002%2Fcbic.200500034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15742380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=455-459&author=H.+Weinmannauthor=R.+Metternich&title=Drug+discovery+process+for+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery process for kinase inhibitors</span></div><div class="casAuthors">Weinmann Hilmar; Metternich Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-9</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2pa-m03MzviEJCPKhJPuqfW6udTcc2eZS24Cb7hKMIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D&md5=62db1c09267fe56d34abef8d5b651750</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500034%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DMetternich%26aufirst%3DR.%26atitle%3DDrug%2520discovery%2520process%2520for%2520kinase%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2FS0165-6147%2802%2902071-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12237154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVWmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=417-425&author=M.+Knockaertauthor=P.+Greengardauthor=L.+Meijer&title=Pharmacological+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibitors of cyclin-dependent kinases</span></div><div class="casAuthors">Knockaert, Marie; Greengard, Paul; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (CDKs) regulate the cell division cycle, apoptosis, transcription and differentiation in addn. to functions in the nervous system.  Deregulation of CDKs in various diseases has stimulated an intensive search for selective pharmacol. inhibitors of these kinases.  More than 50 inhibitors have been identified, among which >20 have been co-crystd. with CDK2.  These inhibitors all target the ATP-binding pocket of the catalytic site of the kinase.  The actual selectivity of most known CDK inhibitors, and thus the underlying mechanism of their cellular effects, is poorly known.  Pharmacol. inhibitors of CDKs are currently being evaluated for therapeutic use against cancer, alopecia, neurodegenerative disorders (e.g. Alzheimer's disease, amyotrophic lateral sclerosis and stroke), cardiovascular disorders (e.g. atherosclerosis and restenosis), glomerulonephritis, viral infections (e.g. HCMV, HIV and HSV) and parasitic protozoa (Plasmodium sp. and Leishmania sp.).  Pharmacol. inhibitors of cyclin-dependent kinases are being actively investigated in view of their potential therapeutic use against a large variety of indications such as cancers, Alzheimer's disease and other neurodegenerative disorders, and viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokE1X0jvc9GbVg90H21EOLACvtfcHk0lgkL5L6p8UuaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVWmsbY%253D&md5=09bb4b161d30cbff71b80f7aae505843</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2802%2902071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252802%252902071-0%26sid%3Dliteratum%253Aachs%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Smith, P. J.; Yue, E.</span>, Eds.  <span class="citation_source-book">CDK Inhibitors of Cyclin-Dependent Kinases as Antitumor Agents</span>; <span class="NLM_series">Monographs on Enzyme Inhibitors</span>;  <span class="NLM_publisher-name">CRC Press, Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, <div class="note"><p class="first last">448 pp</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+J.+Smith&author=E.+Yue&title=CDK+Inhibitors+of+Cyclin-Dependent+Kinases+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26btitle%3DCDK%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinases%2520as%2520Antitumor%2520Agents%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%26date%3D2006%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=471-480&author=L.+Meijerauthor=M.+Flajoletauthor=P.+Greengard&title=Pharmacological+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DPharmacological%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loehler, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, M.</span><span> </span><span class="NLM_article-title">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.cellsig.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15722192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=675-689&author=U.+Knippschildauthor=A.+Gochtauthor=S.+Wolffauthor=N.+Huberauthor=J+Loehlerauthor=M.+Stoeter&title=The+casein+kinase+1+family%3A+participation+in+multiple+cellular+processes+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span></div><div class="casAuthors">Knippschild, Uwe; Gocht, Andreas; Wolff, Sonja; Huber, Nadine; Loehler, Juergen; Stoeter, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-689</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of Ser, Thr, and Tyr residues by cellular protein kinases plays an important role in the regulation of various cellular processes.  The Ser/Thr-specific casein kinase 1 and 2 protein kinase families, CK1 and CK2, resp., were among the 1st protein kinases that had been described.  In recent years, knowledge of the regulation and function of mammalian CK1 kinase family members has rapidly increased.  Extracellular stimuli, the subcellular localization of CK1 isoforms, their interaction with various cellular structures and proteins, as well as autophosphorylation and proteolytic cleavage of their C-terminal regulatory domains influence CK1 kinase activity.  Mammalian CK1 isoforms phosphorylate many different substrates, among them key regulatory proteins involved in the control of cell differentiation, proliferation, chromosome segregation, and circadian rhythms.  De-regulation and/or the incidence of mutations in the coding sequence of CK1 isoforms have been linked to neurodegenerative diseases and cancer.  Here, the authors summarize the current knowledge about the function and regulation of mammalian CK1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTGvFy5TMyLVg90H21EOLACvtfcHk0lhqXxVQvrmm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D&md5=e44cbddc335887723b171bf889dd2f08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DGocht%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DLoehler%26aufirst%3DJ%26aulast%3DStoeter%26aufirst%3DM.%26atitle%3DThe%2520casein%2520kinase%25201%2520family%253A%2520participation%2520in%2520multiple%2520cellular%2520processes%2520in%2520eukaryotes%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D675%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification of CK1 by affinity chromatography on immobilised axin</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.pep.2007.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17434749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2007&pages=101-109&author=J.+Reinhardtauthor=Y.+Ferandinauthor=L.+Meijer&title=Purification+of+CK1+by+affinity+chromatography+on+immobilised+axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of CK1 by affinity chromatography on immobilised axin</span></div><div class="casAuthors">Reinhardt, Jens; Ferandin, Yoan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Members of the Casein Kinase 1 (CK1) family are implicated in the regulation of a variety of physiol. processes like development and circadian rhythm, as well as in diseases like cancer and Alzheimer's disease.  From that perspective, CK1 family members are interesting targets for potential chemotherapy.  We describe here a rapid and efficient method for the purifn. of CK1 by affinity chromatog. on an immobilized fragment of axin.  Axin is a scaffolding protein that interacts with a multitude of proteins, amongst them APC, GSK-3, β-catenin, CK1α, δ, and ε, and PP2A.  A GST-tagged axin peptide (residues 495-684) was produced in Escherichia coli and either immobilized on glutathione agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These "GST-axin" matrixes were found to selectively bind native CK1α and CK1ε from porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. provides a convenient tool to efficiently purify large amts. of active native CK1 for screening purposes.  This single step purifn. also provides a convenient tool to follow the status of the axin-binding CK1 isoforms α, δ, and ε (protein levels, compn. of isoforms, kinase activity) under different physiol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnaZtPudqbbVg90H21EOLACvtfcHk0lhqXxVQvrmm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D&md5=8edde52c867ca4879a797e498fea8797</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2007.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2007.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520of%2520CK1%2520by%2520affinity%2520chromatography%2520on%2520immobilised%2520axin%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2007%26volume%3D54%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rosemeyer, H.</span><span> </span><span class="NLM_article-title">The chemodiversity of purine as a constituent of natural products</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1002%2Fcbdv.200490033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17191854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=361-401&author=H.+Rosemeyer&title=The+chemodiversity+of+purine+as+a+constituent+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The chemodiversity of purine as a constituent of natural products</span></div><div class="casAuthors">Rosemeyer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-401</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta AG</span>)
        </div><div class="casAbstract">In this review, various natural manifestations of purine systems, i.e., methylated, higher-alkylated, and glycosylated forms, are described.  These comprise the purine alkaloids, cytokinines, as well as the purine nucleoside antibiotics.  In part, the compds. described herein were isolated from natural sources already long ago.  However, some have been reported only during the last few years.  The biol. activities of most of the purine derivs. are briefly described, and, in some cases, syntheses are formulated.  In particular, this article introduces the main synthetic principles for the generation of the purine ring system.  The last chapter describes modern preparative routes for C-alkylation and C-arylation of purines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppvY0HCBfJirVg90H21EOLACvtfcHk0lhqXxVQvrmm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlOht7k%253D&md5=5653bce55e74efb0a8b797514d33b862</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200490033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200490033%26sid%3Dliteratum%253Aachs%26aulast%3DRosemeyer%26aufirst%3DH.%26atitle%3DThe%2520chemodiversity%2520of%2520purine%2520as%2520a%2520constituent%2520of%2520natural%2520products%26jtitle%3DChem.%2520Biodiversity%26date%3D2004%26volume%3D1%26spage%3D361%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Haystead, T. A.</span><span> </span><span class="NLM_article-title">The purinome, a complex mix of drug and toxicity targets</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F156802606777812059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16842150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1117-1127&author=T.+A.+Haystead&title=The+purinome%2C+a+complex+mix+of+drug+and+toxicity+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The purinome, a complex mix of drug and toxicity targets</span></div><div class="casAuthors">Haystead, Timothy A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Much attention has focused on the development of protein kinases as drug targets to treat a variety of human diseases including diabetes, cancer, hypertension and arthritis.  To date, Gleevec is one example of a drug targeting protein that has successfully treated human cancer.  Several other protein kinase inhibitors are in clin. development.  However, protein kinases are in fact part of a larger collection of some 2000 distinct proteins expressed by the genome that like the protein kinases also bind purines (the purinome), either to be utilized as substrates or as co-factors in the form of NAD, NADP and co-enzyme A.  The soln. structures of many representative gene family members within the purinome show these proteins bind purines in a similar orientations to that obsd. in all protein kinases.  Several non-protein kinase purine utilizing proteins are established drug targets such as HMG CoA reductase, dihydrofolate reductase, phosphodiesterase and HSP90.  Searches of OMIM identifies many purine utilizing enzymes that are assocd. with inborn errors in metab.  Inhibition of any one of which by a drug could lead to an undesirable side effect.  The purinome is therefore somewhat of a drug discovery mixed blessing.  It is a rich source of therapeutic targets, but also contains a large collection of diverse proteins whose inhibition could result in an adverse outcome.  Drug discovery within the purinome should therefore encompass strategies that enable broad assessment of selectivity across the entire purinome at the earliest stages of the discovery process.  In this article we review the purinome within the context of drug discovery and discuss approaches for avoiding off target binding during the discovery/lead optimization process with particular emphasis on use of proteome mining technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobI5dz-INnDLVg90H21EOLACvtfcHk0lgDwR0uVlRkaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7k%253D&md5=7aaff9cac57cda09e06a468599f20106</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156802606777812059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812059%26sid%3Dliteratum%253Aachs%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26atitle%3DThe%2520purinome%252C%2520a%2520complex%2520mix%2520of%2520drug%2520and%2520toxicity%2520targets%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Legraverend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span> </span><span class="NLM_article-title">The purines: potent and versatile small molecule inhibitors and modulators of key biological targets</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3987-4006&author=M.+Legraverendauthor=D.+S.+Grierson&title=The+purines%3A+potent+and+versatile+small+molecule+inhibitors+and+modulators+of+key+biological+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegraverend%26aufirst%3DM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26atitle%3DThe%2520purines%253A%2520potent%2520and%2520versatile%2520small%2520molecule%2520inhibitors%2520and%2520modulators%2520of%2520key%2520biological%2520targets%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3987%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Haesslein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jullian, N.</span><span> </span><span class="NLM_article-title">Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anticancer agents. Roles and perspectives for the future</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F1568026023393291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12171570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1037-1050&author=J.+L.+Haessleinauthor=N.+Jullian&title=Recent+advances+in+cyclin-dependent+kinase+inhibition.+Purine-based+derivatives+as+anticancer+agents.+Roles+and+perspectives+for+the+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anti-cancer agents. Roles and perspectives for the future</span></div><div class="casAuthors">Haesslein, Jean-Luc; Jullian, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1037-1050</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases (Ser/Thr and Tyr) play a key role in signal transduction pathways.  It has been shown that deregulation of the Cdk activity is linked to cell proliferation and cancer.  Inhibition of cyclin-dependent kinases (Cdks) is an important target for potential new anti-cancer drugs.  Following the discovery of Olomoucine, a wide range of tri-substituted purine derivs. have been synthesized, leading to potent Cdk inhibitors.  These purine-derived compds. bind to the ATP pocket of the protein.  Of interest for structure-based drug design, the different crystal structures published to date show evidence for three different binding modes for the purine ring, allowing diverse exploration of the ATP binding site.  Some examples of synthesis and structure activity relationships are discussed for a set of purine derivs., tri-substituted on C-2, N-9 and C-6.  Finally, in vivo activities are reviewed, as well as the applications in other therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNa6znCVspGbVg90H21EOLACvtfcHk0lgDwR0uVlRkaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOitbg%253D&md5=d5de74dff3a50cdfcf974b1189a9497a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026023393291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393291%26sid%3Dliteratum%253Aachs%26aulast%3DHaesslein%26aufirst%3DJ.%2BL.%26aulast%3DJullian%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520cyclin-dependent%2520kinase%2520inhibition.%2520Purine-based%2520derivatives%2520as%2520anticancer%2520agents.%2520Roles%2520and%2520perspectives%2520for%2520the%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D1037%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar0201198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=417-425&author=L.+Meijerauthor=E.+Raymond&title=Roscovitine+and+other+purines+as+kinase+inhibitors.+From+starfish+oocytes+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Far0201198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far0201198%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DRoscovitine%2520and%2520other%2520purines%2520as%2520kinase%2520inhibitors.%2520From%2520starfish%2520oocytes%2520to%2520clinical%2520trials%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulner, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, J. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delcros, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulinoux, J. P.</span><span> </span><span class="NLM_article-title">Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1111%2Fj.1432-1033.1997.t01-2-00527.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=9030781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1997&pages=527-536&author=L.+Meijerauthor=A.+Borgneauthor=O.+Mulnerauthor=J.+P.+J.+Chongauthor=J.+J.+Blowauthor=N.+Inagakiauthor=M.+Inagakiauthor=J.+G.+Delcrosauthor=J.+P.+Moulinoux&title=Biochemical+and+cellular+effects+of+roscovitine%2C+a+potent+and+selective+inhibitor+of+the+cyclin-dependent+kinases+cdc2%2C+cdk2+and+cdk5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5</span></div><div class="casAuthors">Meijer, Laurent; Borgne, Annie; Mulner, Odile; Chong, James P. J.; Blow, J. Julian; Inagaki, Naoyuki; Inagaki, Masaki; Delcros, Jean Guy; Moulinoux, Jacques Philippe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">527-536</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (cdk) play an essential role in the intracellular control of the cell division cycle (cdc).  These kinases and their regulators are frequently deregulated in human tumors.  Enzymic screening has recently led to the discovery of specific inhibitors of cyclin-dependent kinases, such as butyrolactone I, flavopiridol and the purine olomoucine.  Among a series of C2, N6,N9-substituted adenines tested on purified cdc2/cyclin B, 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine) displays high efficiency and high selectivity towards some cyclin-dependent kinases.  The kinase specificity of roscovitine was investigated with 25 highly purified kinases (including protein kinase A, G and C isoforms, myosin light-chain kinase, casein kinase 2, insulin receptor tyrosine kinase, c-src, v-abl).  Most kinases are not significantly inhibited by roscovitine.  Cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p35 only are substantially inhibited (IC50 values of 0.65, 0.7, 0.7 and 0.2 μM, resp.).  Cdk4/cyclin D1 and cdk6/cyclin D2 are very poorly inhibited by roscovitine (IC50>100 μM).  Extracellular regulated kinases erk1 and erk2 are inhibited with an IC50 of 34 μM and 14 μM, resp.  Roscovitine reversibly arrests starfish oocytes and sea urchin embryos in late prophase.  Roscovitine inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg exts.  It blocks progesterone-induced oocyte maturation of Xenopus oocytes and in vivo phosphorylation of the elongation factor eEF-1.  Roscovitine inhibits the proliferation of mammalian cell lines with an av. IC50 of 16 μM.  In the presence of roscovitine L1210 cells arrest in G1 and accumulate in G2.  In vivo phosphorylation of vimentin on Ser55 by cdc2/cyclin B is inhibited by roscovitine.  Through its unique selectivity for some cyclin-dependent kinases, roscovitine provides a useful anti-mitotic reagent for cell cycle studies and may prove interesting to control cells with deregulated cdc2, cdk2 or cdk5 kinase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO61Tu2_0pWLVg90H21EOLACvtfcHk0liBV97g2Cf8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVWiu7g%253D&md5=d55100def53ac8811e485d9d34c46b79</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.t01-2-00527.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.t01-2-00527.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBorgne%26aufirst%3DA.%26aulast%3DMulner%26aufirst%3DO.%26aulast%3DChong%26aufirst%3DJ.%2BP.%2BJ.%26aulast%3DBlow%26aufirst%3DJ.%2BJ.%26aulast%3DInagaki%26aufirst%3DN.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DDelcros%26aufirst%3DJ.%2BG.%26aulast%3DMoulinoux%26aufirst%3DJ.%2BP.%26atitle%3DBiochemical%2520and%2520cellular%2520effects%2520of%2520roscovitine%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520cyclin-dependent%2520kinases%2520cdc2%252C%2520cdk2%2520and%2520cdk5%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D243%26spage%3D527%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K; Galons, H.</span><span> </span><span class="NLM_article-title">Roscovitine (CYC202, Seliciclib)</span>. In  <span class="citation_source-book">CDK Inhibitors and their Potential as Antitumor Agents</span>; <span class="NLM_series">Monographs on Enzyme Inhibitors</span>; <span class="NLM_contrib-group">Smith, P. J.; Yue, E.</span>, Eds.; <span class="NLM_publisher-name">CRC Press, Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, Chapter 9, pp  <span class="NLM_fpage">187</span>− <span class="NLM_lpage">226</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=187-226&author=L.+Meijer&author=K+Bettayeb&author=H.+Galonsauthor=P.+J.+Smith&author=E.+Yue&title=CDK+Inhibitors+and+their+Potential+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26btitle%3DCDK%2520Inhibitors%2520and%2520their%2520Potential%2520as%2520Antitumor%2520Agents%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%26date%3D2006%26volume%3D2%26spage%3D187%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bukanov, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledbetter, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibraghimov-Beskrovnaya, O.</span><span> </span><span class="NLM_article-title">Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor Roscovitine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=949-952&author=N.+O.+Bukanovauthor=L.+A.+Smithauthor=K.+W.+Klingerauthor=S.+R.+Ledbetterauthor=O.+Ibraghimov-Beskrovnaya&title=Long-lasting+arrest+of+murine+polycystic+kidney+disease+with+CDK+inhibitor+Roscovitine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBukanov%26aufirst%3DN.%2BO.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DKlinger%26aufirst%3DK.%2BW.%26aulast%3DLedbetter%26aufirst%3DS.%2BR.%26aulast%3DIbraghimov-Beskrovnaya%26aufirst%3DO.%26atitle%3DLong-lasting%2520arrest%2520of%2520murine%2520polycystic%2520kidney%2520disease%2520with%2520CDK%2520inhibitor%2520Roscovitine%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D949%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Menn, B.; Ivanov, A.; Bach, S.; Ben-Ari, Y.; Meijer, L.; Timsit, S.</span><span> </span><span class="NLM_article-title">Systemic (<i>S</i>)-roscovitine provides neuroprotection in stroke model</span>.  <span class="citation_source-journal">Ann. Neurol.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Menn&author=A.+Ivanov&author=S.+Bach&author=Y.+Ben-Ari&author=L.+Meijer&author=S.+Timsit&title=Systemic+%28S%29-roscovitine+provides+neuroprotection+in+stroke+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenn%26aufirst%3DB.%26atitle%3DSystemic%2520%2528S%2529-roscovitine%2520provides%2520neuroprotection%2520in%2520stroke%2520model%26jtitle%3DAnn.%2520Neurol.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rossi, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawatzky, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldicott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Losa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savill, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslett, C.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1056</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1038%2Fnm1468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16951685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1056-1064&author=A.+G.+Rossiauthor=D.+A.+Sawatzkyauthor=A.+Walkerauthor=C.+Wardauthor=T.+A.+Sheldrakeauthor=N.+A.+Rileyauthor=A.+Caldicottauthor=M.+Martinez-Losaauthor=T.+R.+Walkerauthor=R.+Duffinauthor=M.+Grayauthor=E.+Crescenziauthor=M.+C.+Martinauthor=H.+J.+Bradyauthor=J.+S.+Savillauthor=I.+Dransfieldauthor=C.+Haslett&title=Cyclin-dependent+kinase+inhibitors+enhance+the+resolution+of+inflammation+by+promoting+inflammatory+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis</span></div><div class="casAuthors">Rossi, Adriano G.; Sawatzky, Deborah A.; Walker, Annemieke; Ward, Carol; Sheldrake, Tara A.; Riley, Nicola A.; Caldicott, Alison; Martinez-Losa, Magdalena; Walker, Trevor R.; Duffin, Rodger; Gray, Mohini; Crescenzi, Elvira; Martin, Morag C.; Brady, Hugh J.; Savill, John S.; Dransfield, Ian; Haslett, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1056-1064</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is essential for clearance of potentially injurious inflammatory cells and subsequent efficient resoln. of inflammation.  Here the authors report that human neutrophils contain functionally active cyclin-dependent kinases (CDKs), and that structurally diverse CDK inhibitors induce caspase-dependent apoptosis and override powerful anti-apoptosis signals from survival factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF).  The authors show that the CDK inhibitor R-roscovitine (Seliciclib or CYC202) markedly enhances resoln. of established neutrophil-dependent inflammation in carrageenan-elicited acute pleurisy, bleomycin-induced lung injury, and passively induced arthritis in mice.  In the pleurisy model, the caspase inhibitor zVAD-fmk prevents R-roscovitine-enhanced resoln. of inflammation, indicating that this CDK inhibitor augments inflammatory cell apoptosis.  The authors also provide evidence that R-roscovitine promotes apoptosis by reducing concns. of the anti-apoptotic protein Mcl-1.  Thus, CDK inhibitors enhance the resoln. of established inflammation by promoting apoptosis of inflammatory cells, thereby demonstrating a hitherto unrecognized potential for the treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrgjIOkXitzrVg90H21EOLACvtfcHk0liBV97g2Cf8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFClur8%253D&md5=022715d2e6890ee33c5f53ebdbc46e15</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm1468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1468%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BG.%26aulast%3DSawatzky%26aufirst%3DD.%2BA.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DSheldrake%26aufirst%3DT.%2BA.%26aulast%3DRiley%26aufirst%3DN.%2BA.%26aulast%3DCaldicott%26aufirst%3DA.%26aulast%3DMartinez-Losa%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DT.%2BR.%26aulast%3DDuffin%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DM.%2BC.%26aulast%3DBrady%26aufirst%3DH.%2BJ.%26aulast%3DSavill%26aufirst%3DJ.%2BS.%26aulast%3DDransfield%26aufirst%3DI.%26aulast%3DHaslett%26aufirst%3DC.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520enhance%2520the%2520resolution%2520of%2520inflammation%2520by%2520promoting%2520inflammatory%2520cell%2520apoptosis%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1056%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nutley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClue, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15657360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=125-139&author=B.+P.+Nutleyauthor=F.+I.+Raynaudauthor=S.+C.+Wilsonauthor=P.+M.+Fischerauthor=A.+Hayesauthor=P.+M.+Goddardauthor=S.+J.+McClueauthor=M.+Jarmanauthor=D.+P.+Laneauthor=P.+Workman&title=Metabolism+and+pharmacokinetics+of+the+cyclin-dependent+kinase+inhibitor+R-roscovitine+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse</span></div><div class="casAuthors">Nutley, Bernard P.; Raynaud, Florence I.; Wilson, Stuart C.; Fischer, Peter M.; Hayes, Angela; Goddard, Phyllis M.; McClue, Steven J.; Jarman, Michael; Lane, David P.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-139</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">R-roscovitine (seliciclib, CYC202) is a cyclin-dependent kinase inhibitor currently in phase II clin. trials in patients with cancer.  Here, we describe its mouse metab. and pharmacokinetics as well as the identification of the principal metabolites in hepatic microsomes, plasma, and urine.  Following microsomal incubation of R-roscovitine at 10 μg/mL (28 μmol/L) for 60 min, 86.7% of the parent drug was metabolized and 60% of this loss was due to formation of one particular metabolite.  This was identified as the carboxylic acid resulting from oxidn. of the hydroxymethyl group of the amino alc. substituent at C2 of the purine core present in R-roscovitine.  Identification was confirmed by chem. synthesis and comparison of an authentic sample of the R-roscovitine-derived carboxylate metabolite (COOH-R-roscovitine).  Other minor metabolites were identified as C8-oxo-R-roscovitine and N9-desisopropyl-R-roscovitine; these accounted for 4.9% and 2.6% of the parent, resp.  The same metabolic pattern was obsd. in vivo, with a 4.5-fold lower AUC∞ for R-roscovitine (38μmol/L/h) than for COOH-R-roscovitine (174 μmol/L/h).  Excretion of R-roscovitine in the urine up to 24 h post-dosing accounted for an av. of only 0.02% of the administered dose of 50 mg/kg, whereas COOH-R-roscovitine represented 65% to 68% of the dose irresp. of the route of administration (i.v., i.p., or p.o.).  A partially deuterated deriv. (R-roscovitine-d9) was synthesized to investigate if formation of COOH-R-roscovitine could be inhibited by replacement of metabolically labile protons with deuterium.  After 60 min of incubation of R-roscovitine-d9 or R-roscovitine with mouse liver microsomes, formation of COOH-R-roscovitine-d9 was decreased by ∼24% compared with the prodn. of COOH-R-roscovitine.  In addn., the levels of R-roscovitine-d9 remaining were 33% higher than those of R-roscovitine.  However, formation of several minor R-roscovitine metabolites was enhanced with R-roscovitine-d9, suggesting that metabolic switching from the major carbinol oxidn. pathway had occurred.  Synthetic COOH-R-roscovitine and C8-oxo-R-roscovitine were tested in functional cyclin-dependent kinase assays and shown to be less active than R-roscovitine, confirming that these metabolic reactions are deactivation pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBj5J1kUae7Vg90H21EOLACvtfcHk0lh_T_7gvE_CDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFyqtA%253D%253D&md5=5607206b139c515dae5ec69729059af7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutley%26aufirst%3DB.%2BP.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWilson%26aufirst%3DS.%2BC.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DGoddard%26aufirst%3DP.%2BM.%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DMetabolism%2520and%2520pharmacokinetics%2520of%2520the%2520cyclin-dependent%2520kinase%2520inhibitor%2520R-roscovitine%2520in%2520the%2520mouse%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D125%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Vita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Rehim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, M.</span><span> </span><span class="NLM_article-title">Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.ejps.2005.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15854805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=91-103&author=M.+Vitaauthor=M.+Abdel-Rehimauthor=S.+Olofssonauthor=Z.+Hassanauthor=L.+Meurlingauthor=A.+Sidenauthor=M.+Sidenauthor=T.+Petterssonauthor=M.+Hassan&title=Tissue+distribution%2C+pharmacokinetics+and+identification+of+roscovitine+metabolites+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat</span></div><div class="casAuthors">Vita, Marina; Abdel-Rehim, Mohamed; Olofsson, Susanne; Hassan, Zuzana; Meurling, Lennart; Siden, Aake; Siden, Mabel; Pettersson, Tommy; Hassan, Moustapha</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-103</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacokinetics, biodistribution and the metabolic pathway of roscovitine were investigated in Sprague-Dawley rats after a single i.v. dose of 25 mg/kg.  Blood, lungs, kidney, liver, testis, adipose tissue, spleen and brain were removed at different time-points.  Plasma and tissue samples were analyzed using high performance liq. chromatog.  The metabolites were identified using liq. chromatog./tandem mass spectrometry and NMR spectroscopy.  Roscovitine (MW = 354) was cleared rapidly from circulation and highly distributed to the tissues.  The elimination half-life of roscovitine in plasma and tissues was short (<30 min).  A major metabolite (M1) was obsd. mainly in plasma and in lower levels in all other tissues.  M1 was identified as conversion of the hydroxyl-group at C2 to carboxylic acid (MW = 368).  A second metabolite (M2) was obsd. mainly in liver and kidney and identified as a hydroxylation product of the C8 of the purine-ring (MW = 370).  A third metabolite (M3) was found in several organs and corresponded to N-dealkylation of the N9-iso-Pr side-chain (MW = 312).  Roscovitine concns. in the brain were 30% of that obsd. in plasma, however no metabolites were detected in brain.  In this investigation, three major metabolites of roscovitine were isolated and identified.  Also, it was shown that roscovitine eliminates rapidly from both blood and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCxxGyXcWbLVg90H21EOLACvtfcHk0lh_T_7gvE_CDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Kmsro%253D&md5=c4b7c6c0f7876cb67fb7ee6c91326262</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DVita%26aufirst%3DM.%26aulast%3DAbdel-Rehim%26aufirst%3DM.%26aulast%3DOlofsson%26aufirst%3DS.%26aulast%3DHassan%26aufirst%3DZ.%26aulast%3DMeurling%26aufirst%3DL.%26aulast%3DSiden%26aufirst%3DA.%26aulast%3DSiden%26aufirst%3DM.%26aulast%3DPettersson%26aufirst%3DT.%26aulast%3DHassan%26aufirst%3DM.%26atitle%3DTissue%2520distribution%252C%2520pharmacokinetics%2520and%2520identification%2520of%2520roscovitine%2520metabolites%2520in%2520rat%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D25%26spage%3D91%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lh_T_7gvE_CDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule−kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%88%92kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2588%2592kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierick, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaechtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Roscovitine targets, protein kinases and pyridoxal kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31208</span><span class="NLM_x">–</span> <span class="NLM_lpage">31219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31208-31219&author=S.+Bachauthor=M.+Knockaertauthor=J.+Reinhardtauthor=O.+Lozachauthor=S.+Schmittauthor=B.+Baratteauthor=M.+Kokenauthor=S.+P.+Coburnauthor=L.+Tangauthor=T.+Jiangauthor=D.-C.+Liangauthor=H.+Galonsauthor=J.-F.+Dierickauthor=L.+A.+Pinnaauthor=F.+Meggioauthor=F.+Totzkeauthor=C.+Schaechteleauthor=A.+S.+Lermanauthor=A.+Carneroauthor=Y.+Wanauthor=N.+Grayauthor=L.+Meijer&title=Roscovitine+targets%2C+protein+kinases+and+pyridoxal+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DS.%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DSchmitt%26aufirst%3DS.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DKoken%26aufirst%3DM.%26aulast%3DCoburn%26aufirst%3DS.%2BP.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DD.-C.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DDierick%26aufirst%3DJ.-F.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSchaechtele%26aufirst%3DC.%26aulast%3DLerman%26aufirst%3DA.%2BS.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520targets%252C%2520protein%2520kinases%2520and%2520pyridoxal%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31208%26epage%3D31219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lhPeGHugIQjhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1111%2Fj.1460-9568.2006.05226.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17241267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=59-68&author=J.+Z.+Wangauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Kinases+and+phosphatases+and+tau+sites+involved+in+Alzheimer+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span></div><div class="casAuthors">Wang Jian-Zhi; Grundke-Iqbal Inge; Iqbal Khalid</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Microtubule associated protein (MAP) tau is abnormally hyperphosphorylated in Alzheimer's disease (AD) and related tauopathies; in this form it is the major protein subunit of paired helical filaments (PHF)/neurofibrillary tangles.  However, the nature of protein kinases and phosphatases and tau sites involved in this lesion has been elusive.  We investigated self-assembly and microtubule assembly promoting activities of hyperphosphorylated tau isolated from Alzheimer disease brain cytosol, the AD abnormally hyperphosphorylated tau (AD P-tau) before and after dephosphorylation by phosphoseryl/phosphothreonyl protein phosphatase-2A (PP-2A), and then rephosphorylation by cyclic AMP-dependent protein kinase (PKA), calcium, calmodulin-dependent protein kinase II (CaMKII), glycogen synthase kinase-3beta (GSK-3beta) and cyclin-dependent protein kinase 5 (cdk5) in different kinase combinations.  We found that (i) dephosphorylation of AD P-tau by PP-2A inhibits its polymerization into PHF/straight filaments (SF) and restores its binding and ability to promote assembly of tubulin into microtubules; (ii) rephosphorylation of PP-2A-dephosphorylated AD P-tau by sequential phosphorylation by PKA, CaMKII and GSK-3beta or cdk5, and as well as by cdk5 and GSK-3beta, promotes its self-assembly into tangles of PHF similar to those seen in Alzheimer brain, and (iii) phosphorylation of tau sites required for this pathology are Thr231 and Ser262, along with several sites flanking the microtubule binding repeat region.  Phosphorylation of recombinant human brain tau(441) yielded similar results as the PP-2A dephosphorylated AD P-tau, except that mostly SF were formed.  The conditions for the abnormal hyperphosphorylation of tau that promoted its self-assembly also induced the microtubule assembly inhibitory activity.  These findings suggest that activation of PP-2A or inhibition of either both GSK-3beta and cdk5 or one of these two kinases plus PKA or CaMKII might be required to inhibit Alzheimer neurofibrillary degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI9DB-4K5ZmF1C8OJBvdfbfW6udTcc2eaL9bzRrsukvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D&md5=b8f8ba0a76085995f6c652cc737c55b2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2006.05226.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2006.05226.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DKinases%2520and%2520phosphatases%2520and%2520tau%2520sites%2520involved%2520in%2520Alzheimer%2520neurofibrillary%2520degeneration%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Mi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">The role of tau phosphorylation in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F156720506779025279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17168644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=449-463&author=K.+Miauthor=G.+V.+Johnson&title=The+role+of+tau+phosphorylation+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tau phosphorylation in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Mi, Kaihong; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau, which is abundantly expressed in neurons, is deposited in cells in an abnormally phosphorylated state as fibrillar lesions in numerous neurodegenerative diseases, with the most notable being Alzheimer's disease.  Tau plays a crucial role in the neuron as it binds and stabilizes microtubules, and can regulate axonal transport; functions that are regulated by site-specific phosphorylation events.  In pathol. conditions such as Alzheimer's disease and other tauopathies, tau is abnormally phosphorylated, and that this contributes to its dysfunction.  Given the increasing evidence that a disruption in the normal phosphorylation state of tau followed by conformational changes plays a key role in the pathogenic events that occur in Alzheimer's disease and other tauopathies; it is crit. to elucidate the regulation of tau phosphorylation.  This review focuses on recent literature pertaining to the regulation of tau phosphorylation and function, and the role that a dysregulation of tau phosphorylation may play in the neuronal dysfunction in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9dvtaMDpfbVg90H21EOLACvtfcHk0li3oFQWgtXd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM&md5=1e0ea8f6bceba1b430a44392ceb34181</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F156720506779025279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025279%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DThe%2520role%2520of%2520tau%2520phosphorylation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">Cdk5 deregulation in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=452-8&author=J.+C.+Cruzauthor=L.+H.+Tsai&title=Cdk5+deregulation+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DCdk5%2520deregulation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D452%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">GSK-3 is essential in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16914869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=309-17&author=A.+Takashima&title=GSK-3+is+essential+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 is essential in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">309-317</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) is a pivotal mol. in the development of Alzheimer's disease (AD).  GSK-3β is involved in the formation of paired helical filament (PHF)-tau, which is an integral component of the neurofibrillary tangle (NFT) deposits that disrupt neuronal function, and a marker of neurodegeneration in AD.  GSK-3β has exactly the same oligonucleotide sequence as tau-protein kinase I (TPKI), which was first purified from the microtubule fraction of bovine brain.  Initially, we discovered that GSK-3β was involved in amyloid-β (Aβ)-induced neuronal death in rat hippocampal cultures.  In the present review, we discuss our initial in vitro results and addnl. investigations showing that Aβ activates GSK-3β through impairment of phosphatidylinositol-3 (PI3)/Akt signaling; that Aβ-activated GSK-3β induces hyperphosphorylation of tau, NFT formation, neuronal death, and synaptic loss (all found in the AD brain); that GSK-3β can induce memory deficits in vivo; and that inhibition of GSK-3α (an isoform of GSK-3β) reduces Aβ prodn.  These combined results strongly suggest that GSK-3 activation is a crit. step in brain aging and the cascade of detrimental events in AD, preceding both the NFT and neuronal death pathways.  Therefore, therapeutics targeted to inhibiting GSK-3 may be beneficial in the treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4pguAPgiQLVg90H21EOLACvtfcHk0li3oFQWgtXd3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKktLo%253D&md5=d7157eb2d6a985a3489bb143113d7500</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DGSK-3%2520is%2520essential%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D309%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Phiel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=435-439&author=C.+J.+Phielauthor=C.+A.+Wilsonauthor=V.+M.+Leeauthor=P.+S.+Klein&title=GSK-3alpha+regulates+production+of+Alzheimer%E2%80%99s+disease+amyloid-beta+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DWilson%26aufirst%3DC.%2BA.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DGSK-3alpha%2520regulates%2520production%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-beta%2520peptides%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-beta formation by casein kinase I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-64&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-beta+formation+by+casein+kinase+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-beta%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Aulia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B. L.</span><span> </span><span class="NLM_article-title">Cdh1-APC/C, cyclin B-Cdc2, and Alzheimer’s disease pathology</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2006&pages=1-6&author=S.+Auliaauthor=B.+L.+Tang&title=Cdh1-APC%2FC%2C+cyclin+B-Cdc2%2C+and+Alzheimer%E2%80%99s+disease+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAulia%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DB.%2BL.%26atitle%3DCdh1-APC%252FC%252C%2520cyclin%2520B-Cdc2%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathology%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D339%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlund, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer’s disease</span> <span class="citation_source-journal">Dementia Geriatr. Cognit. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1159%2F000088634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16192727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1aiurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=367-374&author=A.+Johanssonauthor=H.+Zetterbergauthor=H.+Hampelauthor=K.+Buergerauthor=J.+A.+Princeauthor=L.+Minthonauthor=L.+O.+Wahlundauthor=K.+Blennow&title=Genetic+association+of+CDC2+with+cerebrospinal+fluid+tau+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease</span></div><div class="casAuthors">Johansson, Annica; Zetterberg, Henrik; Hampel, Harald; Buerger, Katharina; Prince, Jonathan A.; Minthon, Lennart; Wahlund, Lars-Olof; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Dementia and Geriatric Cognitive Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">DGCDFX</span>;
        ISSN:<span class="NLM_cas:issn">1420-8008</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have recently reported that a polymorphism in the cell division cycle (CDC2)gene, designated Ex6 + 7I/D, is assocd. with Alzheimer's disease (AD).  The CDC2 gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD.  Active cdc2 accumulates in neurons contg. neurofibrillary tangles (NFT), a process that can precede the formation of NFT.  Therefore, CDC2is a promising candidate susceptibility gene for AD.  We investigated the possible effects of the CDC2 polymorphism on cerebrospinal fluid (CSF) biomarkers in AD patients.  CDC2 genotypes were evaluated in relation to CSF protein levels of total tau, phospho-tau and β-amyloid(1-42) in AD patients and control individuals, and in relation to the amt. of senile plaques and NFT in the frontal cortex and in the hippocampus in patients with autopsy-proven AD and controls.  The CDC2 Ex6 + 7I allele was assocd. with a gene dose-dependent increase of CSF total tau levels (F2, 626 = 7.0, p = 0.001) and the homozygous CDC2 Ex6 + 7II genotype was significantly more frequent among AD patients compared to controls (p = 0.006, OR = 1.57, 95% CI 1.13-2.17).  Our results provide further evidence for an involvement of cdc2 in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0nJEP6Okt67Vg90H21EOLACvtfcHk0lizu_B3RJql-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1aiurvO&md5=bf664d515fa435d51be5c746ce4fe14f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000088634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000088634%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBuerger%26aufirst%3DK.%26aulast%3DPrince%26aufirst%3DJ.%2BA.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DWahlund%26aufirst%3DL.%2BO.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DGenetic%2520association%2520of%2520CDC2%2520with%2520cerebrospinal%2520fluid%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2005%26volume%3D20%26spage%3D367%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer’s disease neurofibrillary degeneration</span> <span class="citation_source-journal">Acta Neuropathol. (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12200623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFGrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2002&pages=369-376&author=J.+J.+Peiauthor=H.+Braakauthor=C.+X.+Gongauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=B+Winbladauthor=R.+F.+Cowburn&title=Up-regulation+of+cell+division+cycle+%28cdc%29+2+kinase+in+neurons+with+early+stage+Alzheimer%E2%80%99s+disease+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration</span></div><div class="casAuthors">Pei, Jin-Jing; Braak, Heiko; Gong, Cheng-Xin; Grundke-Iqbal, Inge; Iqbal, Khalid; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">369-376</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The major component of Alzheimer's disease (AD) neurofibrillary tangles (NFTs) is abnormally hyperphosphorylated tau aggregated as paired helical filaments (PHFs).  Cell division cycle (cdc) 2 kinase is one of the main candidate kinases that phosphorylates normal tau in vitro at several sites seen in PHF-tau.  Using brains staged according to Braak and Braak criteria, we investigated the role of cdc2 in neurofibrillary changes in the hippocampal formation, and the entorhinal and temporal cortices.  Neurons with tangle-like inclusions pos. for active cdc2 were found to appear first in the Pre-α layer of the entorhinal cortex, and then extend to other brain regions co-incident with the progressive sequence of neurofibrillary changes.  This predictable progressive pattern is not assocd. with amyloid.  The intraneuronal accumulation of active cdc2 appeared to precede the deposition of PHF-tau phosphorylated at Ser 202/Thr 205 sites.  These data are consistent with the notion that cdc2 might be involved in the abnormal hyperphosphorylation of tau and consequently aggregation of tau into PHF at an early stage and that increased cdc2 activity is not consequent to the deposition of β-amyloid in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB91vksOg9VbVg90H21EOLACvtfcHk0li-FFNWlnAeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFGrtro%253D&md5=1dfee72e3e3eee6cec11f7186a0dc50d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DWinblad%26aufirst%3DB%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DUp-regulation%2520of%2520cell%2520division%2520cycle%2520%2528cdc%2529%25202%2520kinase%2520in%2520neurons%2520with%2520early%2520stage%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520degeneration%26jtitle%3DActa%2520Neuropathol.%2520%2528Berlin%2529%26date%3D2002%26volume%3D104%26spage%3D369%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canudas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span> </span><span class="NLM_article-title">The role of CDK5/P25 formation/inhibition in neurodegeneration</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1358%2Fdnp.2006.19.8.1043961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17160145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=453-460&author=A.+Caminsauthor=E.+Verdaguerauthor=J.+Folchauthor=A.+M.+Canudasauthor=M.+Pallas&title=The+role+of+CDK5%2FP25+formation%2Finhibition+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CDK5/P25 formation/inhibition in neurodegeneration</span></div><div class="casAuthors">Camins, Antoni; Verdaguer, Ester; Folch, Jaume; Canudas, Anna Maria; Pallas, Merce</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cdk5 is an atypical cyclin-dependent kinase localized in the brain, and its activity is dependent upon binding to p35/p39.  In addn., while cdk5 has important physiol. functions related to brain development, the breakdown of cdk5/p35 into cdk5/p25 increases its kinase activity and neurotoxicity.  Interestingly, in recent years increased cdk5/p25 expression has been demonstrated in the brains of patients with Alzheimer's and Parkinson's diseases.  Exptl. studies performed in neuronal cell cultures indicate that cdk5/p25 plays a prominent role in apoptosis.  Moreover, an apoptotic pathway, via an intracellular calcium increase following calpain activation and cdk5/p25 formation, has been postulated.  Cdk5/p25 subsequently phosphorylates the nuclear transcription factor myocyte enhancer factor (MEF2), thereby inhibiting its prosurvival activity.  However, cdk5/p25 could phosphorylate other substrates such as tau and p53, as well as the retinoblastoma protein pRb.  All these data lend credence to the hypothesis that cdk5/p25 acts as a master regulator of neuronal cell death.  In addn., cdk5/p25 might also interact with other pathways such as glycogen synthetase kinase 3β (GSK3β) and c-JUN kinase.  Drugs like roscovitine, flavopiridol, calpain inhibitors, kenpaullone and induribins, which inhibit cdk5/p25 formation, constitute potential drugs for the treatment of neurol. disorders.  Furthermore, the dual inhibitory effect of some of these drugs on cdk5 and GSK3β could be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOxQ0IEe0BrVg90H21EOLACvtfcHk0li-FFNWlnAeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Cktw%253D%253D&md5=7cc22392cdc933c8aac503cbb8a0cede</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2006.19.8.1043961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2006.19.8.1043961%26sid%3Dliteratum%253Aachs%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DCanudas%26aufirst%3DA.%2BM.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520CDK5%252FP25%2520formation%252Finhibition%2520in%2520neurodegeneration%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2006%26volume%3D19%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">10536</span><span class="NLM_x">–</span> <span class="NLM_lpage">10541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.3133-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17035538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFegurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10536-10541&author=J.+C.+Cruzauthor=D.+Kimauthor=L.+Y.+Moyauthor=M.+M.+Dobbinauthor=X.+Sunauthor=R.+T.+Bronsonauthor=L.+H.+Tsai&title=p25%2Fcyclin-dependent+kinase+5+induces+production+and+intraneuronal+accumulation+of+amyloid+beta+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo</span></div><div class="casAuthors">Cruz, Jonathan C.; Kim, Dohoon; Moy, Lily Y.; Dobbin, Matthew M.; Sun, Xiaoyan; Bronson, Roderick T.; Tsai, Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10536-10541</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Aberrant processing of the amyloid precursor protein (APP) and the subsequent accumulation of amyloid β (Aβ) peptide has been widely established as a central event in Alzheimer's disease (AD) pathogenesis.  The sequential cleavage steps required for the generation of Aβ are well outlined; however, there is a relative dearth of knowledge pertaining to signaling pathways and mol. mechanisms that can modulate this process.  Here, we demonstrate a novel role for p25/cyclin-dependent kinase 5 (Cdk5) in regulating APP processing, Aβ peptide generation, and intraneuronal Aβ accumulation in inducible p25 transgenic and compd. PD-APP transgenic mouse models that demonstrate deregulated Cdk5 activity and a neurodegenerative phenotype.  Induction of p25 resulted in enhanced forebrain Aβ levels before any evidence of neuropathol. in these mice.  Intracellular Aβ accumulated in perinuclear regions and distended axons within the forebrains of these mice.  Evidence for modulations in axonal transport or β-site APP cleaving enzyme 1 protein levels and activity are presented as mechanisms that may account for the Aβ accumulation caused by p25/Cdk5 deregulation.  Collectively, these findings delineate a novel pathol. mechanism involving aberrant APP processing by p25/Cdk5 and have important implications in AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVz0iGp5L1DrVg90H21EOLACvtfcHk0ljYiCtOr9sM5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFegurzJ&md5=de2f38810b69f4c3dc6a8108cf2baaa1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3133-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3133-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DDobbin%26aufirst%3DM.%2BM.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3Dp25%252Fcyclin-dependent%2520kinase%25205%2520induces%2520production%2520and%2520intraneuronal%2520accumulation%2520of%2520amyloid%2520beta%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10536%26epage%3D10541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17100579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1389-1397&author=H.+C.+Huangauthor=P.+S.+Klein&title=Multiple+roles+for+glycogen+synthase+kinase-3+as+a+drug+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple roles for glycogen synthase kinase-3 as a drug target in alzheimer's disease</span></div><div class="casAuthors">Huang, Hui-Chuan; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1389-1397</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder that presents clin. as inexorable cognitive impairment and decline in performance of activities of daily living.  AD is characterized pathol. by neuronal depopulation, extracellular amyloid plaques, and intraneuronal accumulation of neurofibrillary tangles (NFTs).  Accumulation of these polypeptide aggregates is generally believed to be integral to the pathogenesis of AD.  Recent evidence implicates the protein kinase glycogen synthase kinase 3 (GSK-3) in the regulation of both of these processes.  GSK-3 has long been studied as one of several tau protein kinases, and has more recently been shown to be involved in the generation of Aβ peptides.  GSK-3 activity may also promote cell death and conversely, inhibition of GSK-3 has been assocd. with increased cell survival under a variety of cytotoxic conditions.  Thus drugs that target GSK-3 could attack AD pathogenesis on multiple fronts simultaneously.  Here we will briefly review the mol. understanding of AD pathogenesis as it stands at this point, and then discuss the emerging role of GSK-3 in regulating these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpauigv98zKTLVg90H21EOLACvtfcHk0ljYiCtOr9sM5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FE&md5=78732ad65a149a092327eb614acad091</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DMultiple%2520roles%2520for%2520glycogen%2520synthase%2520kinase-3%2520as%2520a%2520drug%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D1389%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rockenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-on, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.4321-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17314294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1981-1991&author=E.+Rockensteinauthor=M.+Torranceauthor=A.+Adameauthor=M.+Manteauthor=P.+Bar-onauthor=J.+B.+Roseauthor=L.+Crewsauthor=E.+Masliah&title=Neuroprotective+effects+of+regulators+of+the+glycogen+synthase+kinase-3beta+signaling+pathway+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease+are+associated+with+reduced+amyloid+precursor+protein+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation</span></div><div class="casAuthors">Rockenstein, Edward; Torrance, Magdalena; Adame, Anthony; Mante, Michael; Bar-on, Pazit; Rose, John B.; Crews, Leslie; Masliah, Eliezer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1981-1991</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The glycogen synthase kinase-3β (GSK3β) pathway plays an important role in mediating neuronal fate and synaptic plasticity.  In Alzheimer's disease (AD), abnormal activation of this pathway might play an important role in neurodegeneration, and compds. such as lithium that modulate GSK3β activity have been shown to reduce amyloid prodn. and tau phosphorylation in amyloid precursor protein (APP) transgenic (tg) mice.  However, it is unclear whether regulation of GSK3β is neuroprotective in APP tg mice.  In this context, the main objective of the present study was to det. whether pharmacol. or genetic manipulations that block the GSK3β pathway might ameliorate the neurodegenerative alterations in APP tg mice and to better understand the mechanisms involved.  For this purpose, two sets of expts. were performed.  First, tg mice expressing mutant human APP under the Thy1 promoter (hAPP tg) were treated with either lithium chloride or saline alone.  Second, hAPP tg mice were crossed with GSK3β tg mice, in which overexpression of this signaling mol. results in a dominant-neg. (DN) effect with inhibition of activity.  HAPP tg mice that were treated with lithium or that were crossed with DN-GSK3β tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation.  Moreover, reduced activation of GSK3β was assocd. with decreased levels of APP phosphorylation that resulted in decreased amyloid-β prodn.  In conclusion, the present study showed that modulation of the GSK3β signaling pathway might also have neuroprotective effects in tg mice by regulating APP maturation and processing and further supports the notion that GSK3β might be a suitable target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUuW0UdsjNrVg90H21EOLACvtfcHk0liMU6icJXVqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D&md5=a94686f980fa6039d682ce16759f838c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4321-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4321-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRockenstein%26aufirst%3DE.%26aulast%3DTorrance%26aufirst%3DM.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DMante%26aufirst%3DM.%26aulast%3DBar-on%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DL.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DNeuroprotective%2520effects%2520of%2520regulators%2520of%2520the%2520glycogen%2520synthase%2520kinase-3beta%2520signaling%2520pathway%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520are%2520associated%2520with%2520reduced%2520amyloid%2520precursor%2520protein%2520phosphorylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Rockenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-on, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.4321-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17314294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1981-1991&author=E.+Rockensteinauthor=M.+Torranceauthor=A.+Adameauthor=M.+Manteauthor=P.+Bar-onauthor=J.+B.+Roseauthor=L.+Crewsauthor=E.+Masliah&title=Neuroprotective+effects+of+regulators+of+the+glycogen+synthase+kinase-3beta+signaling+pathway+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease+are+associated+with+reduced+amyloid+precursor+protein+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation</span></div><div class="casAuthors">Rockenstein, Edward; Torrance, Magdalena; Adame, Anthony; Mante, Michael; Bar-on, Pazit; Rose, John B.; Crews, Leslie; Masliah, Eliezer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1981-1991</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The glycogen synthase kinase-3β (GSK3β) pathway plays an important role in mediating neuronal fate and synaptic plasticity.  In Alzheimer's disease (AD), abnormal activation of this pathway might play an important role in neurodegeneration, and compds. such as lithium that modulate GSK3β activity have been shown to reduce amyloid prodn. and tau phosphorylation in amyloid precursor protein (APP) transgenic (tg) mice.  However, it is unclear whether regulation of GSK3β is neuroprotective in APP tg mice.  In this context, the main objective of the present study was to det. whether pharmacol. or genetic manipulations that block the GSK3β pathway might ameliorate the neurodegenerative alterations in APP tg mice and to better understand the mechanisms involved.  For this purpose, two sets of expts. were performed.  First, tg mice expressing mutant human APP under the Thy1 promoter (hAPP tg) were treated with either lithium chloride or saline alone.  Second, hAPP tg mice were crossed with GSK3β tg mice, in which overexpression of this signaling mol. results in a dominant-neg. (DN) effect with inhibition of activity.  HAPP tg mice that were treated with lithium or that were crossed with DN-GSK3β tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation.  Moreover, reduced activation of GSK3β was assocd. with decreased levels of APP phosphorylation that resulted in decreased amyloid-β prodn.  In conclusion, the present study showed that modulation of the GSK3β signaling pathway might also have neuroprotective effects in tg mice by regulating APP maturation and processing and further supports the notion that GSK3β might be a suitable target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUuW0UdsjNrVg90H21EOLACvtfcHk0liMU6icJXVqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D&md5=a94686f980fa6039d682ce16759f838c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4321-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4321-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRockenstein%26aufirst%3DE.%26aulast%3DTorrance%26aufirst%3DM.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DMante%26aufirst%3DM.%26aulast%3DBar-on%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DL.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DNeuroprotective%2520effects%2520of%2520regulators%2520of%2520the%2520glycogen%2520synthase%2520kinase-3beta%2520signaling%2520pathway%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520are%2520associated%2520with%2520reduced%2520amyloid%2520precursor%2520protein%2520phosphorylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seereeram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span> </span><span class="NLM_article-title">Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">23645</span><span class="NLM_x">–</span> <span class="NLM_lpage">23654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=23645-23654&author=D.+P.+Hangerauthor=H.+L.+Byersauthor=S.+Wrayauthor=K.+Y.+Leungauthor=M.+J.+Saxtonauthor=A.+Seereeramauthor=C.+H.+Reynoldsauthor=M.+A.+Wardauthor=B.+H.+Anderton&title=Novel+phosphorylation+sites+in+tau+from+Alzheimer+brain+support+a+role+for+casein+kinase+1+in+disease+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DByers%26aufirst%3DH.%2BL.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DK.%2BY.%26aulast%3DSaxton%26aufirst%3DM.%2BJ.%26aulast%3DSeereeram%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DWard%26aufirst%3DM.%2BA.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520phosphorylation%2520sites%2520in%2520tau%2520from%2520Alzheimer%2520brain%2520support%2520a%2520role%2520for%2520casein%2520kinase%25201%2520in%2520disease%2520pathogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D23645%26epage%3D23654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15938</span><span class="NLM_x">–</span> <span class="NLM_lpage">15945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15938-15945&author=G.+Liauthor=H.+Yinauthor=J.+Kuret&title=Casein+kinase+1+delta+phosphorylates+tau+and+disrupts+its+binding+to+microtubules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCasein%2520kinase%25201%2520delta%2520phosphorylates%2520tau%2520and%2520disrupts%2520its%2520binding%2520to%2520microtubules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15938%26epage%3D15945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Singh, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1046%2Fj.1471-4159.1995.64031420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=7532213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=1420-1423&author=T.+J.+Singhauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Phosphorylation+of+tau+protein+by+casein+kinase-1+converts+it+to+an+abnormal+Alzheimer-like+state"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of τ protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span></div><div class="casAuthors">Singh, Toolsee; Grundke-Iqbal, Inge; Iqbal, Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1420-3</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Microtubule-assocd. protein τ is abnormally hyperphosphorylated in Alzheimer's disease.  Both proline-dependent protein kinases (PDPKs) and non-PDPKs are involved in this hyperphosphorylation of τ.  Several PDPKs can phosphorylate τ in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies.  A similar induction has not been reported with non-PDPKs.  Here, the authors evaluated 6 non-PDPKs [cAMP-dependent (A-kinase), Ca2+/phospholipid-dependent (C-kinase), casein kinase-1 (CK-1), casein kinase-2 (CK-2), Ca2+/calmodulin-dependent protein kinase II, and Ca2+/calmodulin-dependent protein kinase from rat cerebellum] for their abilities to induce Alzheimer-like epitopes on τ.  Such epitopes were induced by A-kinase, C-kinase, CK-1, and CK-2, but the degree of induction achieved by CK-1 was much greater than with the other kinases.  These results suggest that CK-1 may play an important role in the conversion of τ from the normal to the abnormal phosphorylation state in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaaD_uS92HrVg90H21EOLACvtfcHk0lhTUmBT0KMiuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D&md5=3827ab9e85b4dc25ab1e3e02dd614a4d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64031420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64031420.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BJ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DPhosphorylation%2520of%2520tau%2520protein%2520by%2520casein%2520kinase-1%2520converts%2520it%2520to%2520an%2520abnormal%2520Alzheimer-like%2520state%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D1420%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Chang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.+T.+Changauthor=N.+G.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0ljlf_-Q4KayWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.%2BT.%26aulast%3DGray%26aufirst%3DN.%2BG.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, A. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeClerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1126%2Fscience.281.5376.533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=9677190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFCltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=533-538&author=N.+S.+Grayauthor=L.+Wodickaauthor=A.+W.+H.+Thunnissenauthor=T.+C.+Normanauthor=S.+Kwonauthor=F.+H.+Espinozaauthor=D.+O.+Morganauthor=G.+Barnesauthor=S.+LeClercauthor=L.+Meijerauthor=S-H.+Kimauthor=D.+J.+Lockhartauthor=P.+G.+Schultz&title=Exploiting+chemical+libraries%2C+structure%2C+and+genomics+in+the+search+for+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors</span></div><div class="casAuthors">Gray, Nathanael S.; Wodicka, Lisa; Thunnissen, Andy-Mark W. H.; Norman, Thea C.; Kwon, Soojin; Espinoza, F. Hernan; Morgan, David O.; Barnes, Georjana; LeClerc, Sophie; Meijer, Laurent; Kim, Sung-Hou; Lockhart, David J.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5376</span>),
    <span class="NLM_cas:pages">533-538</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Selective protein kinase inhibitors were developed on the basis of the unexpected binding mode of 2,6,9-trisubstituted purines to the ATP-binding site of the human cyclin-dependent kinase 2 (CDK2).  By iterating chem. library synthesis and biol. screening, potent inhibitors of the human CDK2-cyclin A kinase complex and of Saccharomyces cerevisiae Cdc28p were identified.  The structural basis for the binding affinity and selectivity was detd. by anal. of a three-dimensional crystal structure of a CDK2-inhibitor complex.  The cellular effects of these compds. were characterized in mammalian cells and yeast.  In the latter case the effects were characterized on a genome-wide scale by monitoring changes in mRNA levels in treated cells with high-d. oligonucleotide probe arrays.  Purine libraries could provide useful tools for analyzing a variety of signaling and regulatory pathways and may led to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRTOOPjk16tbVg90H21EOLACvtfcHk0ljlf_-Q4KayWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFCltr8%253D&md5=08b8debe4d05c1169c152ccd6676def8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5376.533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5376.533%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWodicka%26aufirst%3DL.%26aulast%3DThunnissen%26aufirst%3DA.%2BW.%2BH.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DEspinoza%26aufirst%3DF.%2BH.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3DLeClerc%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS-H.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DExploiting%2520chemical%2520libraries%252C%2520structure%252C%2520and%2520genomics%2520in%2520the%2520search%2520for%2520kinase%2520inhibitors%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D533%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A Concise and Traceless Linker Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8273</span><span class="NLM_x">–</span> <span class="NLM_lpage">8276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo016010f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8273-8276&author=S.+Dingauthor=N.+S.+Grayauthor=Q.+Dingauthor=P.+G.+Schultz&title=A+Concise+and+Traceless+Linker+Strategy+toward+Combinatorial+Libraries+of+2%2C6%2C9-Substituted+Purines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo016010f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016010f%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520Concise%2520and%2520Traceless%2520Linker%2520Strategy%2520toward%2520Combinatorial%2520Libraries%2520of%25202%252C6%252C9-Substituted%2520Purines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8273%26epage%3D8276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, Nathanael, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. and</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Resin-capture and release strategy toward combinatorial libraries of 2,6,9-substituted purines</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc010080i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=183-186&author=S.+Dingauthor=S.+Gray%2C+Nathanaelauthor=Q.+Dingauthor=X.+and+Wuauthor=P.+G.+Schultz&title=Resin-capture+and+release+strategy+toward+combinatorial+libraries+of+2%2C6%2C9-substituted+purines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Resin-Capture and Release Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines</span></div><div class="casAuthors">Ding, Sheng; Gray, Nathanael S.; Ding, Qiang; Wu, Xu; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-186</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A resin-capture and release strategy for making combinatorial 2,6,9-trisubstituted purine libraries is demonstrated by capturing N9-derivatized purines at the C6 position with a thio-modified polymer.  The C2 fluoro group is subsequently substituted with primary and secondary amines followed by thioether oxidn. and release by C6 substitution with amines and anilines.  This approach complements a previously reported strategy where a 6-phenylsulfenylpurine scaffold was captured at the C2 position with a resin-bound amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3l9Kkqq10p7Vg90H21EOLACvtfcHk0liQgz-U6d9W9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlOitg%253D%253D&md5=7a864bd42a6d2e288d0c413aceaf25b0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcc010080i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc010080i%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%252C%2BNathanael%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DX.%2Band%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DResin-capture%2520and%2520release%2520strategy%2520toward%2520combinatorial%2520libraries%2520of%25202%252C6%252C9-substituted%2520purines%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2002%26volume%3D4%26spage%3D183%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Brun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legraverend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span> </span><span class="NLM_article-title">Traceless solid-phase synthesis of 2,6,9- trisubstituted purines from resin bound 6-thiopurines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7911</span><span class="NLM_x">–</span> <span class="NLM_lpage">7923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=7911-7923&author=V.+Brunauthor=M.+Legraverendauthor=D.+S.+Grierson&title=Traceless+solid-phase+synthesis+of+2%2C6%2C9-+trisubstituted+purines+from+resin+bound+6-thiopurines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrun%26aufirst%3DV.%26aulast%3DLegraverend%26aufirst%3DM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26atitle%3DTraceless%2520solid-phase%2520synthesis%2520of%25202%252C6%252C9-%2520trisubstituted%2520purines%2520from%2520resin%2520bound%25206-thiopurines%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D7911%26epage%3D7923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Abraham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, L.</span><span> </span><span class="NLM_article-title">NMR Method for the determination of solute hydrogen bond acidity</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052631n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3389-3394&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=J.+Byrneauthor=L.+Griffiths&title=NMR+Method+for+the+determination+of+solute+hydrogen+bond+acidity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Byrne, Jonathan; Griffiths, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is shown that the difference in the 1H NMR chem. shift of a protic hydrogen in DMSO and CDCl3 solvents is directly related to the overall, or summation, hydrogen bond acidity for a wide range of solutes.  This provides a new and direct method of measuring the hydrogen bond acidity.  For 54 compds., the obsd. shifts for 72 protic hydrogens could be correlated to the Abraham solute hydrogen bond acidity parameter, A, with a correlation coeff. squared, R2, of 0.938 and a std. deviation, SD, of 0.054 units in A.  A training equation that used half the data could predict A values for the remaining data with an av. error of 0.001 and a std. deviation, SD, of 0.053 units, thus demonstrating the predictive power of the method.  Unlike any previous method for the detn. of solute hydrogen bond acidities, the NMR method allows the detn. of A values for individual protic hydrogens in multifunctional solutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjlb-QytDX37Vg90H21EOLACvtfcHk0lgW1UJaiEc6Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D&md5=6c74f59a2aba5d0ac75d2bbb842c97ea</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo052631n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052631n%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DGriffiths%26aufirst%3DL.%26atitle%3DNMR%2520Method%2520for%2520the%2520determination%2520of%2520solute%2520hydrogen%2520bond%2520acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3389%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, D. C.</span><span> </span><span class="NLM_article-title">Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31220</span><span class="NLM_x">–</span> <span class="NLM_lpage">31229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31220-31229&author=L.+Tangauthor=M.+H.+Liauthor=P.+Caoauthor=F.+Wangauthor=W.+R.+Changauthor=S.+Bachauthor=J.+Reinhardtauthor=Y.+Ferandinauthor=H.+Galonsauthor=Y.+Wanauthor=N.+Grayauthor=L.+Meijerauthor=T.+Jiangauthor=D.+C.+Liang&title=Crystal+structure+of+pyridoxal+kinase+in+complex+with+roscovitine+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DW.%2BR.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DD.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520pyridoxal%2520kinase%2520in%2520complex%2520with%2520roscovitine%2520and%2520derivatives%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31220%26epage%3D31229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer’s disease; A property common to most CDK inhibitors?</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=251-260&author=S.+Leclercauthor=M.+Garnierauthor=R.+Hoesselauthor=D.+Markoauthor=J.+A.+Bibbauthor=G.+L.+Snyderauthor=P.+Greengardauthor=J.+Biernatauthor=Y.+Z.+Wuauthor=E.-M.+Mandelkowauthor=G.+Eisenbrandauthor=L.+Meijer&title=Indirubins+inhibit+glycogen+synthase+kinase-3%CE%B2+and+CDK5%2Fp25%2C+two+protein+kinases+involved+in+abnormal+tau+phosphorylation+in+Alzheimer%E2%80%99s+disease%3B+A+property+common+to+most+CDK+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DHoessel%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DIndirubins%2520inhibit%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520and%2520CDK5%252Fp25%252C%2520two%2520protein%2520kinases%2520involved%2520in%2520abnormal%2520tau%2520phosphorylation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520A%2520property%2520common%2520to%2520most%2520CDK%2520inhibitors%253F%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J.; Galons, H.; Meijer, L.</span><span> </span><span class="NLM_article-title">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><span class="refDoi"> DOI: in press</span> .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+Bettayeb&author=N.+Oumata&author=A.+Echalier&author=Y.+Ferandin&author=J.+Endicott&author=H.+Galons&author=L.+Meijer&title=CR8%2C+a+potent+and+selective%2C+roscovitine-derived+inhibitor+of+cyclin-dependent+kinases&doi=in+press"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26atitle%3DCR8%252C%2520a%2520potent%2520and%2520selective%252C%2520roscovitine-derived%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DOncogene%26date%3D2008%26doi%3Din+press" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span> </span><span class="NLM_article-title">An integrated computational approach to the phenomenon of potent and selective inhibition of Aurora kinases B and C by a series of 7-substituted indirubins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4027</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4027-4037&author=V.+Myrianthopoulosauthor=P.+Magiatisauthor=Y.+Ferandinauthor=A.-L.+Skaltsounisauthor=L.+Meijerauthor=E.+Mikros&title=An+integrated+computational+approach+to+the+phenomenon+of+potent+and+selective+inhibition+of+Aurora+kinases+B+and+C+by+a+series+of+7-substituted+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm070077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070077z%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26atitle%3DAn%2520integrated%2520computational%2520approach%2520to%2520the%2520phenomenon%2520of%2520potent%2520and%2520selective%2520inhibition%2520of%2520Aurora%2520kinases%2520B%2520and%2520C%2520by%2520a%2520series%2520of%25207-substituted%2520indirubins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4027%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">Macromodel: an intergrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=Macromodel%3A+an+intergrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacromodel%253A%2520an%2520intergrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Gouet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courcelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metoz, F.</span><span> </span><span class="NLM_article-title">ESPript: analysis of multiple sequence alignments in PostScript</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1093%2Fbioinformatics%2F15.4.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=10320398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1MXjslCmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=305-308&author=P.+Gouetauthor=E.+Courcelleauthor=D.+I.+Stuartauthor=F.+Metoz&title=ESPript%3A+analysis+of+multiple+sequence+alignments+in+PostScript"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ESPript: analysis of multiple sequence alignments in PostScript</span></div><div class="casAuthors">Gouet, Patrice; Courcelle, Emmanuel; Stuart, David I.; Metoz, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-308</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The program ESPript (Easy Sequencing in PostScript) allows the rapid visualization, via PostScript output, of sequences aligned with popular programs such as CLUSTAL-W or GCG PILEUP.  It can read secondary structure files (such as that created by the program DSSP) to produce a synthesis of both sequence and structural information.  ESPript can be run via a command file or a friendly html-based user interface.  The program calcs. an homol. score by columns of residues and can sort this calcn. by groups of sequences.  It offers a palette of markers to highlight important regions in the alignment.  ESPript can also paste information on residue conservation into coordinate files, for subsequent visualization with a graphics program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf-fAq5SJgT7Vg90H21EOLACvtfcHk0lg6zyxw5T-m2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslCmtrY%253D&md5=6829ce0fbc54c94d93bc9d5fc8fd8f40</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2F15.4.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252F15.4.305%26sid%3Dliteratum%253Aachs%26aulast%3DGouet%26aufirst%3DP.%26aulast%3DCourcelle%26aufirst%3DE.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DMetoz%26aufirst%3DF.%26atitle%3DESPript%253A%2520analysis%2520of%2520multiple%2520sequence%2520alignments%2520in%2520PostScript%26jtitle%3DBioinformatics%26date%3D1999%26volume%3D15%26spage%3D305%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span>JAGUAR 4.2; <span class="NLM_publisher-name">Schrödinger, Inc.</span>, <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">1991−2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JAGUAR+4.2%3B+Schr%C3%B6dinger%2C+Inc.%2C+Portland%2C+OR%2C+1991%E2%88%922000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJAGUAR%25204.2%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1991%25E2%2588%25922000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Boys, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, F.</span><span> </span><span class="NLM_article-title">Calculation of small molecular interactions by differences of separate total energies. Some procedures with reduced errors</span> <span class="citation_source-journal">Mol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1970&pages=553-566&author=S.+F.+Boysauthor=F.+Bernardi&title=Calculation+of+small+molecular+interactions+by+differences+of+separate+total+energies.+Some+procedures+with+reduced+errors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DS.%2BF.%26aulast%3DBernardi%26aufirst%3DF.%26atitle%3DCalculation%2520of%2520small%2520molecular%2520interactions%2520by%2520differences%2520of%2520separate%2520total%2520energies.%2520Some%2520procedures%2520with%2520reduced%2520errors%26jtitle%3DMol.%2520Phys.%26date%3D1970%26volume%3D19%26spage%3D553%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Ribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boix, J.</span><span> </span><span class="NLM_article-title">Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.yexcr.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15051486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Whu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2004&pages=9-24&author=J.+Ribasauthor=J.+Boix&title=Cell+differentiation%2C+caspase+inhibition%2C+and+macromolecular+synthesis+blockage%2C+but+not+BCL-2+or+BCL-XL+proteins%2C+protect+SH-SY5Y+cells+from+apoptosis+triggered+by+two+CDK+inhibitory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs</span></div><div class="casAuthors">Ribas, Judit; Boix, Jacint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-24</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Olomoucine and roscovitine are two ATP-competing compds. described as specific inhibitors of cyclin-dependent kinases (CDK).  Both drugs showed to induce apoptosis in SH-SY5Y, a neuroblastoma-derived cell line.  In these cells, neither Bcl-2 nor Bcl-XL overexpression conferred any resistance to both drugs.  However, a partial protective effect was detected when cells were treated with a general inhibitor of caspases (zVADfmk), cycloheximide (CHX), or actinomycin D (DAct).  Interestingly, a synergism in cell protection was obsd. between zVADfmk and macromol. synthesis inhibitors, thus suggesting different apoptotic pathways in distinct subpopulations of the cell culture.  On the other hand, no lethality was found when cells were treated with either PD98059 or UO126.  This discarded Erk1/Erk2 inhibition as the cause of apoptosis.  Furthermore, SH-SY5Y cells became resistant to either Olomoucine or Roscovitine upon the induction of differentiation.  This resistance correlated with the extent of differentiation and, therefore, the no. of cells entering a quiescent state.  In conclusion, the results seem to support a role for CDK inhibition as the cause of the apoptotic process triggered by olomoucine and roscovitine.  Both compds. are promising anticancer drugs., at least for the treatment of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvNQ_XHcCZ7Vg90H21EOLACvtfcHk0lhL42njxVxaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Whu78%253D&md5=e196d961db076496865e8b68e06b31cd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DJ.%26aulast%3DBoix%26aufirst%3DJ.%26atitle%3DCell%2520differentiation%252C%2520caspase%2520inhibition%252C%2520and%2520macromolecular%2520synthesis%2520blockage%252C%2520but%2520not%2520BCL-2%2520or%2520BCL-XL%2520proteins%252C%2520protect%2520SH-SY5Y%2520cells%2520from%2520apoptosis%2520triggered%2520by%2520two%2520CDK%2520inhibitory%2520drugs%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2004%26volume%3D295%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['ref3_1'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 93 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Radek Jorda, Libor Havlíček, Antonín Šturc, Diana Tušková, Lenka Daumová, Mahmudul Alam, Jana Škerlová, Michaela Nekardová, Miroslav Peřina, Tomáš Pospíšil, Jitka Široká, Lubor Urbánek, Petr Pachl, Pavlína Řezáčová, Miroslav Strnad, Pavel Klener, <span class="NLM_string-name hlFld-ContribAuthor">Vladimír Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4606-4623. <a href="https://doi.org/10.1021/acs.jmedchem.9b00189" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00189%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3%25252C5%25252C7-Substituted%252BPyrazolo%25255B4%25252C3-d%25255Dpyrimidine%252BInhibitors%252Bof%252BCyclin-Dependent%252BKinases%252Band%252BTheir%252BEvaluation%252Bin%252BLymphoma%252BModels%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30012019%26date%3D17042019%26date%3D03042019%26volume%3D62%26issue%3D9%26spage%3D4606%26epage%3D4623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radek Jorda, Denisa Hendrychová, Jiří Voller, Eva Řezníčková, Tomáš Gucký, <span class="NLM_string-name hlFld-ContribAuthor">Vladimír Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9105-9120. <a href="https://doi.org/10.1021/acs.jmedchem.8b00049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BSelective%252BAre%252BPharmacological%252BInhibitors%252Bof%252BCell-Cycle-Regulating%252BCyclin-Dependent%252BKinases%25253F%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31012018%26date%3D05102018%26date%3D20092018%26volume%3D61%26issue%3D20%26spage%3D9105%26epage%3D9120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soňa  Krajčovičová</span>, <span class="hlFld-ContribAuthor ">Tomáš  Gucký</span>, <span class="hlFld-ContribAuthor ">Denisa  Hendrychová</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, and <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>  . </span><span class="cited-content_cbyCitation_article-title">A Stepwise Approach for the Synthesis of Folic Acid Conjugates with Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13530-13541. <a href="https://doi.org/10.1021/acs.joc.7b02650" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02650%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BStepwise%252BApproach%252Bfor%252Bthe%252BSynthesis%252Bof%252BFolic%252BAcid%252BConjugates%252Bwith%252BProtein%252BKinase%252BInhibitors%26aulast%3DKraj%25C4%258Dovi%25C4%258Dov%25C3%25A1%26aufirst%3DSo%25C5%2588a%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18102017%26date%3D05122017%26date%3D15122017%26date%3D24112017%26volume%3D82%26issue%3D24%26spage%3D13530%26epage%3D13541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhoulong  Fan</span>, <span class="hlFld-ContribAuthor ">Jiabin  Ni</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Meta-Selective CAr–H Nitration of Arenes through a Ru3(CO)12-Catalyzed Ortho-Metalation Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (27)
                                     , 8470-8475. <a href="https://doi.org/10.1021/jacs.6b03402" title="DOI URL">https://doi.org/10.1021/jacs.6b03402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b03402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b03402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DMeta-Selective%252BCAr%2525E2%252580%252593H%252BNitration%252Bof%252BArenes%252Bthrough%252Ba%252BRu3%252528CO%25252912-Catalyzed%252BOrtho-Metalation%252BStrategy%26aulast%3DFan%26aufirst%3DZhoulong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02042016%26date%3D20052016%26date%3D13072016%26date%3D15052016%26volume%3D138%26issue%3D27%26spage%3D8470%26epage%3D8475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Richter</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>, <span class="hlFld-ContribAuthor ">Mirko  Zaja</span>, <span class="hlFld-ContribAuthor ">Hella  Kohlhof</span>, <span class="hlFld-ContribAuthor ">Olaf  Othersen</span>, <span class="hlFld-ContribAuthor ">Daniel  Vitt</span>, <span class="hlFld-ContribAuthor ">Vanessa  Alscher</span>, <span class="hlFld-ContribAuthor ">Irmgard  Pospiech</span>, <span class="hlFld-ContribAuthor ">Balbina  García-Reyes</span>, <span class="hlFld-ContribAuthor ">Sebastian  Berg</span>, <span class="hlFld-ContribAuthor ">Johann  Leban</span>, and <span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>  . </span><span class="cited-content_cbyCitation_article-title">Difluoro-dioxolo-benzoimidazol-benzamides As Potent Inhibitors of CK1δ and ε with Nanomolar Inhibitory Activity on Cancer Cell Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (19)
                                     , 7933-7946. <a href="https://doi.org/10.1021/jm500600b" title="DOI URL">https://doi.org/10.1021/jm500600b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500600b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500600b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDifluoro-dioxolo-benzoimidazol-benzamides%252BAs%252BPotent%252BInhibitors%252Bof%252BCK1%2525CE%2525B4%252Band%252B%2525CE%2525B5%252Bwith%252BNanomolar%252BInhibitory%252BActivity%252Bon%252BCancer%252BCell%252BProliferation%26aulast%3DRichter%26aufirst%3DJulia%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17042014%26date%3D17092014%26date%3D09102014%26date%3D05092014%26volume%3D57%26issue%3D19%26spage%3D7933%26epage%3D7946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomáš  Gucký</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Marek  Zatloukal</span>, <span class="hlFld-ContribAuthor ">Václav  Bazgier</span>, <span class="hlFld-ContribAuthor ">Karel  Berka</span>, <span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Tibor  Béres</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, and <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (15)
                                     , 6234-6247. <a href="https://doi.org/10.1021/jm4006884" title="DOI URL">https://doi.org/10.1021/jm4006884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4006884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4006884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BSeries%252Bof%252BHighly%252BPotent%252B2%25252C6%25252C9-Trisubstituted%252BPurine%252BCyclin-Dependent%252BKinase%252BInhibitors%26aulast%3DGuck%25C3%25BD%26aufirst%3DTom%25C3%25A1%25C5%25A1%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09052013%26date%3D24072013%26date%3D08082013%26date%3D06072013%26volume%3D56%26issue%3D15%26spage%3D6234%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary  Liang</span>, <span class="hlFld-ContribAuthor ">Tyler B.  Tarr</span>, <span class="hlFld-ContribAuthor ">Karla  Bravo-Altamirano</span>, <span class="hlFld-ContribAuthor ">Guillermo  Valdomir</span>, <span class="hlFld-ContribAuthor ">Gabriel  Rensch</span>, <span class="hlFld-ContribAuthor ">Lauren  Swanson</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  DeStefino</span>, <span class="hlFld-ContribAuthor ">Cara M.  Mazzarisi</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Olszewski</span>, <span class="hlFld-ContribAuthor ">Gabriela Mustata  Wilson</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Meriney</span>, and <span class="hlFld-ContribAuthor ">Peter  Wipf</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of a Selective N- and P/Q-Type Calcium Channel Agonist. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (12)
                                     , 985-990. <a href="https://doi.org/10.1021/ml3002083" title="DOI URL">https://doi.org/10.1021/ml3002083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3002083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3002083%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BSelective%252BN-%252Band%252BP%25252FQ-Type%252BCalcium%252BChannel%252BAgonist%26aulast%3DLiang%26aufirst%3DMary%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D19072012%26date%3D01102012%26date%3D09102012%26date%3D13122012%26date%3D01102012%26volume%3D3%26issue%3D12%26spage%3D985%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Libor  Havlíček</span>, <span class="hlFld-ContribAuthor ">Iain W.  McNae</span>, <span class="hlFld-ContribAuthor ">Malcolm D.  Walkinshaw</span>, <span class="hlFld-ContribAuthor ">Jiří  Voller</span>, <span class="hlFld-ContribAuthor ">Antonín  Šturc</span>, <span class="hlFld-ContribAuthor ">Jana  Navrátilová</span>, <span class="hlFld-ContribAuthor ">Marek  Kuzma</span>, <span class="hlFld-ContribAuthor ">Martin  Mistrík</span>, <span class="hlFld-ContribAuthor ">Jiří  Bártek</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, and <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (8)
                                     , 2980-2993. <a href="https://doi.org/10.1021/jm200064p" title="DOI URL">https://doi.org/10.1021/jm200064p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200064p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200064p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazolo%25255B4%25252C3-d%25255Dpyrimidine%252BBioisostere%252Bof%252BRoscovitine%25253A%252BEvaluation%252Bof%252Ba%252BNovel%252BSelective%252BInhibitor%252Bof%252BCyclin-Dependent%252BKinases%252Bwith%252BAntiproliferative%252BActivity%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21012011%26date%3D06042011%26date%3D28042011%26date%3D21032011%26volume%3D54%26issue%3D8%26spage%3D2980%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savade  Solanki</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Corine  Mas-Droux</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Caterina  Barillari</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, and <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (6)
                                     , 1626-1639. <a href="https://doi.org/10.1021/jm1011726" title="DOI URL">https://doi.org/10.1021/jm1011726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1011726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1011726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%252BInhibitors%252BInduce%252Ba%252BDFG-Out%252BConformation%252Bof%252BNever%252Bin%252BMitosis%252BGene%252BA-Related%252BKinase%252B2%252B%252528Nek2%252529%252Bwithout%252BBinding%252Bto%252Bthe%252BBack%252BPocket%252Band%252BReveal%252Ba%252BNonlinear%252BStructure%2525E2%252588%252592Activity%252BRelationship%26aulast%3DSolanki%26aufirst%3DSavade%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D09092010%26date%3D02032011%26date%3D24032011%26volume%3D54%26issue%3D6%26spage%3D1626%26epage%3D1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Morphy</span>. </span><span class="cited-content_cbyCitation_article-title">Selectively Nonselective Kinase Inhibition: Striking the Right Balance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (4)
                                     , 1413-1437. <a href="https://doi.org/10.1021/jm901132v" title="DOI URL">https://doi.org/10.1021/jm901132v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901132v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelectively%252BNonselective%252BKinase%252BInhibition%25253A%252BStriking%252Bthe%252BRight%252BBalance%26aulast%3DMorphy%26aufirst%3DRichard%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D30072009%26date%3D27102009%26date%3D25022010%26volume%3D53%26issue%3D4%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Yoan  Ferandin</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span> and <span class="hlFld-ContribAuthor ">Hervé  Galons</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Synthesis of Roscovitine and CR8. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2009,</strong> <em>13 </em>
                                    (3)
                                     , 641-644. <a href="https://doi.org/10.1021/op800284k" title="DOI URL">https://doi.org/10.1021/op800284k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op800284k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop800284k%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPractical%252BSynthesis%252Bof%252BRoscovitine%252Band%252BCR8%26aulast%3DOumata%26aufirst%3DNassima%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D9%252011%25202008%26date%3D26022009%26date%3D15052009%26volume%3D13%26issue%3D3%26spage%3D641%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nishtha  Malhotra</span>, <span class="hlFld-ContribAuthor ">Rohan  Gupta</span>, <span class="hlFld-ContribAuthor ">Pravir  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological relevance of CDK inhibitors in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2021,</strong> <em>148 </em>, 105115. <a href="https://doi.org/10.1016/j.neuint.2021.105115" title="DOI URL">https://doi.org/10.1016/j.neuint.2021.105115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2021.105115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2021.105115%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DPharmacological%252Brelevance%252Bof%252BCDK%252Binhibitors%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DMalhotra%26aufirst%3DNishtha%26date%3D2021%26volume%3D148%26spage%3D105115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh R.  D’Mello</span>. </span><span class="cited-content_cbyCitation_article-title">When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5911. <a href="https://doi.org/10.3390/ijms22115911" title="DOI URL">https://doi.org/10.3390/ijms22115911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115911%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DWhen%252BGood%252BKinases%252BGo%252BRogue%25253A%252BGSK3%25252C%252Bp38%252BMAPK%252Band%252BCDKs%252Bas%252BTherapeutic%252BTargets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Band%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DSantosh%2BR.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilenia  Grieco</span>, <span class="hlFld-ContribAuthor ">Maicol  Bissaro</span>, <span class="hlFld-ContribAuthor ">Davide Benedetto  Tiz</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Conception  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Sara  Redenti</span>, <span class="hlFld-ContribAuthor ">Elena  Mariotto</span>, <span class="hlFld-ContribAuthor ">Roberta  Bortolozzi</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>, <span class="hlFld-ContribAuthor ">Giorgio  Cozza</span>, <span class="hlFld-ContribAuthor ">Giampiero  Spalluto</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Stephanie  Federico</span>. </span><span class="cited-content_cbyCitation_article-title">Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113331. <a href="https://doi.org/10.1016/j.ejmech.2021.113331" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113331%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Bnovel%252Bclasses%252Bof%252Bprotein%252Bkinase%252BCK1%2525CE%2525B4%252Binhibitors%252Bby%252Bfusing%252B%25255B1%25252C2%25252C4%25255Dtriazole%252Bwith%252Bdifferent%252Bbicyclic%252Bheteroaromatic%252Bsystems%26aulast%3DGrieco%26aufirst%3DIlenia%26date%3D2021%26volume%3D216%26spage%3D113331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bethany  Carter</span>, <span class="hlFld-ContribAuthor ">Hannah S.  Justin</span>, <span class="hlFld-ContribAuthor ">Danielle  Gulick</span>, <span class="hlFld-ContribAuthor ">Joshua J.  Gamsby</span>. </span><span class="cited-content_cbyCitation_article-title">The Molecule Clock and Neurodegenerative Disease: A Stressful Time. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.644747" title="DOI URL">https://doi.org/10.3389/fmolb.2021.644747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.644747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.644747%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DThe%252BMolecule%252BClock%252Band%252BNeurodegenerative%252BDisease%25253A%252BA%252BStressful%252BTime%26aulast%3DCarter%26aufirst%3DBethany%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qin  Qin</span>, <span class="hlFld-ContribAuthor ">Chun-Jie  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115948. <a href="https://doi.org/10.1016/j.bmc.2020.115948" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115948%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DMitochondria-localizing%252Bcurcumin-cryptolepine%252BZn%252528II%252529%252Bcomplexes%252Band%252Btheir%252Bantitumor%252Bactivity%26aulast%3DQin%26aufirst%3DLi-Qin%26date%3D2021%26volume%3D30%26spage%3D115948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne-Cécile  Guyot</span>, <span class="hlFld-ContribAuthor ">Charlotte  Leuxe</span>, <span class="hlFld-ContribAuthor ">Clémence  Disdier</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Narciso  Costa</span>, <span class="hlFld-ContribAuthor ">Gwenaëlle Le  Roux</span>, <span class="hlFld-ContribAuthor ">Paloma F.  Varela</span>, <span class="hlFld-ContribAuthor ">Arnaud  Duchon</span>, <span class="hlFld-ContribAuthor ">Jean Baptiste  Charbonnier</span>, <span class="hlFld-ContribAuthor ">Yann  Herault</span>, <span class="hlFld-ContribAuthor ">Serena  Pavoni</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Emile  Andriambeloson</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Wagner</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Amie K.  Lund</span>, <span class="hlFld-ContribAuthor ">Aloïse  Mabondzo</span>. </span><span class="cited-content_cbyCitation_article-title">A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-57560-3" title="DOI URL">https://doi.org/10.1038/s41598-020-57560-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-57560-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-57560-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252BSmall%252BCompound%252BTargeting%252BProhibitin%252Bwith%252BPotential%252BInterest%252Bfor%252BCognitive%252BDeficit%252BRescue%252Bin%252BAging%252Bmice%252Band%252BTau%252BPathology%252BTreatment%26aulast%3DGuyot%26aufirst%3DAnne-C%25C3%25A9cile%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikołaj  Słabicki</span>, <span class="hlFld-ContribAuthor ">Zuzanna  Kozicka</span>, <span class="hlFld-ContribAuthor ">Georg  Petzold</span>, <span class="hlFld-ContribAuthor ">Yen-Der  Li</span>, <span class="hlFld-ContribAuthor ">Manisha  Manojkumar</span>, <span class="hlFld-ContribAuthor ">Richard D.  Bunker</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Quinlan L.  Sievers</span>, <span class="hlFld-ContribAuthor ">Jonas  Koeppel</span>, <span class="hlFld-ContribAuthor ">Dakota  Suchyta</span>, <span class="hlFld-ContribAuthor ">Adam S.  Sperling</span>, <span class="hlFld-ContribAuthor ">Emma C.  Fink</span>, <span class="hlFld-ContribAuthor ">Jessica A.  Gasser</span>, <span class="hlFld-ContribAuthor ">Li R.  Wang</span>, <span class="hlFld-ContribAuthor ">Steven M.  Corsello</span>, <span class="hlFld-ContribAuthor ">Rob S.  Sellar</span>, <span class="hlFld-ContribAuthor ">Max  Jan</span>, <span class="hlFld-ContribAuthor ">Dennis  Gillingham</span>, <span class="hlFld-ContribAuthor ">Claudia  Scholl</span>, <span class="hlFld-ContribAuthor ">Stefan  Fröhling</span>, <span class="hlFld-ContribAuthor ">Todd R.  Golub</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nicolas H.  Thomä</span>, <span class="hlFld-ContribAuthor ">Benjamin L.  Ebert</span>. </span><span class="cited-content_cbyCitation_article-title">The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2020,</strong> <em>585 </em>
                                    (7824)
                                     , 293-297. <a href="https://doi.org/10.1038/s41586-020-2374-x" title="DOI URL">https://doi.org/10.1038/s41586-020-2374-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-020-2374-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-020-2374-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DThe%252BCDK%252Binhibitor%252BCR8%252Bacts%252Bas%252Ba%252Bmolecular%252Bglue%252Bdegrader%252Bthat%252Bdepletes%252Bcyclin%252BK%26aulast%3DS%25C5%2582abicki%26aufirst%3DMiko%25C5%2582aj%26date%3D2020%26date%3D2020%26volume%3D585%26issue%3D7824%26spage%3D293%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Tsung-Han  Hsieh</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>, <span class="hlFld-ContribAuthor ">Chun-Han  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">CK1δ as a potential therapeutic target to treat bladder cancer. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 5764-5780. <a href="https://doi.org/10.18632/aging.102966" title="DOI URL">https://doi.org/10.18632/aging.102966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.102966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.102966%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DCK1%2525CE%2525B4%252Bas%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bto%252Btreat%252Bbladder%252Bcancer%26aulast%3DLin%26aufirst%3DYu-Chen%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D5764%26epage%3D5780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Meng</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Zi-Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Hua-Hong  Zou</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Fu-Pei  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclometalated Ir(III)-8-oxychinolin complexes acting as red-colored probes for specific mitochondrial imaging and anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112192. <a href="https://doi.org/10.1016/j.ejmech.2020.112192" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112192%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclometalated%252BIr%252528III%252529-8-oxychinolin%252Bcomplexes%252Bacting%252Bas%252Bred-colored%252Bprobes%252Bfor%252Bspecific%252Bmitochondrial%252Bimaging%252Band%252Banticancer%252Bdrugs%26aulast%3DMeng%26aufirst%3DTing%26date%3D2020%26volume%3D192%26spage%3D112192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Luc  Décout</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems—Purines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14915-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14915-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14915-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14915-7%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%2525E2%252580%252594Purines%26aulast%3DD%25C3%25A9cout%26aufirst%3DJean-Luc%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiangsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi  Hu</span>, <span class="hlFld-ContribAuthor ">Guoquan  Wan</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Li</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111728. <a href="https://doi.org/10.1016/j.ejmech.2019.111728" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111728%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%252528%252528%2525289H-purin-6-yl%252529amino%252529methyl%252529-4%25252C6-dimethylpyridin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bnovel%252Btubulin%252Bpolymerization%252Binhibitors%252Bfor%252Btreatment%252Bof%252Bcancer%26aulast%3DZhang%26aufirst%3DQiangsheng%26date%3D2019%26volume%3D184%26spage%3D111728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Bi-Qun  Zou</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111751. <a href="https://doi.org/10.1016/j.ejmech.2019.111751" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111751%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStrong%252Bin%2525C2%2525A0vitro%252Band%252Bvivo%252Bcytotoxicity%252Bof%252Bnovel%252Borganoplatinum%252528II%252529%252Bcomplexes%252Bwith%252Bquinoline-coumarin%252Bderivatives%26aulast%3DQin%26aufirst%3DQi-Pin%26date%3D2019%26volume%3D184%26spage%3D111751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Sundaram</span>, <span class="hlFld-ContribAuthor ">S.  Nagaraj</span>, <span class="hlFld-ContribAuthor ">H.  Mahoney</span>, <span class="hlFld-ContribAuthor ">A.  Portugues</span>, <span class="hlFld-ContribAuthor ">W.  Li</span>, <span class="hlFld-ContribAuthor ">K.  Millsaps</span>, <span class="hlFld-ContribAuthor ">J.  Faulkner</span>, <span class="hlFld-ContribAuthor ">A.  Yunus</span>, <span class="hlFld-ContribAuthor ">C.  Burns</span>, <span class="hlFld-ContribAuthor ">C.  Bloom</span>, <span class="hlFld-ContribAuthor ">M.  Said</span>, <span class="hlFld-ContribAuthor ">L.  Pinto</span>, <span class="hlFld-ContribAuthor ">S.  Azam</span>, <span class="hlFld-ContribAuthor ">M.  Flores</span>, <span class="hlFld-ContribAuthor ">A.  Henriksen</span>, <span class="hlFld-ContribAuthor ">J.  Gamsby</span>, <span class="hlFld-ContribAuthor ">D.  Gulick</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of casein kinase 1δ/εimproves cognitive-affective behavior and reduces amyloid load in the APP-PS1 mouse model of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-50197-x" title="DOI URL">https://doi.org/10.1038/s41598-019-50197-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-50197-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-50197-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DInhibition%252Bof%252Bcasein%252Bkinase%252B1%2525CE%2525B4%25252F%2525CE%2525B5improves%252Bcognitive-affective%252Bbehavior%252Band%252Breduces%252Bamyloid%252Bload%252Bin%252Bthe%252BAPP-PS1%252Bmouse%252Bmodel%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSundaram%26aufirst%3DS.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Tingkai  Chen</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qinglong  Guo</span>, <span class="hlFld-ContribAuthor ">Zongliang  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule modulators targeting protein kinase CK1 and CK2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111581. <a href="https://doi.org/10.1016/j.ejmech.2019.111581" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111581%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecule%252Bmodulators%252Btargeting%252Bprotein%252Bkinase%252BCK1%252Band%252BCK2%26aulast%3DQiao%26aufirst%3DYuting%26date%3D2019%26volume%3D181%26spage%3D111581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Chiara  Ianes</span>, <span class="hlFld-ContribAuthor ">Fabian  Gärtner</span>, <span class="hlFld-ContribAuthor ">Congxing  Liu</span>, <span class="hlFld-ContribAuthor ">Timo  Burster</span>, <span class="hlFld-ContribAuthor ">Vasiliy  Bakulev</span>, <span class="hlFld-ContribAuthor ">Najma  Rachidi</span>, <span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D). </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2019,</strong> <em>715 </em>, 144005. <a href="https://doi.org/10.1016/j.gene.2019.144005" title="DOI URL">https://doi.org/10.1016/j.gene.2019.144005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2019.144005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2019.144005%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DStructure%25252C%252Bregulation%25252C%252Band%252B%252528patho-%252529physiological%252Bfunctions%252Bof%252Bthe%252Bstress-induced%252Bprotein%252Bkinase%252BCK1%252Bdelta%252B%252528CSNK1D%252529%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2019%26volume%3D715%26spage%3D144005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nienke  Moret</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Clark</span>, <span class="hlFld-ContribAuthor ">Marc  Hafner</span>, <span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Eugen  Lounkine</span>, <span class="hlFld-ContribAuthor ">Mario  Medvedovic</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Nathanael  Gray</span>, <span class="hlFld-ContribAuthor ">Jeremy  Jenkins</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>. </span><span class="cited-content_cbyCitation_article-title">Cheminformatics Tools for Analyzing and Designing Optimized Small-Molecule Collections and Libraries. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (5)
                                     , 765-777.e3. <a href="https://doi.org/10.1016/j.chembiol.2019.02.018" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DCheminformatics%252BTools%252Bfor%252BAnalyzing%252Band%252BDesigning%252BOptimized%252BSmall-Molecule%252BCollections%252Band%252BLibraries%26aulast%3DMoret%26aufirst%3DNienke%26date%3D2019%26volume%3D26%26issue%3D5%26spage%3D765%26epage%3D777.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Rubenstein</span>, <span class="hlFld-ContribAuthor ">Deep R.  Sharma</span>, <span class="hlFld-ContribAuthor ">Binggong  Chang</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Morgane  Cam</span>, <span class="hlFld-ContribAuthor ">Lise  Vaucelle</span>, <span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Allen  Chiu</span>, <span class="hlFld-ContribAuthor ">Thomas  Wisniewski</span>, <span class="hlFld-ContribAuthor ">Kevin K. W.  Wang</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neurology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fneur.2019.00124" title="DOI URL">https://doi.org/10.3389/fneur.2019.00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fneur.2019.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffneur.2019.00124%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neurology%26atitle%3DNovel%252BMouse%252BTauopathy%252BModel%252Bfor%252BRepetitive%252BMild%252BTraumatic%252BBrain%252BInjury%25253A%252BEvaluation%252Bof%252BLong-Term%252BEffects%252Bon%252BCognition%252Band%252BBiomarker%252BLevels%252BAfter%252BTherapeutic%252BInhibition%252Bof%252BTau%252BPhosphorylation%26aulast%3DRubenstein%26aufirst%3DRichard%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jahangir  Alam</span>, <span class="hlFld-ContribAuthor ">Lalit  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (3)
                                     , 316-339. <a href="https://doi.org/10.2174/1389450119666180820104723" title="DOI URL">https://doi.org/10.2174/1389450119666180820104723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450119666180820104723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450119666180820104723%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DPotential%252BEnzymatic%252BTargets%252Bin%252BAlzheimer%2525E2%252580%252599s%25253A%252BA%252BComprehensive%252BReview%26aulast%3DAlam%26aufirst%3DJahangir%26date%3D2019%26volume%3D20%26issue%3D3%26spage%3D316%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy B  Heptinstall</span>, <span class="hlFld-ContribAuthor ">IWS  Adiyasa</span>, <span class="hlFld-ContribAuthor ">Céline  Cano</span>, <span class="hlFld-ContribAuthor ">Ian R  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in CDK inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (11)
                                     , 1369-1388. <a href="https://doi.org/10.4155/fmc-2017-0246" title="DOI URL">https://doi.org/10.4155/fmc-2017-0246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0246%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252BCDK%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DHeptinstall%26aufirst%3DAmy%2BB%26date%3D2018%26volume%3D10%26issue%3D11%26spage%3D1369%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrii  Monastyrskyi</span>, <span class="hlFld-ContribAuthor ">Napon  Nilchan</span>, <span class="hlFld-ContribAuthor ">Victor  Quereda</span>, <span class="hlFld-ContribAuthor ">Yoshihiko  Noguchi</span>, <span class="hlFld-ContribAuthor ">Claudia  Ruiz</span>, <span class="hlFld-ContribAuthor ">Wayne  Grant</span>, <span class="hlFld-ContribAuthor ">Michael  Cameron</span>, <span class="hlFld-ContribAuthor ">Derek  Duckett</span>, <span class="hlFld-ContribAuthor ">William  Roush</span>. </span><span class="cited-content_cbyCitation_article-title">Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (3)
                                     , 590-602. <a href="https://doi.org/10.1016/j.bmc.2017.12.020" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.12.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.12.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bdual%252Bcasein%252Bkinase%252B1%2525CE%2525B4%25252F1%2525CE%2525B5%252B%252528CK1%2525CE%2525B4%25252F%2525CE%2525B5%252529%252Binhibitors%252Bfor%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DMonastyrskyi%26aufirst%3DAndrii%26date%3D2018%26volume%3D26%26issue%3D3%26spage%3D590%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mange Ram  Yadav</span>, <span class="hlFld-ContribAuthor ">Mahesh A.  Barmade</span>, <span class="hlFld-ContribAuthor ">Rupesh V.  Chikhale</span>, <span class="hlFld-ContribAuthor ">Prashant R.  Murumkar</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Modelling of Kinase Inhibitors as Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 347-417. <a href="https://doi.org/10.1007/978-1-4939-7404-7_14" title="DOI URL">https://doi.org/10.1007/978-1-4939-7404-7_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7404-7_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7404-7_14%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BModelling%252Bof%252BKinase%252BInhibitors%252Bas%252BAnti-Alzheimer%252BAgents%26aulast%3DYadav%26aufirst%3DMange%2BRam%26date%3D2018%26date%3D2017%26spage%3D347%26epage%3D417%26pub%3DSpringer%2520New%2520York%26atitle%3DComputational%252BModeling%252Bof%252BDrugs%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2018%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nienke  Moret</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Clark</span>, <span class="hlFld-ContribAuthor ">Marc  Hafner</span>, <span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Eugen  Lounkine</span>, <span class="hlFld-ContribAuthor ">Mario  Medvedovic</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Nathanael  Gray</span>, <span class="hlFld-ContribAuthor ">Jeremy  Jenkins</span>, <span class="hlFld-ContribAuthor ">Peter  Sorger</span>. </span><span class="cited-content_cbyCitation_article-title">Cheminformatics Tools for Analyzing and Designing Optimized Small Molecule Collections and Libraries. </span><span class="cited-content_cbyCitation_journal-name">SSRN Electronic Journal</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.2139/ssrn.3219258" title="DOI URL">https://doi.org/10.2139/ssrn.3219258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2139/ssrn.3219258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2139%2Fssrn.3219258%26sid%3Dliteratum%253Aachs%26jtitle%3DSSRN%2520Electronic%2520Journal%26atitle%3DCheminformatics%252BTools%252Bfor%252BAnalyzing%252Band%252BDesigning%252BOptimized%252BSmall%252BMolecule%252BCollections%252Band%252BLibraries%26aulast%3DMoret%26aufirst%3DNienke%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Tutone</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Almerico</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on CDK inhibitors: An insight by means of in silico methods. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 300-315. <a href="https://doi.org/10.1016/j.ejmech.2017.07.067" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.067%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bon%252BCDK%252Binhibitors%25253A%252BAn%252Binsight%252Bby%252Bmeans%252Bof%252Bin%252Bsilico%252Bmethods%26aulast%3DTutone%26aufirst%3DMarco%26date%3D2017%26volume%3D142%26spage%3D300%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vassilios  Myrianthopoulos</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Danae  Zareifi</span>, <span class="hlFld-ContribAuthor ">Leonidas  Alexopoulos</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Vassilis  Gorgoulis</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (10)
                                     , 2102. <a href="https://doi.org/10.3390/ijms18102102" title="DOI URL">https://doi.org/10.3390/ijms18102102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18102102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18102102%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCombined%252BVirtual%252Band%252BExperimental%252BScreening%252Bfor%252BCK1%252BInhibitors%252BIdentifies%252Ba%252BModulator%252Bof%252Bp53%252Band%252BReveals%252BImportant%252BAspects%252Bof%252Bin%252BSilico%252BScreening%252BPerformance%26aulast%3DMyrianthopoulos%26aufirst%3DVassilios%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D10%26spage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward  Fielder</span>, <span class="hlFld-ContribAuthor ">Thomas  von Zglinicki</span>, <span class="hlFld-ContribAuthor ">Diana  Jurk</span>. </span><span class="cited-content_cbyCitation_article-title">The DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2017,</strong> <em>60 </em>
                                    (s1)
                                     , S107-S131. <a href="https://doi.org/10.3233/JAD-161221" title="DOI URL">https://doi.org/10.3233/JAD-161221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-161221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-161221%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DThe%252BDNA%252BDamage%252BResponse%252Bin%252BNeurons%25253A%252BDie%252Bby%252BApoptosis%252Bor%252BSurvive%252Bin%252Ba%252BSenescence-Like%252BState%25253F%26aulast%3DFielder%26aufirst%3DEdward%26date%3D2017%26volume%3D60%26issue%3Ds1%26spage%3DS107%26epage%3DS131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">LouJin  Song</span>, <span class="hlFld-ContribAuthor ">Seon-hye E.  Park</span>, <span class="hlFld-ContribAuthor ">Yehuda  Isseroff</span>, <span class="hlFld-ContribAuthor ">Kumi  Morikawa</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yazawa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Stem Cell Reports</span><span> <strong>2017,</strong> <em>9 </em>
                                    (1)
                                     , 50-57. <a href="https://doi.org/10.1016/j.stemcr.2017.05.028" title="DOI URL">https://doi.org/10.1016/j.stemcr.2017.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.stemcr.2017.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.stemcr.2017.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cell%2520Reports%26atitle%3DInhibition%252Bof%252BCDK5%252BAlleviates%252Bthe%252BCardiac%252BPhenotypes%252Bin%252BTimothy%252BSyndrome%26aulast%3DSong%26aufirst%3DLouJin%26date%3D2017%26volume%3D9%26issue%3D1%26spage%3D50%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franciska  Erdő</span>, <span class="hlFld-ContribAuthor ">Ildikó  Nagy</span>, <span class="hlFld-ContribAuthor ">Beáta  Tóth</span>, <span class="hlFld-ContribAuthor ">Annamária  Bui</span>, <span class="hlFld-ContribAuthor ">Éva  Molnár</span>, <span class="hlFld-ContribAuthor ">Zoltán  Tímár</span>, <span class="hlFld-ContribAuthor ">Rémi  Magnan</span>, <span class="hlFld-ContribAuthor ">Peter  Krajcsi</span>. </span><span class="cited-content_cbyCitation_article-title">Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2017,</strong> <em>132 </em>, 232-236. <a href="https://doi.org/10.1016/j.brainresbull.2017.06.013" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2017.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2017.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DAbcb1a%252B%252528P-glycoprotein%252529%252Blimits%252Bbrain%252Bexposure%252Bof%252Bthe%252Banticancer%252Bdrug%252Bcandidate%252Bseliciclib%252Bin%252Bvivo%252Bin%252Badult%252Bmice%26aulast%3DErd%25C5%2591%26aufirst%3DFranciska%26date%3D2017%26volume%3D132%26spage%3D232%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihui  Shi</span>, <span class="hlFld-ContribAuthor ">Jaehyeon  Park</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Lagisetti</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Lidia C.  Sambucetti</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (3)
                                     , 406-412. <a href="https://doi.org/10.1016/j.bmcl.2016.12.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Btriple%252Bexon-skipping%252Bluciferase%252Breporter%252Bassay%252Bidentifies%252Ba%252Bnew%252BCLK%252Binhibitor%252Bpharmacophore%26aulast%3DShi%26aufirst%3DYihui%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D406%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyamin Z.  Bendjeddou</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Benoît  Villiers</span>, <span class="hlFld-ContribAuthor ">Eric  Prina</span>, <span class="hlFld-ContribAuthor ">Gerald F.  Späth</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 696-709. <a href="https://doi.org/10.1016/j.ejmech.2016.09.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bthe%252Bimidazo%25255B1%25252C2-b%25255Dpyridazine%252Bscaffold%252Bas%252Ba%252Bprotein%252Bkinase%252Binhibitor%26aulast%3DBendjeddou%26aufirst%3DLyamin%2BZ.%26date%3D2017%26volume%3D125%26spage%3D696%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Squarcialupi</span>, <span class="hlFld-ContribAuthor ">Marco  Betti</span>, <span class="hlFld-ContribAuthor ">Daniela  Catarzi</span>, <span class="hlFld-ContribAuthor ">Flavia  Varano</span>, <span class="hlFld-ContribAuthor ">Matteo  Falsini</span>, <span class="hlFld-ContribAuthor ">Annalisa  Ravani</span>, <span class="hlFld-ContribAuthor ">Silvia  Pasquini</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Vittoria  Colotta</span>. </span><span class="cited-content_cbyCitation_article-title">The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-
              d
              ]pyrimidine core in affecting adenosine A
              1
              and A
              2A
              receptor affinity and selectivity profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 248-263. <a href="https://doi.org/10.1080/14756366.2016.1247060" title="DOI URL">https://doi.org/10.1080/14756366.2016.1247060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1247060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1247060%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DThe%252Brole%252Bof%252B5-arylalkylamino-%252Band%252B5-piperazino-%252Bmoieties%252Bon%252Bthe%252B7-aminopyrazolo%25255B4%25252C3-%252Bd%252B%25255Dpyrimidine%252Bcore%252Bin%252Baffecting%252Badenosine%252BA%252B1%252Band%252BA%252B2A%252Breceptor%252Baffinity%252Band%252Bselectivity%252Bprofiles%26aulast%3DSquarcialupi%26aufirst%3DLucia%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D248%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keke  Dong</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xueyu  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Binding mechanism of CDK5 with roscovitine derivatives based on molecular dynamics simulations and MM/PBSA methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>68 </em>, 57-67. <a href="https://doi.org/10.1016/j.jmgm.2016.06.007" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DBinding%252Bmechanism%252Bof%252BCDK5%252Bwith%252Broscovitine%252Bderivatives%252Bbased%252Bon%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252BMM%25252FPBSA%252Bmethods%26aulast%3DDong%26aufirst%3DKeke%26date%3D2016%26volume%3D68%26spage%3D57%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Durieu</span>, <span class="hlFld-ContribAuthor ">Eric  Prina</span>, <span class="hlFld-ContribAuthor ">Olivier  Leclercq</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Konstantina  Vougogiannopoulou</span>, <span class="hlFld-ContribAuthor ">Nathalie  Aulner</span>, <span class="hlFld-ContribAuthor ">Audrey  Defontaine</span>, <span class="hlFld-ContribAuthor ">Joo Hwan  No</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Gerald F.  Späth</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Najma  Rachidi</span>. </span><span class="cited-content_cbyCitation_article-title">From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2016,</strong> <em>60 </em>
                                    (5)
                                     , 2822-2833. <a href="https://doi.org/10.1128/AAC.00021-16" title="DOI URL">https://doi.org/10.1128/AAC.00021-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00021-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00021-16%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DFrom%252BDrug%252BScreening%252Bto%252BTarget%252BDeconvolution%25253A%252Ba%252BTarget-Based%252BDrug%252BDiscovery%252BPipeline%252BUsing%252BLeishmania%252BCasein%252BKinase%252B1%252BIsoform%252B2%252BTo%252BIdentify%252BCompounds%252Bwith%252BAntileishmanial%252BActivity%26aulast%3DDurieu%26aufirst%3DEmilie%26date%3D2016%26volume%3D60%26issue%3D5%26spage%3D2822%26epage%3D2833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgio  Cozza</span>, <span class="hlFld-ContribAuthor ">Lorenzo A  Pinna</span>. </span><span class="cited-content_cbyCitation_article-title">Casein kinases as potential therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2016,</strong> <em>20 </em>
                                    (3)
                                     , 319-340. <a href="https://doi.org/10.1517/14728222.2016.1091883" title="DOI URL">https://doi.org/10.1517/14728222.2016.1091883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2016.1091883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2016.1091883%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DCasein%252Bkinases%252Bas%252Bpotential%252Btherapeutic%252Btargets%26aulast%3DCozza%26aufirst%3DGiorgio%26date%3D2016%26date%3D2015%26volume%3D20%26issue%3D3%26spage%3D319%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ladislava  Vymětalová</span>, <span class="hlFld-ContribAuthor ">Libor  Havlíček</span>, <span class="hlFld-ContribAuthor ">Antonín  Šturc</span>, <span class="hlFld-ContribAuthor ">Zuzana  Skrášková</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Tomáš  Pospíšil</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">5-Substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with anti-proliferative activity as potent and selective inhibitors of cyclin-dependent kinases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>110 </em>, 291-301. <a href="https://doi.org/10.1016/j.ejmech.2016.01.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Substituted%252B3-isopropyl-7-%25255B4-%2525282-pyridyl%252529benzyl%25255Damino-1%2525282%252529H-pyrazolo%25255B4%25252C3-d%25255Dpyrimidines%252Bwith%252Banti-proliferative%252Bactivity%252Bas%252Bpotent%252Band%252Bselective%252Binhibitors%252Bof%252Bcyclin-dependent%252Bkinases%26aulast%3DVym%25C4%259Btalov%25C3%25A1%26aufirst%3DLadislava%26date%3D2016%26volume%3D110%26spage%3D291%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Jenny  Desantis</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (4)
                                     , 421-442. <a href="https://doi.org/10.4155/fmc.16.3" title="DOI URL">https://doi.org/10.4155/fmc.16.3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.16.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.16.3%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bidentification%252Bof%252BTat-mediated%252Btransactivation%252Binhibitors%25253A%252Bprogressing%252Btoward%252Ba%252Bfunctional%252Bcure%252Bof%252BHIV%26aulast%3DTabarrini%26aufirst%3DOriana%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D421%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Sabine  Weitensteiner</span>, <span class="hlFld-ContribAuthor ">Libor  Havlíček</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Tomáš  Gucký</span>, <span class="hlFld-ContribAuthor ">Karel  Berka</span>, <span class="hlFld-ContribAuthor ">Václav  Bazgier</span>, <span class="hlFld-ContribAuthor ">Stefan  Zahler</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of a Pyrazolo[4,3-
              d
              ]pyrimidine Inhibitor of Cyclin-Dependent Kinases 2 and 5 and Aurora A With Pro-Apoptotic and Anti-Angiogenic Activity
              In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (6)
                                     , 1528-1540. <a href="https://doi.org/10.1111/cbdd.12618" title="DOI URL">https://doi.org/10.1111/cbdd.12618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12618%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DCharacterization%252Bof%252Ba%252BPyrazolo%25255B4%25252C3-%252Bd%252B%25255Dpyrimidine%252BInhibitor%252Bof%252BCyclin-Dependent%252BKinases%252B2%252Band%252B5%252Band%252BAurora%252BA%252BWith%252BPro-Apoptotic%252Band%252BAnti-Angiogenic%252BActivity%252BIn%252BVitro%26aulast%3D%25C5%2598ezn%25C3%25AD%25C4%258Dkov%25C3%25A1%26aufirst%3DEva%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D6%26spage%3D1528%26epage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel  Troadec</span>, <span class="hlFld-ContribAuthor ">Mélina  Blairvacq</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Christian  Berthou</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2015,</strong> <em>22 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-015-0163-x" title="DOI URL">https://doi.org/10.1186/s12929-015-0163-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-015-0163-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-015-0163-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DAntitumoral%252Beffects%252Bof%252Bcyclin-dependent%252Bkinases%252Binhibitors%252BCR8%252Band%252BMR4%252Bon%252Bchronic%252Bmyeloid%252Bleukemia%252Bcell%252Blines%26aulast%3DTroadec%26aufirst%3DSamuel%26date%3D2015%26date%3D2015%26volume%3D22%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Liu</span>, <span class="hlFld-ContribAuthor ">Junxie  Du</span>, <span class="hlFld-ContribAuthor ">Yanrui  Yang</span>, <span class="hlFld-ContribAuthor ">Yun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2015,</strong> <em>273 </em>, 253-262. <a href="https://doi.org/10.1016/j.expneurol.2015.09.005" title="DOI URL">https://doi.org/10.1016/j.expneurol.2015.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2015.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2015.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DPhosphorylation%252Bof%252BTRPV1%252Bby%252Bcyclin-dependent%252Bkinase%252B5%252Bpromotes%252BTRPV1%252Bsurface%252Blocalization%25252C%252Bleading%252Bto%252Binflammatory%252Bthermal%252Bhyperalgesia%26aulast%3DLiu%26aufirst%3DJiao%26date%3D2015%26volume%3D273%26spage%3D253%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C  Delehouzé</span>, <span class="hlFld-ContribAuthor ">K  Godl</span>, <span class="hlFld-ContribAuthor ">N  Loaëc</span>, <span class="hlFld-ContribAuthor ">C  Bruyère</span>, <span class="hlFld-ContribAuthor ">N  Desban</span>, <span class="hlFld-ContribAuthor ">N  Oumata</span>, <span class="hlFld-ContribAuthor ">H  Galons</span>, <span class="hlFld-ContribAuthor ">T I  Roumeliotis</span>, <span class="hlFld-ContribAuthor ">E G  Giannopoulou</span>, <span class="hlFld-ContribAuthor ">J  Grenet</span>, <span class="hlFld-ContribAuthor ">D  Twitchell</span>, <span class="hlFld-ContribAuthor ">J  Lahti</span>, <span class="hlFld-ContribAuthor ">N  Mouchet</span>, <span class="hlFld-ContribAuthor ">M-D  Galibert</span>, <span class="hlFld-ContribAuthor ">S D  Garbis</span>, <span class="hlFld-ContribAuthor ">L  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2014,</strong> <em>33 </em>
                                    (50)
                                     , 5675-5687. <a href="https://doi.org/10.1038/onc.2013.513" title="DOI URL">https://doi.org/10.1038/onc.2013.513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2013.513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2013.513%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DCDK%25252FCK1%252Binhibitors%252Broscovitine%252Band%252BCR8%252Bdownregulate%252Bamplified%252BMYCN%252Bin%252Bneuroblastoma%252Bcells%26aulast%3DDelehouz%25C3%25A9%26aufirst%3DC%26date%3D2014%26date%3D2013%26volume%3D33%26issue%3D50%26spage%3D5675%26epage%3D5687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Houzé</span>, <span class="hlFld-ContribAuthor ">Nha-Thu  Hoang</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Jacques  Le Bras</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>. </span><span class="cited-content_cbyCitation_article-title">Several Human Cyclin-Dependent Kinase Inhibitors, Structurally Related to Roscovitine, As New Anti-Malarial Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (9)
                                     , 15237-15257. <a href="https://doi.org/10.3390/molecules190915237" title="DOI URL">https://doi.org/10.3390/molecules190915237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules190915237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules190915237%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSeveral%252BHuman%252BCyclin-Dependent%252BKinase%252BInhibitors%25252C%252BStructurally%252BRelated%252Bto%252BRoscovitine%25252C%252BAs%252BNew%252BAnti-Malarial%252BAgents%26aulast%3DHouz%25C3%25A9%26aufirst%3DSandrine%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D9%26spage%3D15237%26epage%3D15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Paul G.  Seerden</span>, <span class="hlFld-ContribAuthor ">Gabriela  Leusink-Ionescu</span>, <span class="hlFld-ContribAuthor ">Titia  Woudenberg-Vrenken</span>, <span class="hlFld-ContribAuthor ">Bas  Dros</span>, <span class="hlFld-ContribAuthor ">Grietje  Molema</span>, <span class="hlFld-ContribAuthor ">Jan A.A.M.  Kamps</span>, <span class="hlFld-ContribAuthor ">Richard M.  Kellogg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of 4-fluorophenyl-imidazole p38α MAPK, CK1δ and JAK2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (15)
                                     , 3412-3418. <a href="https://doi.org/10.1016/j.bmcl.2014.05.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.05.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.05.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.05.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252B4-fluorophenyl-imidazole%252Bp38%2525CE%2525B1%252BMAPK%25252C%252BCK1%2525CE%2525B4%252Band%252BJAK2%252Bkinase%252Binhibitors%26aulast%3DSeerden%26aufirst%3DJean-Paul%2BG.%26date%3D2014%26volume%3D24%26issue%3D15%26spage%3D3412%26epage%3D3418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara  Penas</span>, <span class="hlFld-ContribAuthor ">Vimal  Ramachandran</span>, <span class="hlFld-ContribAuthor ">Scott  Simanski</span>, <span class="hlFld-ContribAuthor ">Choogon  Lee</span>, <span class="hlFld-ContribAuthor ">Franck  Madoux</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Rahaim</span>, <span class="hlFld-ContribAuthor ">Ruchi  Chauhan</span>, <span class="hlFld-ContribAuthor ">Omar  Barnaby</span>, <span class="hlFld-ContribAuthor ">Stephan  Schurer</span>, <span class="hlFld-ContribAuthor ">Peter  Hodder</span>, <span class="hlFld-ContribAuthor ">Judith  Steen</span>, <span class="hlFld-ContribAuthor ">William R.  Roush</span>, <span class="hlFld-ContribAuthor ">Nagi G.  Ayad</span>. </span><span class="cited-content_cbyCitation_article-title">Casein Kinase 1δ-dependent Wee1 Protein Degradation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2014,</strong> <em>289 </em>
                                    (27)
                                     , 18893-18903. <a href="https://doi.org/10.1074/jbc.M114.547661" title="DOI URL">https://doi.org/10.1074/jbc.M114.547661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.547661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.547661%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DCasein%252BKinase%252B1%2525CE%2525B4-dependent%252BWee1%252BProtein%252BDegradation%26aulast%3DPenas%26aufirst%3DClara%26date%3D2014%26volume%3D289%26issue%3D27%26spage%3D18893%26epage%3D18903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Marc  KrÃ¼ger</span>, <span class="hlFld-ContribAuthor ">Julia  Richter</span>, <span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Balbina  GarcÃ­a-Reyes</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>, <span class="hlFld-ContribAuthor ">Jakob  Halekotte</span>, <span class="hlFld-ContribAuthor ">Vasiliy  Bakulev</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>. </span><span class="cited-content_cbyCitation_article-title">The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2014,</strong> <em>4 </em><a href="https://doi.org/10.3389/fonc.2014.00096" title="DOI URL">https://doi.org/10.3389/fonc.2014.00096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2014.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2014.00096%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DThe%252BCK1%252BFamily%25253A%252BContribution%252Bto%252BCellular%252BStress%252BResponse%252Band%252BIts%252BRole%252Bin%252BCarcinogenesis%26aulast%3DKnippschild%26aufirst%3DUwe%26date%3D2014%26date%3D2014%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hatem  Sallam</span>, <span class="hlFld-ContribAuthor ">Ibrahim  El-Serafi</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Moustapha  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice. </span><span class="cited-content_cbyCitation_journal-name">BMC Pharmacology and Toxicology</span><span> <strong>2013,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/2050-6511-14-50" title="DOI URL">https://doi.org/10.1186/2050-6511-14-50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2050-6511-14-50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2050-6511-14-50%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Pharmacology%2520and%2520Toxicology%26atitle%3DPharmacokinetics%252Band%252Bbiodistribution%252Bof%252Bthe%252Bcyclin-dependent%252Bkinase%252Binhibitor%252B-CR8-%252Bin%252Bmice%26aulast%3DSallam%26aufirst%3DHatem%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">James  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Shuping  Xu</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Qiming Jane  Wang</span>, . </span><span class="cited-content_cbyCitation_article-title">New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (9)
                                     , e75601. <a href="https://doi.org/10.1371/journal.pone.0075601" title="DOI URL">https://doi.org/10.1371/journal.pone.0075601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0075601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0075601%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DNew%252BPyrazolopyrimidine%252BInhibitors%252Bof%252BProtein%252BKinase%252BD%252Bas%252BPotent%252BAnticancer%252BAgents%252Bfor%252BProstate%252BCancer%252BCells%26aulast%3DTandon%26aufirst%3DManuj%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3De75601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathieu  Bibian</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Rahaim</span>, <span class="hlFld-ContribAuthor ">Jun Yong  Choi</span>, <span class="hlFld-ContribAuthor ">Yoshihiko  Noguchi</span>, <span class="hlFld-ContribAuthor ">Stephan  Schürer</span>, <span class="hlFld-ContribAuthor ">Weimin  Chen</span>, <span class="hlFld-ContribAuthor ">Shima  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Konstantin  Licht</span>, <span class="hlFld-ContribAuthor ">Laura H.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Yangbo  Feng</span>, <span class="hlFld-ContribAuthor ">Michael D.  Cameron</span>, <span class="hlFld-ContribAuthor ">Derek R.  Duckett</span>, <span class="hlFld-ContribAuthor ">John L.  Cleveland</span>, <span class="hlFld-ContribAuthor ">William R.  Roush</span>. </span><span class="cited-content_cbyCitation_article-title">Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (15)
                                     , 4374-4380. <a href="https://doi.org/10.1016/j.bmcl.2013.05.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bhighly%252Bselective%252Bcasein%252Bkinase%252B1%2525CE%2525B4%25252F1%2525CE%2525B5%252B%252528CK1%2525CE%2525B4%25252F%2525CE%2525B5%252529%252Binhibitors%252Bwith%252Bpotent%252Bantiproliferative%252Bproperties%26aulast%3DBibian%26aufirst%3DMathieu%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4374%26epage%3D4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Yoan  Ferandin</span>, <span class="hlFld-ContribAuthor ">Nha Thu  Hoang</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (7)
                                     , 3247-3258. <a href="https://doi.org/10.1007/s00044-012-0334-1" title="DOI URL">https://doi.org/10.1007/s00044-012-0334-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0334-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0334-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bpotent%252Binhibitors%252Bof%252BCK1%252Band%252BCDK5%25252C%252Btwo%252Bkinases%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DDemange%26aufirst%3DLuc%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D3247%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhu</span>, <span class="hlFld-ContribAuthor ">Yongliang  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2013,</strong> <em>19 </em>
                                    (6)
                                     , 2635-2645. <a href="https://doi.org/10.1007/s00894-013-1815-y" title="DOI URL">https://doi.org/10.1007/s00894-013-1815-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-013-1815-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-013-1815-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMolecular%252Bdynamic%252Bsimulations%252Bgive%252Binsight%252Binto%252Bthe%252Bmechanism%252Bof%252Bbinding%252Bbetween%252B2-aminothiazole%252Binhibitors%252Band%252BCDK5%26aulast%3DWang%26aufirst%3DWei%26date%3D2013%26date%3D2013%26volume%3D19%26issue%3D6%26spage%3D2635%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Hongmei  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Niu</span>, <span class="hlFld-ContribAuthor ">Shuying  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of kinetic parameters and structure-activity relationships of ginsenosides as inhibitors of cyclin-dependent kinase 5/p25 using ultra-pressure liquid chromatography with triple quadrupole tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Rapid Communications in Mass Spectrometry</span><span> <strong>2013,</strong> <em>27 </em>
                                    (9)
                                     , 985-992. <a href="https://doi.org/10.1002/rcm.6537" title="DOI URL">https://doi.org/10.1002/rcm.6537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rcm.6537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frcm.6537%26sid%3Dliteratum%253Aachs%26jtitle%3DRapid%2520Communications%2520in%2520Mass%2520Spectrometry%26atitle%3DDetermination%252Bof%252Bkinetic%252Bparameters%252Band%252Bstructure-activity%252Brelationships%252Bof%252Bginsenosides%252Bas%252Binhibitors%252Bof%252Bcyclin-dependent%252Bkinase%252B5%25252Fp25%252Busing%252Bultra-pressure%252Bliquid%252Bchromatography%252Bwith%252Btriple%252Bquadrupole%252Btandem%252Bmass%252Bspectrometry%26aulast%3DChen%26aufirst%3DNing%26date%3D2013%26date%3D2013%26volume%3D27%26issue%3D9%26spage%3D985%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilio  Cosimo</span>, <span class="hlFld-ContribAuthor ">Alison M.  McCaig</span>, <span class="hlFld-ContribAuthor ">Luke J.M.  Carter-Brzezinski</span>, <span class="hlFld-ContribAuthor ">Helen  Wheadon</span>, <span class="hlFld-ContribAuthor ">Michael T.  Leach</span>, <span class="hlFld-ContribAuthor ">Karine  Le Ster</span>, <span class="hlFld-ContribAuthor ">Christian  Berthou</span>, <span class="hlFld-ContribAuthor ">Emilie  Durieu</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Alison M.  Michie</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2013,</strong> <em>19 </em>
                                    (9)
                                     , 2393-2405. <a href="https://doi.org/10.1158/1078-0432.CCR-12-2170" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-12-2170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-12-2170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-12-2170%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DInhibition%252Bof%252BNF-%2525CE%2525BAB%2525E2%252580%252593Mediated%252BSignaling%252Bby%252Bthe%252BCyclin-Dependent%252BKinase%252BInhibitor%252BCR8%252BOvercomes%252BProsurvival%252BStimuli%252Bto%252BInduce%252BApoptosis%252Bin%252BChronic%252BLymphocytic%252BLeukemia%252BCells%26aulast%3DCosimo%26aufirst%3DEmilio%26date%3D2013%26date%3D2013%26volume%3D19%26issue%3D9%26spage%3D2393%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Elagawany</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Hany Emary  Ali Ahmed</span>, <span class="hlFld-ContribAuthor ">A.Sh.  El-Etrawy</span>, <span class="hlFld-ContribAuthor ">Adel  Ghiaty</span>, <span class="hlFld-ContribAuthor ">Zakaria K.  Abdel-Samii</span>, <span class="hlFld-ContribAuthor ">Said A.  El-Feky</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 2007-2013. <a href="https://doi.org/10.1016/j.bmcl.2013.02.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bmolecular%252Bmodelling%252Bof%252Bpyridazinone%252Band%252Bphthalazinone%252Bderivatives%252Bas%252Bprotein%252Bkinases%252Binhibitors%26aulast%3DElagawany%26aufirst%3DMohamed%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D2007%26epage%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iva  Dolečková</span>, <span class="hlFld-ContribAuthor ">Michal  Česnek</span>, <span class="hlFld-ContribAuthor ">Martin  Dračinský</span>, <span class="hlFld-ContribAuthor ">Jiří  Brynda</span>, <span class="hlFld-ContribAuthor ">Jiří  Voller</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of guanidino analogues of roscovitine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>62 </em>, 443-452. <a href="https://doi.org/10.1016/j.ejmech.2013.01.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bguanidino%252Banalogues%252Bof%252Broscovitine%26aulast%3DDole%25C4%258Dkov%25C3%25A1%26aufirst%3DIva%26date%3D2013%26volume%3D62%26spage%3D443%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Antonio G.  Garcia</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (1)
                                     , 139-189. <a href="https://doi.org/10.1002/med.20248" title="DOI URL">https://doi.org/10.1002/med.20248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20248%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmultitarget-directed%252Bligands%252Bapproach%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLe%25C3%25B3n%26aufirst%3DRafael%26date%3D2013%26date%3D2011%26volume%3D33%26issue%3D1%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Medda</span>, <span class="hlFld-ContribAuthor ">Breland  Smith</span>, <span class="hlFld-ContribAuthor ">Vijay  Gokhale</span>, <span class="hlFld-ContribAuthor ">Arthur Y.  Shaw</span>, <span class="hlFld-ContribAuthor ">Travis  Dunckley</span>, <span class="hlFld-ContribAuthor ">Christopher  Hulme</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond Secretases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 57-71. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00005-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00005-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00005-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00005-3%26sid%3Dliteratum%253Aachs%26atitle%3DBeyond%252BSecretases%26aulast%3DMedda%26aufirst%3DFederico%26date%3D2013%26spage%3D57%26epage%3D71%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludovic  Martin</span>, <span class="hlFld-ContribAuthor ">Xenia  Latypova</span>, <span class="hlFld-ContribAuthor ">Cornelia M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Amandine  Magnaudeix</span>, <span class="hlFld-ContribAuthor ">Marie-Laure  Perrin</span>, <span class="hlFld-ContribAuthor ">Catherine  Yardin</span>, <span class="hlFld-ContribAuthor ">Faraj  Terro</span>. </span><span class="cited-content_cbyCitation_article-title">Tau protein kinases: Involvement in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2013,</strong> <em>12 </em>
                                    (1)
                                     , 289-309. <a href="https://doi.org/10.1016/j.arr.2012.06.003" title="DOI URL">https://doi.org/10.1016/j.arr.2012.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2012.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2012.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DTau%252Bprotein%252Bkinases%25253A%252BInvolvement%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DMartin%26aufirst%3DLudovic%26date%3D2013%26volume%3D12%26issue%3D1%26spage%3D289%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Fatma Nait  Abdellah</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Yoan  Ferandin</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>. </span><span class="cited-content_cbyCitation_article-title">Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (1)
                                     , 125-131. <a href="https://doi.org/10.1016/j.bmcl.2012.10.141" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.141%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Binhibitors%252Bof%252BCDK5%252Bderived%252Bfrom%252Broscovitine%25253A%252BSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%26aulast%3DDemange%26aufirst%3DLuc%26date%3D2013%26volume%3D23%26issue%3D1%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karima  Bettayeb</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenjie  Luo</span>, <span class="hlFld-ContribAuthor ">Victor  Bustos</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Paul  Greengard</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Marc  Flajolet</span>. </span><span class="cited-content_cbyCitation_article-title">Small‐molecule inducers of Aβ‐42 peptide production share a common mechanism of action. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2012,</strong> <em>26 </em>
                                    (12)
                                     , 5115-5123. <a href="https://doi.org/10.1096/fj.12-212985" title="DOI URL">https://doi.org/10.1096/fj.12-212985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.12-212985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.12-212985%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DSmall%2525E2%252580%252590molecule%252Binducers%252Bof%252BA%2525CE%2525B2%2525E2%252580%25259042%252Bpeptide%252Bproduction%252Bshare%252Ba%252Bcommon%252Bmechanism%252Bof%252Baction%26aulast%3DBettayeb%26aufirst%3DKarima%26date%3D2012%26date%3D2012%26volume%3D26%26issue%3D12%26spage%3D5115%26epage%3D5123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay O.  Bukanov</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Moreno</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Natoli</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Rogers</span>, <span class="hlFld-ContribAuthor ">Laurie A.  Smith</span>, <span class="hlFld-ContribAuthor ">Steven R.  Ledbetter</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Oxana  Ibraghimov-Beskrovnaya</span>. </span><span class="cited-content_cbyCitation_article-title">CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2012,</strong> <em>11 </em>
                                    (21)
                                     , 4040-4046. <a href="https://doi.org/10.4161/cc.22375" title="DOI URL">https://doi.org/10.4161/cc.22375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cc.22375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcc.22375%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DCDK%252Binhibitors%252BR-roscovitine%252Band%252BS-CR8%252Beffectively%252Bblock%252Brenal%252Band%252Bhepatic%252Bcystogenesis%252Bin%252Ban%252Borthologous%252Bmodel%252Bof%252BADPKD%26aulast%3DBukanov%26aufirst%3DNikolay%2BO.%26date%3D2012%26date%3D2014%26volume%3D11%26issue%3D21%26spage%3D4040%26epage%3D4046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Bischof</span>, <span class="hlFld-ContribAuthor ">Johann  Leban</span>, <span class="hlFld-ContribAuthor ">Mirko  Zaja</span>, <span class="hlFld-ContribAuthor ">Arnhild  Grothey</span>, <span class="hlFld-ContribAuthor ">Barbara  Radunsky</span>, <span class="hlFld-ContribAuthor ">Olaf  Othersen</span>, <span class="hlFld-ContribAuthor ">Stefan  Strobl</span>, <span class="hlFld-ContribAuthor ">Daniel  Vitt</span>, <span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>. </span><span class="cited-content_cbyCitation_article-title">2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2012,</strong> <em>43 </em>
                                    (4)
                                     , 1577-1591. <a href="https://doi.org/10.1007/s00726-012-1234-x" title="DOI URL">https://doi.org/10.1007/s00726-012-1234-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-012-1234-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-012-1234-x%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3D2-Benzamido-N-%2525281H-benzo%25255Bd%25255Dimidazol-2-yl%252529thiazole-4-carboxamide%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252BCK1%2525CE%2525B4%25252F%2525CE%2525B5%26aulast%3DBischof%26aufirst%3DJoachim%26date%3D2012%26date%3D2012%26volume%3D43%26issue%3D4%26spage%3D1577%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Heng-Xiu  Yan</span>, <span class="hlFld-ContribAuthor ">Qi-Zheng  Sun</span>, <span class="hlFld-ContribAuthor ">Shuang  Ma</span>, <span class="hlFld-ContribAuthor ">Pan  Ji</span>, <span class="hlFld-ContribAuthor ">Ze-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Shan  Feng</span>, <span class="hlFld-ContribAuthor ">Jun  Zou</span>, <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>56 </em>, 30-38. <a href="https://doi.org/10.1016/j.ejmech.2012.08.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN6-phenyl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidine-3%25252C6-diamine%252Bderivatives%252Bas%252Bnovel%252BCK1%252Binhibitors%252Busing%252Bcommon-feature%252Bpharmacophore%252Bmodel%252Bbased%252Bvirtual%252Bscreening%252Band%252Bhit-to-lead%252Boptimization%26aulast%3DYang%26aufirst%3DLing-Ling%26date%3D2012%26volume%3D56%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joannah  N'gompaza-Diarra</span>, <span class="hlFld-ContribAuthor ">Karima  Bettayeb</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>56 </em>, 210-216. <a href="https://doi.org/10.1016/j.ejmech.2012.08.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.08.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.08.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bselective%252Band%252Bpotent%252Bcyclin-dependent%252Bkinase%252Binhibitors%26aulast%3DN%2527gompaza-Diarra%26aufirst%3DJoannah%26date%3D2012%26volume%3D56%26spage%3D210%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aarthi  Narayanan</span>, <span class="hlFld-ContribAuthor ">Gavin  Sampey</span>, <span class="hlFld-ContribAuthor ">Rachel  Van Duyne</span>, <span class="hlFld-ContribAuthor ">Irene  Guendel</span>, <span class="hlFld-ContribAuthor ">Kylene  Kehn-Hall</span>, <span class="hlFld-ContribAuthor ">Jessica  Roman</span>, <span class="hlFld-ContribAuthor ">Robert  Currer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Massimo  Caputi</span>, <span class="hlFld-ContribAuthor ">Sergei  Nekhai</span>, <span class="hlFld-ContribAuthor ">Fatah  Kashanchi</span>. </span><span class="cited-content_cbyCitation_article-title">Use of ATP analogs to inhibit HIV-1 transcription. </span><span class="cited-content_cbyCitation_journal-name">Virology</span><span> <strong>2012,</strong> <em>432 </em>
                                    (1)
                                     , 219-231. <a href="https://doi.org/10.1016/j.virol.2012.06.007" title="DOI URL">https://doi.org/10.1016/j.virol.2012.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.virol.2012.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.virol.2012.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DVirology%26atitle%3DUse%252Bof%252BATP%252Banalogs%252Bto%252Binhibit%252BHIV-1%252Btranscription%26aulast%3DNarayanan%26aufirst%3DAarthi%26date%3D2012%26volume%3D432%26issue%3D1%26spage%3D219%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2011,</strong> <em>31 </em>
                                    (6)
                                     , 924-954. <a href="https://doi.org/10.1002/med.20207" title="DOI URL">https://doi.org/10.1002/med.20207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20207%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProtein%252Bkinases%252BCK1%252Band%252BCK2%252Bas%252Bnew%252Btargets%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DPerez%26aufirst%3DDaniel%2BI.%26date%3D2011%26date%3D2010%26volume%3D31%26issue%3D6%26spage%3D924%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart C.  Wilson</span>, <span class="hlFld-ContribAuthor ">Butrus  Atrash</span>, <span class="hlFld-ContribAuthor ">Clare  Barlow</span>, <span class="hlFld-ContribAuthor ">Susan  Eccles</span>, <span class="hlFld-ContribAuthor ">Peter M.  Fischer</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Lloyd  Kelland</span>, <span class="hlFld-ContribAuthor ">Wayne  Jackson</span>, <span class="hlFld-ContribAuthor ">Michael  Jarman</span>, <span class="hlFld-ContribAuthor ">Amin  Mirza</span>, <span class="hlFld-ContribAuthor ">Javier  Moreno</span>, <span class="hlFld-ContribAuthor ">Bernard P.  Nutley</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Peter  Sheldrake</span>, <span class="hlFld-ContribAuthor ">Mike  Walton</span>, <span class="hlFld-ContribAuthor ">Robert  Westwood</span>, <span class="hlFld-ContribAuthor ">Steven  Whittaker</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Edward  McDonald</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (22)
                                     , 6949-6965. <a href="https://doi.org/10.1016/j.bmc.2011.08.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.08.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.08.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.08.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B6-pyridylmethylaminopurines%252Bas%252BCDK%252Binhibitors%26aulast%3DWilson%26aufirst%3DStuart%2BC.%26date%3D2011%26volume%3D19%26issue%3D22%26spage%3D6949%26epage%3D6965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pamela  Kassis</span>, <span class="hlFld-ContribAuthor ">Joanna  Brzeszcz</span>, <span class="hlFld-ContribAuthor ">Valérie  Bénéteau</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Rémi  Le Guével</span>, <span class="hlFld-ContribAuthor ">Christiane  Guillouzo</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Lewiński</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Lionel  Colliandre</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (11)
                                     , 5416-5434. <a href="https://doi.org/10.1016/j.ejmech.2011.08.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.08.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.08.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B3-%2525286-hydroxyindol-2-yl%252529-5-%252528Phenyl%252529%252Bpyridine%252Bor%252Bpyrazine%252BV-Shaped%252Bmolecules%252Bas%252Bkinase%252Binhibitors%252Band%252Bcytotoxic%252Bagents%26aulast%3DKassis%26aufirst%3DPamela%26date%3D2011%26volume%3D46%26issue%3D11%26spage%3D5416%26epage%3D5434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Medeiros</span>, <span class="hlFld-ContribAuthor ">David  Baglietto-Vargas</span>, <span class="hlFld-ContribAuthor ">Frank M.  LaFerla</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Tau in Alzheimer's Disease and Related Disorders. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2011,</strong> <em>17 </em>
                                    (5)
                                     , 514-524. <a href="https://doi.org/10.1111/j.1755-5949.2010.00177.x" title="DOI URL">https://doi.org/10.1111/j.1755-5949.2010.00177.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1755-5949.2010.00177.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1755-5949.2010.00177.x%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DThe%252BRole%252Bof%252BTau%252Bin%252BAlzheimer%252527s%252BDisease%252Band%252BRelated%252BDisorders%26aulast%3DMedeiros%26aufirst%3DRodrigo%26date%3D2011%26date%3D2010%26volume%3D17%26issue%3D5%26spage%3D514%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanditha  Nair</span>, <span class="hlFld-ContribAuthor ">Wataru  Kudo</span>, <span class="hlFld-ContribAuthor ">Mark A.  Smith</span>, <span class="hlFld-ContribAuthor ">Ravinder  Abrol</span>, <span class="hlFld-ContribAuthor ">William A.  Goddard</span>, <span class="hlFld-ContribAuthor ">V. Prakash  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (13)
                                     , 3957-3961. <a href="https://doi.org/10.1016/j.bmcl.2011.05.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bpurine-based%252Bfluoroaryl-1%25252C2%25252C3-triazoles%252Bas%252Bneuroprotecting%252Bagents%25253A%252BSynthesis%25252C%252Bneuronal%252Bcell%252Bculture%252Binvestigations%25252C%252Band%252BCDK5%252Bdocking%252Bstudies%26aulast%3DNair%26aufirst%3DNanditha%26date%3D2011%26volume%3D21%26issue%3D13%26spage%3D3957%26epage%3D3961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassan M.  Shallal</span>, <span class="hlFld-ContribAuthor ">Wade A.  Russu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2043-2057. <a href="https://doi.org/10.1016/j.ejmech.2011.02.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.02.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.02.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bsynthesis%25252C%252Band%252Binvestigation%252Bof%252Bthe%252Bantitumor%252Bactivity%252Bof%252Bnovel%252Bpiperazinylpyrimidine%252Bderivatives%26aulast%3DShallal%26aufirst%3DHassan%2BM.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2043%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lotfi  Tak-Tak</span>, <span class="hlFld-ContribAuthor ">Florent  Barbault</span>, <span class="hlFld-ContribAuthor ">François  Maurel</span>, <span class="hlFld-ContribAuthor ">Patricia  Busca</span>, <span class="hlFld-ContribAuthor ">Yves  Le Merrer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of purin-2-yl and purin-6-yl-aminoglucitols as C-nucleosidic ATP mimics and biological evaluation as FGFR3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (4)
                                     , 1254-1262. <a href="https://doi.org/10.1016/j.ejmech.2011.01.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpurin-2-yl%252Band%252Bpurin-6-yl-aminoglucitols%252Bas%252BC-nucleosidic%252BATP%252Bmimics%252Band%252Bbiological%252Bevaluation%252Bas%252BFGFR3%252Binhibitors%26aulast%3DTak-Tak%26aufirst%3DLotfi%26date%3D2011%26volume%3D46%26issue%3D4%26spage%3D1254%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">James  Offord</span>, <span class="hlFld-ContribAuthor ">George J.  DeMarco</span>, <span class="hlFld-ContribAuthor ">Jeffrey F.  Ohren</span>, <span class="hlFld-ContribAuthor ">Ivan  Efremov</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>. </span><span class="cited-content_cbyCitation_article-title">Central Modulation of Circadian Rhythm via CK1 Inhibition for Psychiatric Indications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 33-51. <a href="https://doi.org/10.1016/B978-0-12-386009-5.00024-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-386009-5.00024-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-386009-5.00024-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-386009-5.00024-2%26sid%3Dliteratum%253Aachs%26atitle%3DCentral%252BModulation%252Bof%252BCircadian%252BRhythm%252Bvia%252BCK1%252BInhibition%252Bfor%252BPsychiatric%252BIndications%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2011%26spage%3D33%26epage%3D51%26pub%3DElsevier%26date%3D2011%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Jin  Ham</span>, <span class="hlFld-ContribAuthor ">Duck-Hyung  Lee</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Jung-Mi  Hah</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>. </span><span class="cited-content_cbyCitation_article-title">The efficient one-step chlorination of methylsulfanyl group on pyrimidine ring system with sulfuryl chloride. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (35)
                                     , 4609-4611. <a href="https://doi.org/10.1016/j.tetlet.2010.06.056" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.06.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.06.056%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DThe%252Befficient%252Bone-step%252Bchlorination%252Bof%252Bmethylsulfanyl%252Bgroup%252Bon%252Bpyrimidine%252Bring%252Bsystem%252Bwith%252Bsulfuryl%252Bchloride%26aulast%3DHam%26aufirst%3DYoung%2BJin%26date%3D2010%26volume%3D51%26issue%3D35%26spage%3D4609%26epage%3D4611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhou Cheng  Su</span>, <span class="hlFld-ContribAuthor ">Tong Earn  Tay</span>, <span class="hlFld-ContribAuthor ">Vincent B. C.  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2010,</strong> <em>16 </em>
                                    (6)
                                     , 1159-1168. <a href="https://doi.org/10.1007/s00894-009-0629-4" title="DOI URL">https://doi.org/10.1007/s00894-009-0629-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-009-0629-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-009-0629-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMechanism%252Bof%252BCDK5%252Bactivation%252Brevealed%252Bby%252Bsteered%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Benergy%252Bcalculations%26aulast%3DZhang%26aufirst%3DBing%26date%3D2010%26date%3D2009%26volume%3D16%26issue%3D6%26spage%3D1159%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria S  Burchell</span>, <span class="hlFld-ContribAuthor ">Sonia  Gandhi</span>, <span class="hlFld-ContribAuthor ">Emma  Deas</span>, <span class="hlFld-ContribAuthor ">Nicholas W  Wood</span>, <span class="hlFld-ContribAuthor ">Andrey Y  Abramov</span>, <span class="hlFld-ContribAuthor ">Hélène  Plun-Favreau</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mitochondrial dysfunction in neurodegenerative disease: Part II. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2010,</strong> <em>14 </em>
                                    (5)
                                     , 497-511. <a href="https://doi.org/10.1517/14728221003730434" title="DOI URL">https://doi.org/10.1517/14728221003730434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728221003730434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728221003730434%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bmitochondrial%252Bdysfunction%252Bin%252Bneurodegenerative%252Bdisease%25253A%252BPart%252BII%26aulast%3DBurchell%26aufirst%3DVictoria%2BS%26date%3D2010%26date%3D2010%26volume%3D14%26issue%3D5%26spage%3D497%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene M.  Sroka</span>, <span class="hlFld-ContribAuthor ">Elke H.  Heiss</span>, <span class="hlFld-ContribAuthor ">Libor  Havlicek</span>, <span class="hlFld-ContribAuthor ">Frank  Totzke</span>, <span class="hlFld-ContribAuthor ">Yasmin  Aristei</span>, <span class="hlFld-ContribAuthor ">Paul  Pechan</span>, <span class="hlFld-ContribAuthor ">Michael H. G.  Kubbutat</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, <span class="hlFld-ContribAuthor ">Verena M.  Dirsch</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Roscovitine Derivative Potently Induces G
              1
              -Phase Arrest in Platelet-Derived Growth Factor-BB-Activated Vascular Smooth Muscle Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2010,</strong> <em>77 </em>
                                    (2)
                                     , 255-261. <a href="https://doi.org/10.1124/mol.109.060327" title="DOI URL">https://doi.org/10.1124/mol.109.060327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.109.060327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.109.060327%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DA%252BNovel%252BRoscovitine%252BDerivative%252BPotently%252BInduces%252BG%252B1%252B-Phase%252BArrest%252Bin%252BPlatelet-Derived%252BGrowth%252BFactor-BB-Activated%252BVascular%252BSmooth%252BMuscle%252BCells%26aulast%3DSroka%26aufirst%3DIrene%2BM.%26date%3D2010%26date%3D2009%26volume%3D77%26issue%3D2%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis  Lévi</span>, <span class="hlFld-ContribAuthor ">Alper  Okyar</span>, <span class="hlFld-ContribAuthor ">Sandrine  Dulong</span>, <span class="hlFld-ContribAuthor ">Pasquale F.  Innominato</span>, <span class="hlFld-ContribAuthor ">Jean  Clairambault</span>. </span><span class="cited-content_cbyCitation_article-title">Circadian Timing in Cancer Treatments. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2010,</strong> <em>50 </em>
                                    (1)
                                     , 377-421. <a href="https://doi.org/10.1146/annurev.pharmtox.48.113006.094626" title="DOI URL">https://doi.org/10.1146/annurev.pharmtox.48.113006.094626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev.pharmtox.48.113006.094626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev.pharmtox.48.113006.094626%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DCircadian%252BTiming%252Bin%252BCancer%252BTreatments%26aulast%3DL%25C3%25A9vi%26aufirst%3DFrancis%26date%3D2010%26volume%3D50%26issue%3D1%26spage%3D377%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Venturoni</span>, <span class="hlFld-ContribAuthor ">Nikzad  Nikbin</span>, <span class="hlFld-ContribAuthor ">Steven V.  Ley</span>, <span class="hlFld-ContribAuthor ">Ian R.  Baxendale</span>. </span><span class="cited-content_cbyCitation_article-title">The application of flow microreactors to the preparation of a family of casein kinase I inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2010,</strong> <em>8 </em>
                                    (8)
                                     , 1798. <a href="https://doi.org/10.1039/b925327k" title="DOI URL">https://doi.org/10.1039/b925327k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b925327k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb925327k%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bapplication%252Bof%252Bflow%252Bmicroreactors%252Bto%252Bthe%252Bpreparation%252Bof%252Ba%252Bfamily%252Bof%252Bcasein%252Bkinase%252BI%252Binhibitors%26aulast%3DVenturoni%26aufirst%3DFrancesco%26date%3D2010%26volume%3D8%26issue%3D8%26spage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Trova</span>, <span class="hlFld-ContribAuthor ">Keith D.  Barnes</span>, <span class="hlFld-ContribAuthor ">Curt  Barford</span>, <span class="hlFld-ContribAuthor ">Travis  Benanti</span>, <span class="hlFld-ContribAuthor ">Mark  Bielaska</span>, <span class="hlFld-ContribAuthor ">Lori  Burry</span>, <span class="hlFld-ContribAuthor ">John M.  Lehman</span>, <span class="hlFld-ContribAuthor ">Christine  Murphy</span>, <span class="hlFld-ContribAuthor ">Harold  O’Grady</span>, <span class="hlFld-ContribAuthor ">Denise  Peace</span>, <span class="hlFld-ContribAuthor ">Susan  Salamone</span>, <span class="hlFld-ContribAuthor ">Jennifer  Smith</span>, <span class="hlFld-ContribAuthor ">Patricia  Snider</span>, <span class="hlFld-ContribAuthor ">Joseph  Toporowski</span>, <span class="hlFld-ContribAuthor ">Steven  Tregay</span>, <span class="hlFld-ContribAuthor ">Alison  Wilson</span>, <span class="hlFld-ContribAuthor ">Michael  Wyle</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Thomas D.  Friedrich</span>. </span><span class="cited-content_cbyCitation_article-title">Biaryl purine derivatives as potent antiproliferative agents: Inhibitors of cyclin dependent kinases. Part I. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (23)
                                     , 6608-6612. <a href="https://doi.org/10.1016/j.bmcl.2009.10.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiaryl%252Bpurine%252Bderivatives%252Bas%252Bpotent%252Bantiproliferative%252Bagents%25253A%252BInhibitors%252Bof%252Bcyclin%252Bdependent%252Bkinases.%252BPart%252BI%26aulast%3DTrova%26aufirst%3DMichael%2BP.%26date%3D2009%26volume%3D19%26issue%3D23%26spage%3D6608%26epage%3D6612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elias  Utreras</span>, <span class="hlFld-ContribAuthor ">Akira  Futatsugi</span>, <span class="hlFld-ContribAuthor ">Tej Kumar  Pareek</span>, <span class="hlFld-ContribAuthor ">Ashok B.  Kulkarni</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular roles of Cdk5 in pain signaling. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Therapeutic Strategies</span><span> <strong>2009,</strong> <em>6 </em>
                                    (3)
                                     , 105-111. <a href="https://doi.org/10.1016/j.ddstr.2009.04.004" title="DOI URL">https://doi.org/10.1016/j.ddstr.2009.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddstr.2009.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddstr.2009.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Therapeutic%2520Strategies%26atitle%3DMolecular%252Broles%252Bof%252BCdk5%252Bin%252Bpain%252Bsignaling%26aulast%3DUtreras%26aufirst%3DElias%26date%3D2009%26volume%3D6%26issue%3D3%26spage%3D105%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (16)
                                     , 4566-4569. <a href="https://doi.org/10.1016/j.bmcl.2009.06.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.06.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.06.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.06.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C6-diamino-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DChioua%26aufirst%3DMourad%26date%3D2009%26volume%3D19%26issue%3D16%26spage%3D4566%26epage%3D4569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophian  Sahnoun</span>, <span class="hlFld-ContribAuthor ">Samir  Messaoudi</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Mouâd  Alami</span>. </span><span class="cited-content_cbyCitation_article-title">A site selective C–H arylation of free-(NH2) adenines with aryl chlorides: Application to the synthesis of 6,8-disubstituted adenines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2009,</strong> <em>7 </em>
                                    (20)
                                     , 4271. <a href="https://doi.org/10.1039/b912033e" title="DOI URL">https://doi.org/10.1039/b912033e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b912033e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb912033e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bsite%252Bselective%252BC%2525E2%252580%252593H%252Barylation%252Bof%252Bfree-%252528NH2%252529%252Badenines%252Bwith%252Baryl%252Bchlorides%25253A%252BApplication%252Bto%252Bthe%252Bsynthesis%252Bof%252B6%25252C8-disubstituted%252Badenines%26aulast%3DSahnoun%26aufirst%3DSophian%26date%3D2009%26volume%3D7%26issue%3D20%26spage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K  Bettayeb</span>, <span class="hlFld-ContribAuthor ">N  Oumata</span>, <span class="hlFld-ContribAuthor ">A  Echalier</span>, <span class="hlFld-ContribAuthor ">Y  Ferandin</span>, <span class="hlFld-ContribAuthor ">J A  Endicott</span>, <span class="hlFld-ContribAuthor ">H  Galons</span>, <span class="hlFld-ContribAuthor ">L  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2008,</strong> <em>27 </em>
                                    (44)
                                     , 5797-5807. <a href="https://doi.org/10.1038/onc.2008.191" title="DOI URL">https://doi.org/10.1038/onc.2008.191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2008.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2008.191%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DCR8%25252C%252Ba%252Bpotent%252Band%252Bselective%25252C%252Broscovitine-derived%252Binhibitor%252Bof%252Bcyclin-dependent%252Bkinases%26aulast%3DBettayeb%26aufirst%3DK%26date%3D2008%26date%3D2008%26volume%3D27%26issue%3D44%26spage%3D5797%26epage%3D5807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0006.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-bromopropane, K<sub>2</sub>CO<sub>3</sub>, DMSO 15−18 °C; (b) boronate, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (c) ArNH<sub>2</sub> or ArCH<sub>2</sub>NH<sub>2</sub>, NEt<sub>3</sub>, BuOH 100 °C; (d) RNH<sub>2</sub>, NBu<sub>3</sub>, DMSO, 165 °C.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0007.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArNH<sub>2</sub>, NEt<sub>3</sub>, BuOH 100 °C; (b) boronate, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (c) ArBr, Na<sub>2</sub>CO<sub>3</sub>, Pd[P(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub>]<sub>4</sub>, H<sub>2</sub>O, dioxane, 100 °C; (d) RNH<sub>2</sub>, NBu<sub>3</sub>, DMSO 165 °C.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and DRF053 (<b>13a</b>). IC<sub>50</sub> values for CDK5/p25 and CK1 are indicated under each structure in μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. An alignment of the sequences of CDK1, 2, and 5 and five isoforms of CK1. Identical residues are enclosed in red-filled boxes and similar residues in blue-bordered boxes. The red arrow indicates Arg13<sup>CK1-δ</sup>. This position is occupied by a basic residue, arginine or lysine, in all CK1 isoforms, while in the CDKs, it is a glutamate. A favorable interaction between this residue and the pyridinyl ring of C&R8 (<b>8m</b>) and <b>13a</b> in CK1, and its absence in the CDKs could account for the specificity gain of the latter two analogues with respect to roscovitine for CK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Overall structure of CK1-δ complexed with analogue <b>13a</b> (magenta). The kinase is depicted as a ribbon and colored according to its secondary structure (red: α helix; cyan: beta-sheet; gray: random coil). (B) Analogue <b>13a</b> docked in the ATP-binding pocket of CK1-δ. The hydrogen bonds formed between the ligand and the kinase backbone as well as with the side chain of Arg13 are depicted as yellow dashed lines. The gatekeeper residue Met82 near the hydrophobic cavity of the pocket is also visible. (C) Analogue <b>8m</b> docked in the ATP-binding pocket of CK1-δ. Same representation as in (B). (D) (<i>R</i>)-Roscovitine <b>8a</b> docked in the ATP-binding pocket of CK1-δ. While the two hydrogen bonds formed with the receptor backbone are present, Arg13 does not interact with the ligand and adopts a different orientation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/medium/jm-2008-00109e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent inhibition of amyloid-β production in N2A-APP<sub>695</sub> cells by (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and (<i>R</i>)-DRF053 (<b>13a</b>). N2A cells stably expressing APP-695 were incubated in the absence or presence of various concentrations of (<i>R</i>)-roscovitine (<b>8a</b>), (<i>R</i>)-C&R8 (<b>8m</b>), and (<i>R</i>)-DRF053 (<b>13a</b>). Cell supernatants were collected after 3 h of incubation and subjected to Aβ40 ELISA assays. Data from at least three experiments (mean ± SEM) were compared (GraphPad Prism v4.0) with the control conditions (DMSO). (*: <i>P</i> < 0.05; **: <i>P</i> < 0.01; ***: <i>P</i> < 0.001; one-tailed Student’s <i>t</i> test, 95% significance level).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800109e/production/images/large/jm-2008-00109e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800109e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">1912−1916</span><span class="NLM_x">) </span> <span class="NLM_fpage">1933</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1933-1934&issue=1912%E2%88%921916&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26issue%3D1912%25E2%2588%25921916%26spage%3D1933%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kostich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span> </span><span class="NLM_article-title">Human members of the eukaryotic protein kinase family</span> <span class="citation_source-journal">Genome Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">research0043.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">research0043.12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=research0043.1-research0043.12&issue=9&author=M.+Kostichauthor=J.+Englishauthor=V.+Madisonauthor=F.+Gheyasauthor=L.+Wangauthor=P.+Qiuauthor=J.+Greeneauthor=M.+Thomas&title=Human+members+of+the+eukaryotic+protein+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostich%26aufirst%3DM.%26aulast%3DEnglish%26aufirst%3DJ.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DP.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DM.%26atitle%3DHuman%2520members%2520of%2520the%2520eukaryotic%2520protein%2520kinase%2520family%26jtitle%3DGenome%2520Biology%26date%3D2002%26volume%3D3%26issue%3D9%26spage%3Dresearch0043.1%26epage%3Dresearch0043.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-ref3_1"><span><a href="http://www.kinasenet.org/pkr/Welcome.do" class="extLink">http://www.kinasenet.org/pkr/Welcome.do</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.kinasenet.org%2Fpkr%2FWelcome.do."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref3_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Niedner, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzko, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribskov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Protein kinase resource: an integrated environment for phosphorylation research</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=78-86&author=R.+H.+Niednerauthor=O.+V.+Buzkoauthor=N.+M.+Hasteauthor=A.+Taylorauthor=M.+Gribskovauthor=S.+S.+Taylor&title=Protein+kinase+resource%3A+an+integrated+environment+for+phosphorylation+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiedner%26aufirst%3DR.%2BH.%26aulast%3DBuzko%26aufirst%3DO.%2BV.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DGribskov%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DProtein%2520kinase%2520resource%253A%2520an%2520integrated%2520environment%2520for%2520phosphorylation%2520research%26jtitle%3DProteins%26date%3D2006%26volume%3D63%26spage%3D78%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases: the major drug targets of the twenty-first century</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%3A+the+major+drug+targets+of+the+twenty-first+century"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%253A%2520the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F0929867043365062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15180564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlKlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1563-1583&author=P.+M.+Fischer&title=The+design+of+drug+candidate+molecules+as+selective+inhibitors+of+therapeutically+relevant+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases</span></div><div class="casAuthors">Fischer, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1563-1583</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The human genome encompasses some 2000 proteins that utilize ATP in one way or another and some 500 of these are protein-tyrosine and protein-serine/threonine kinases (PTKs & PSTKs).  Substrate phosphorylation by these enzymes is nature's predominant mol. way of organizing cellular signal transduction and regulating biochem. processes in general.  It is not surprising, therefore, that abnormal phosphorylation of cellular proteins is a hallmark of disease and that there was a growing interest in the use of kinase inhibitors as drugs.  In fact the search for such agents has recently culminated in the approval of the 1st kinase inhibitor drugs for medical use.  Although it was demonstrated exhaustively that potent and structurally diverse ATP-antagonistic small mol. kinase inhibitors can be found through mass screening and structure-guided design, the question of biochem., cellular, and in vivo selectivity of such inhibitors remains much less clear.  Here the medicinal chem. of kinase inhibitors is reviewed critically with particular emphasis on target selectivity and specificity.  Approaches based on chem. genomics, combinatorial target-guided ligand assembly, computational chem., and structural biol. techniques, which aim at classifying both inhibitors and kinase targets, are given special emphasis.  The various strategies in which differences in biochem. mechanism of kinase function can be exploited to attain selective inhibition are also discussed.  Furthermore, recent developments in the design of inhibitors to selected individual validated therapeutic kinase targets, including cell cycle kinases and receptor PTKs, etc. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGG4UXoCMRILVg90H21EOLACvtfcHk0ljHOF9xGQVgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlKlu7c%253D&md5=27aec2f6bdc06f639b3b8eb6b9de8a8f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867043365062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043365062%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DThe%2520design%2520of%2520drug%2520candidate%2520molecules%2520as%2520selective%2520inhibitors%2520of%2520therapeutically%2520relevant%2520protein%2520kinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1563%26epage%3D1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Weinmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metternich, R.</span><span> </span><span class="NLM_article-title">Drug discovery process for kinase inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1002%2Fcbic.200500034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15742380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=455-459&author=H.+Weinmannauthor=R.+Metternich&title=Drug+discovery+process+for+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery process for kinase inhibitors</span></div><div class="casAuthors">Weinmann Hilmar; Metternich Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-9</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2pa-m03MzviEJCPKhJPuqfW6udTcc2eZ32sNFXLlUK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D&md5=62db1c09267fe56d34abef8d5b651750</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500034%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DMetternich%26aufirst%3DR.%26atitle%3DDrug%2520discovery%2520process%2520for%2520kinase%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2FS0165-6147%2802%2902071-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12237154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVWmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=417-425&author=M.+Knockaertauthor=P.+Greengardauthor=L.+Meijer&title=Pharmacological+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibitors of cyclin-dependent kinases</span></div><div class="casAuthors">Knockaert, Marie; Greengard, Paul; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (CDKs) regulate the cell division cycle, apoptosis, transcription and differentiation in addn. to functions in the nervous system.  Deregulation of CDKs in various diseases has stimulated an intensive search for selective pharmacol. inhibitors of these kinases.  More than 50 inhibitors have been identified, among which >20 have been co-crystd. with CDK2.  These inhibitors all target the ATP-binding pocket of the catalytic site of the kinase.  The actual selectivity of most known CDK inhibitors, and thus the underlying mechanism of their cellular effects, is poorly known.  Pharmacol. inhibitors of CDKs are currently being evaluated for therapeutic use against cancer, alopecia, neurodegenerative disorders (e.g. Alzheimer's disease, amyotrophic lateral sclerosis and stroke), cardiovascular disorders (e.g. atherosclerosis and restenosis), glomerulonephritis, viral infections (e.g. HCMV, HIV and HSV) and parasitic protozoa (Plasmodium sp. and Leishmania sp.).  Pharmacol. inhibitors of cyclin-dependent kinases are being actively investigated in view of their potential therapeutic use against a large variety of indications such as cancers, Alzheimer's disease and other neurodegenerative disorders, and viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokE1X0jvc9GbVg90H21EOLACvtfcHk0liX9U6iPu0P1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVWmsbY%253D&md5=09bb4b161d30cbff71b80f7aae505843</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2802%2902071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252802%252902071-0%26sid%3Dliteratum%253Aachs%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Smith, P. J.; Yue, E.</span>, Eds.  <span class="citation_source-book">CDK Inhibitors of Cyclin-Dependent Kinases as Antitumor Agents</span>; <span class="NLM_series">Monographs on Enzyme Inhibitors</span>;  <span class="NLM_publisher-name">CRC Press, Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, <div class="note"><p class="first last">448 pp</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+J.+Smith&author=E.+Yue&title=CDK+Inhibitors+of+Cyclin-Dependent+Kinases+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26btitle%3DCDK%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinases%2520as%2520Antitumor%2520Agents%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%26date%3D2006%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=471-480&author=L.+Meijerauthor=M.+Flajoletauthor=P.+Greengard&title=Pharmacological+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DPharmacological%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loehler, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, M.</span><span> </span><span class="NLM_article-title">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.cellsig.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15722192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=675-689&author=U.+Knippschildauthor=A.+Gochtauthor=S.+Wolffauthor=N.+Huberauthor=J+Loehlerauthor=M.+Stoeter&title=The+casein+kinase+1+family%3A+participation+in+multiple+cellular+processes+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span></div><div class="casAuthors">Knippschild, Uwe; Gocht, Andreas; Wolff, Sonja; Huber, Nadine; Loehler, Juergen; Stoeter, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-689</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of Ser, Thr, and Tyr residues by cellular protein kinases plays an important role in the regulation of various cellular processes.  The Ser/Thr-specific casein kinase 1 and 2 protein kinase families, CK1 and CK2, resp., were among the 1st protein kinases that had been described.  In recent years, knowledge of the regulation and function of mammalian CK1 kinase family members has rapidly increased.  Extracellular stimuli, the subcellular localization of CK1 isoforms, their interaction with various cellular structures and proteins, as well as autophosphorylation and proteolytic cleavage of their C-terminal regulatory domains influence CK1 kinase activity.  Mammalian CK1 isoforms phosphorylate many different substrates, among them key regulatory proteins involved in the control of cell differentiation, proliferation, chromosome segregation, and circadian rhythms.  De-regulation and/or the incidence of mutations in the coding sequence of CK1 isoforms have been linked to neurodegenerative diseases and cancer.  Here, the authors summarize the current knowledge about the function and regulation of mammalian CK1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTGvFy5TMyLVg90H21EOLACvtfcHk0ljzCu-12u6eUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D&md5=e44cbddc335887723b171bf889dd2f08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DGocht%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DLoehler%26aufirst%3DJ%26aulast%3DStoeter%26aufirst%3DM.%26atitle%3DThe%2520casein%2520kinase%25201%2520family%253A%2520participation%2520in%2520multiple%2520cellular%2520processes%2520in%2520eukaryotes%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D675%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification of CK1 by affinity chromatography on immobilised axin</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.pep.2007.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17434749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2007&pages=101-109&author=J.+Reinhardtauthor=Y.+Ferandinauthor=L.+Meijer&title=Purification+of+CK1+by+affinity+chromatography+on+immobilised+axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of CK1 by affinity chromatography on immobilised axin</span></div><div class="casAuthors">Reinhardt, Jens; Ferandin, Yoan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Members of the Casein Kinase 1 (CK1) family are implicated in the regulation of a variety of physiol. processes like development and circadian rhythm, as well as in diseases like cancer and Alzheimer's disease.  From that perspective, CK1 family members are interesting targets for potential chemotherapy.  We describe here a rapid and efficient method for the purifn. of CK1 by affinity chromatog. on an immobilized fragment of axin.  Axin is a scaffolding protein that interacts with a multitude of proteins, amongst them APC, GSK-3, β-catenin, CK1α, δ, and ε, and PP2A.  A GST-tagged axin peptide (residues 495-684) was produced in Escherichia coli and either immobilized on glutathione agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These "GST-axin" matrixes were found to selectively bind native CK1α and CK1ε from porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. provides a convenient tool to efficiently purify large amts. of active native CK1 for screening purposes.  This single step purifn. also provides a convenient tool to follow the status of the axin-binding CK1 isoforms α, δ, and ε (protein levels, compn. of isoforms, kinase activity) under different physiol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnaZtPudqbbVg90H21EOLACvtfcHk0ljzCu-12u6eUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D&md5=8edde52c867ca4879a797e498fea8797</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2007.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2007.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520of%2520CK1%2520by%2520affinity%2520chromatography%2520on%2520immobilised%2520axin%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2007%26volume%3D54%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rosemeyer, H.</span><span> </span><span class="NLM_article-title">The chemodiversity of purine as a constituent of natural products</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1002%2Fcbdv.200490033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17191854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=361-401&author=H.+Rosemeyer&title=The+chemodiversity+of+purine+as+a+constituent+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The chemodiversity of purine as a constituent of natural products</span></div><div class="casAuthors">Rosemeyer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-401</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta AG</span>)
        </div><div class="casAbstract">In this review, various natural manifestations of purine systems, i.e., methylated, higher-alkylated, and glycosylated forms, are described.  These comprise the purine alkaloids, cytokinines, as well as the purine nucleoside antibiotics.  In part, the compds. described herein were isolated from natural sources already long ago.  However, some have been reported only during the last few years.  The biol. activities of most of the purine derivs. are briefly described, and, in some cases, syntheses are formulated.  In particular, this article introduces the main synthetic principles for the generation of the purine ring system.  The last chapter describes modern preparative routes for C-alkylation and C-arylation of purines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppvY0HCBfJirVg90H21EOLACvtfcHk0ljzCu-12u6eUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlOht7k%253D&md5=5653bce55e74efb0a8b797514d33b862</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200490033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200490033%26sid%3Dliteratum%253Aachs%26aulast%3DRosemeyer%26aufirst%3DH.%26atitle%3DThe%2520chemodiversity%2520of%2520purine%2520as%2520a%2520constituent%2520of%2520natural%2520products%26jtitle%3DChem.%2520Biodiversity%26date%3D2004%26volume%3D1%26spage%3D361%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Haystead, T. A.</span><span> </span><span class="NLM_article-title">The purinome, a complex mix of drug and toxicity targets</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F156802606777812059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16842150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1117-1127&author=T.+A.+Haystead&title=The+purinome%2C+a+complex+mix+of+drug+and+toxicity+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The purinome, a complex mix of drug and toxicity targets</span></div><div class="casAuthors">Haystead, Timothy A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Much attention has focused on the development of protein kinases as drug targets to treat a variety of human diseases including diabetes, cancer, hypertension and arthritis.  To date, Gleevec is one example of a drug targeting protein that has successfully treated human cancer.  Several other protein kinase inhibitors are in clin. development.  However, protein kinases are in fact part of a larger collection of some 2000 distinct proteins expressed by the genome that like the protein kinases also bind purines (the purinome), either to be utilized as substrates or as co-factors in the form of NAD, NADP and co-enzyme A.  The soln. structures of many representative gene family members within the purinome show these proteins bind purines in a similar orientations to that obsd. in all protein kinases.  Several non-protein kinase purine utilizing proteins are established drug targets such as HMG CoA reductase, dihydrofolate reductase, phosphodiesterase and HSP90.  Searches of OMIM identifies many purine utilizing enzymes that are assocd. with inborn errors in metab.  Inhibition of any one of which by a drug could lead to an undesirable side effect.  The purinome is therefore somewhat of a drug discovery mixed blessing.  It is a rich source of therapeutic targets, but also contains a large collection of diverse proteins whose inhibition could result in an adverse outcome.  Drug discovery within the purinome should therefore encompass strategies that enable broad assessment of selectivity across the entire purinome at the earliest stages of the discovery process.  In this article we review the purinome within the context of drug discovery and discuss approaches for avoiding off target binding during the discovery/lead optimization process with particular emphasis on use of proteome mining technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobI5dz-INnDLVg90H21EOLACvtfcHk0lgBMYQ7twFotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7k%253D&md5=7aaff9cac57cda09e06a468599f20106</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156802606777812059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812059%26sid%3Dliteratum%253Aachs%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26atitle%3DThe%2520purinome%252C%2520a%2520complex%2520mix%2520of%2520drug%2520and%2520toxicity%2520targets%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Legraverend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span> </span><span class="NLM_article-title">The purines: potent and versatile small molecule inhibitors and modulators of key biological targets</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3987-4006&author=M.+Legraverendauthor=D.+S.+Grierson&title=The+purines%3A+potent+and+versatile+small+molecule+inhibitors+and+modulators+of+key+biological+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegraverend%26aufirst%3DM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26atitle%3DThe%2520purines%253A%2520potent%2520and%2520versatile%2520small%2520molecule%2520inhibitors%2520and%2520modulators%2520of%2520key%2520biological%2520targets%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3987%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Haesslein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jullian, N.</span><span> </span><span class="NLM_article-title">Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anticancer agents. Roles and perspectives for the future</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F1568026023393291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12171570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1037-1050&author=J.+L.+Haessleinauthor=N.+Jullian&title=Recent+advances+in+cyclin-dependent+kinase+inhibition.+Purine-based+derivatives+as+anticancer+agents.+Roles+and+perspectives+for+the+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anti-cancer agents. Roles and perspectives for the future</span></div><div class="casAuthors">Haesslein, Jean-Luc; Jullian, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1037-1050</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases (Ser/Thr and Tyr) play a key role in signal transduction pathways.  It has been shown that deregulation of the Cdk activity is linked to cell proliferation and cancer.  Inhibition of cyclin-dependent kinases (Cdks) is an important target for potential new anti-cancer drugs.  Following the discovery of Olomoucine, a wide range of tri-substituted purine derivs. have been synthesized, leading to potent Cdk inhibitors.  These purine-derived compds. bind to the ATP pocket of the protein.  Of interest for structure-based drug design, the different crystal structures published to date show evidence for three different binding modes for the purine ring, allowing diverse exploration of the ATP binding site.  Some examples of synthesis and structure activity relationships are discussed for a set of purine derivs., tri-substituted on C-2, N-9 and C-6.  Finally, in vivo activities are reviewed, as well as the applications in other therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNa6znCVspGbVg90H21EOLACvtfcHk0lgBMYQ7twFotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOitbg%253D&md5=d5de74dff3a50cdfcf974b1189a9497a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026023393291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393291%26sid%3Dliteratum%253Aachs%26aulast%3DHaesslein%26aufirst%3DJ.%2BL.%26aulast%3DJullian%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520cyclin-dependent%2520kinase%2520inhibition.%2520Purine-based%2520derivatives%2520as%2520anticancer%2520agents.%2520Roles%2520and%2520perspectives%2520for%2520the%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D1037%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar0201198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=417-425&author=L.+Meijerauthor=E.+Raymond&title=Roscovitine+and+other+purines+as+kinase+inhibitors.+From+starfish+oocytes+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Far0201198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far0201198%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DRoscovitine%2520and%2520other%2520purines%2520as%2520kinase%2520inhibitors.%2520From%2520starfish%2520oocytes%2520to%2520clinical%2520trials%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulner, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, J. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delcros, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulinoux, J. P.</span><span> </span><span class="NLM_article-title">Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1111%2Fj.1432-1033.1997.t01-2-00527.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=9030781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1997&pages=527-536&author=L.+Meijerauthor=A.+Borgneauthor=O.+Mulnerauthor=J.+P.+J.+Chongauthor=J.+J.+Blowauthor=N.+Inagakiauthor=M.+Inagakiauthor=J.+G.+Delcrosauthor=J.+P.+Moulinoux&title=Biochemical+and+cellular+effects+of+roscovitine%2C+a+potent+and+selective+inhibitor+of+the+cyclin-dependent+kinases+cdc2%2C+cdk2+and+cdk5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5</span></div><div class="casAuthors">Meijer, Laurent; Borgne, Annie; Mulner, Odile; Chong, James P. J.; Blow, J. Julian; Inagaki, Naoyuki; Inagaki, Masaki; Delcros, Jean Guy; Moulinoux, Jacques Philippe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">527-536</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (cdk) play an essential role in the intracellular control of the cell division cycle (cdc).  These kinases and their regulators are frequently deregulated in human tumors.  Enzymic screening has recently led to the discovery of specific inhibitors of cyclin-dependent kinases, such as butyrolactone I, flavopiridol and the purine olomoucine.  Among a series of C2, N6,N9-substituted adenines tested on purified cdc2/cyclin B, 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine) displays high efficiency and high selectivity towards some cyclin-dependent kinases.  The kinase specificity of roscovitine was investigated with 25 highly purified kinases (including protein kinase A, G and C isoforms, myosin light-chain kinase, casein kinase 2, insulin receptor tyrosine kinase, c-src, v-abl).  Most kinases are not significantly inhibited by roscovitine.  Cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p35 only are substantially inhibited (IC50 values of 0.65, 0.7, 0.7 and 0.2 μM, resp.).  Cdk4/cyclin D1 and cdk6/cyclin D2 are very poorly inhibited by roscovitine (IC50>100 μM).  Extracellular regulated kinases erk1 and erk2 are inhibited with an IC50 of 34 μM and 14 μM, resp.  Roscovitine reversibly arrests starfish oocytes and sea urchin embryos in late prophase.  Roscovitine inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg exts.  It blocks progesterone-induced oocyte maturation of Xenopus oocytes and in vivo phosphorylation of the elongation factor eEF-1.  Roscovitine inhibits the proliferation of mammalian cell lines with an av. IC50 of 16 μM.  In the presence of roscovitine L1210 cells arrest in G1 and accumulate in G2.  In vivo phosphorylation of vimentin on Ser55 by cdc2/cyclin B is inhibited by roscovitine.  Through its unique selectivity for some cyclin-dependent kinases, roscovitine provides a useful anti-mitotic reagent for cell cycle studies and may prove interesting to control cells with deregulated cdc2, cdk2 or cdk5 kinase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO61Tu2_0pWLVg90H21EOLACvtfcHk0ljCwVPsl4fgXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVWiu7g%253D&md5=d55100def53ac8811e485d9d34c46b79</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.t01-2-00527.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.t01-2-00527.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBorgne%26aufirst%3DA.%26aulast%3DMulner%26aufirst%3DO.%26aulast%3DChong%26aufirst%3DJ.%2BP.%2BJ.%26aulast%3DBlow%26aufirst%3DJ.%2BJ.%26aulast%3DInagaki%26aufirst%3DN.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DDelcros%26aufirst%3DJ.%2BG.%26aulast%3DMoulinoux%26aufirst%3DJ.%2BP.%26atitle%3DBiochemical%2520and%2520cellular%2520effects%2520of%2520roscovitine%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520cyclin-dependent%2520kinases%2520cdc2%252C%2520cdk2%2520and%2520cdk5%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D243%26spage%3D527%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K; Galons, H.</span><span> </span><span class="NLM_article-title">Roscovitine (CYC202, Seliciclib)</span>. In  <span class="citation_source-book">CDK Inhibitors and their Potential as Antitumor Agents</span>; <span class="NLM_series">Monographs on Enzyme Inhibitors</span>; <span class="NLM_contrib-group">Smith, P. J.; Yue, E.</span>, Eds.; <span class="NLM_publisher-name">CRC Press, Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, Chapter 9, pp  <span class="NLM_fpage">187</span>− <span class="NLM_lpage">226</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=187-226&author=L.+Meijer&author=K+Bettayeb&author=H.+Galonsauthor=P.+J.+Smith&author=E.+Yue&title=CDK+Inhibitors+and+their+Potential+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26btitle%3DCDK%2520Inhibitors%2520and%2520their%2520Potential%2520as%2520Antitumor%2520Agents%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%26date%3D2006%26volume%3D2%26spage%3D187%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bukanov, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledbetter, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibraghimov-Beskrovnaya, O.</span><span> </span><span class="NLM_article-title">Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor Roscovitine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=949-952&author=N.+O.+Bukanovauthor=L.+A.+Smithauthor=K.+W.+Klingerauthor=S.+R.+Ledbetterauthor=O.+Ibraghimov-Beskrovnaya&title=Long-lasting+arrest+of+murine+polycystic+kidney+disease+with+CDK+inhibitor+Roscovitine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBukanov%26aufirst%3DN.%2BO.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DKlinger%26aufirst%3DK.%2BW.%26aulast%3DLedbetter%26aufirst%3DS.%2BR.%26aulast%3DIbraghimov-Beskrovnaya%26aufirst%3DO.%26atitle%3DLong-lasting%2520arrest%2520of%2520murine%2520polycystic%2520kidney%2520disease%2520with%2520CDK%2520inhibitor%2520Roscovitine%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D949%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Menn, B.; Ivanov, A.; Bach, S.; Ben-Ari, Y.; Meijer, L.; Timsit, S.</span><span> </span><span class="NLM_article-title">Systemic (<i>S</i>)-roscovitine provides neuroprotection in stroke model</span>.  <span class="citation_source-journal">Ann. Neurol.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Menn&author=A.+Ivanov&author=S.+Bach&author=Y.+Ben-Ari&author=L.+Meijer&author=S.+Timsit&title=Systemic+%28S%29-roscovitine+provides+neuroprotection+in+stroke+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenn%26aufirst%3DB.%26atitle%3DSystemic%2520%2528S%2529-roscovitine%2520provides%2520neuroprotection%2520in%2520stroke%2520model%26jtitle%3DAnn.%2520Neurol.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rossi, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawatzky, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldicott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Losa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savill, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslett, C.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1056</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1038%2Fnm1468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16951685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1056-1064&author=A.+G.+Rossiauthor=D.+A.+Sawatzkyauthor=A.+Walkerauthor=C.+Wardauthor=T.+A.+Sheldrakeauthor=N.+A.+Rileyauthor=A.+Caldicottauthor=M.+Martinez-Losaauthor=T.+R.+Walkerauthor=R.+Duffinauthor=M.+Grayauthor=E.+Crescenziauthor=M.+C.+Martinauthor=H.+J.+Bradyauthor=J.+S.+Savillauthor=I.+Dransfieldauthor=C.+Haslett&title=Cyclin-dependent+kinase+inhibitors+enhance+the+resolution+of+inflammation+by+promoting+inflammatory+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis</span></div><div class="casAuthors">Rossi, Adriano G.; Sawatzky, Deborah A.; Walker, Annemieke; Ward, Carol; Sheldrake, Tara A.; Riley, Nicola A.; Caldicott, Alison; Martinez-Losa, Magdalena; Walker, Trevor R.; Duffin, Rodger; Gray, Mohini; Crescenzi, Elvira; Martin, Morag C.; Brady, Hugh J.; Savill, John S.; Dransfield, Ian; Haslett, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1056-1064</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is essential for clearance of potentially injurious inflammatory cells and subsequent efficient resoln. of inflammation.  Here the authors report that human neutrophils contain functionally active cyclin-dependent kinases (CDKs), and that structurally diverse CDK inhibitors induce caspase-dependent apoptosis and override powerful anti-apoptosis signals from survival factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF).  The authors show that the CDK inhibitor R-roscovitine (Seliciclib or CYC202) markedly enhances resoln. of established neutrophil-dependent inflammation in carrageenan-elicited acute pleurisy, bleomycin-induced lung injury, and passively induced arthritis in mice.  In the pleurisy model, the caspase inhibitor zVAD-fmk prevents R-roscovitine-enhanced resoln. of inflammation, indicating that this CDK inhibitor augments inflammatory cell apoptosis.  The authors also provide evidence that R-roscovitine promotes apoptosis by reducing concns. of the anti-apoptotic protein Mcl-1.  Thus, CDK inhibitors enhance the resoln. of established inflammation by promoting apoptosis of inflammatory cells, thereby demonstrating a hitherto unrecognized potential for the treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrgjIOkXitzrVg90H21EOLACvtfcHk0ljCwVPsl4fgXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFClur8%253D&md5=022715d2e6890ee33c5f53ebdbc46e15</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm1468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1468%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BG.%26aulast%3DSawatzky%26aufirst%3DD.%2BA.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DSheldrake%26aufirst%3DT.%2BA.%26aulast%3DRiley%26aufirst%3DN.%2BA.%26aulast%3DCaldicott%26aufirst%3DA.%26aulast%3DMartinez-Losa%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DT.%2BR.%26aulast%3DDuffin%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DM.%2BC.%26aulast%3DBrady%26aufirst%3DH.%2BJ.%26aulast%3DSavill%26aufirst%3DJ.%2BS.%26aulast%3DDransfield%26aufirst%3DI.%26aulast%3DHaslett%26aufirst%3DC.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520enhance%2520the%2520resolution%2520of%2520inflammation%2520by%2520promoting%2520inflammatory%2520cell%2520apoptosis%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1056%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nutley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClue, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15657360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=125-139&author=B.+P.+Nutleyauthor=F.+I.+Raynaudauthor=S.+C.+Wilsonauthor=P.+M.+Fischerauthor=A.+Hayesauthor=P.+M.+Goddardauthor=S.+J.+McClueauthor=M.+Jarmanauthor=D.+P.+Laneauthor=P.+Workman&title=Metabolism+and+pharmacokinetics+of+the+cyclin-dependent+kinase+inhibitor+R-roscovitine+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse</span></div><div class="casAuthors">Nutley, Bernard P.; Raynaud, Florence I.; Wilson, Stuart C.; Fischer, Peter M.; Hayes, Angela; Goddard, Phyllis M.; McClue, Steven J.; Jarman, Michael; Lane, David P.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-139</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">R-roscovitine (seliciclib, CYC202) is a cyclin-dependent kinase inhibitor currently in phase II clin. trials in patients with cancer.  Here, we describe its mouse metab. and pharmacokinetics as well as the identification of the principal metabolites in hepatic microsomes, plasma, and urine.  Following microsomal incubation of R-roscovitine at 10 μg/mL (28 μmol/L) for 60 min, 86.7% of the parent drug was metabolized and 60% of this loss was due to formation of one particular metabolite.  This was identified as the carboxylic acid resulting from oxidn. of the hydroxymethyl group of the amino alc. substituent at C2 of the purine core present in R-roscovitine.  Identification was confirmed by chem. synthesis and comparison of an authentic sample of the R-roscovitine-derived carboxylate metabolite (COOH-R-roscovitine).  Other minor metabolites were identified as C8-oxo-R-roscovitine and N9-desisopropyl-R-roscovitine; these accounted for 4.9% and 2.6% of the parent, resp.  The same metabolic pattern was obsd. in vivo, with a 4.5-fold lower AUC∞ for R-roscovitine (38μmol/L/h) than for COOH-R-roscovitine (174 μmol/L/h).  Excretion of R-roscovitine in the urine up to 24 h post-dosing accounted for an av. of only 0.02% of the administered dose of 50 mg/kg, whereas COOH-R-roscovitine represented 65% to 68% of the dose irresp. of the route of administration (i.v., i.p., or p.o.).  A partially deuterated deriv. (R-roscovitine-d9) was synthesized to investigate if formation of COOH-R-roscovitine could be inhibited by replacement of metabolically labile protons with deuterium.  After 60 min of incubation of R-roscovitine-d9 or R-roscovitine with mouse liver microsomes, formation of COOH-R-roscovitine-d9 was decreased by ∼24% compared with the prodn. of COOH-R-roscovitine.  In addn., the levels of R-roscovitine-d9 remaining were 33% higher than those of R-roscovitine.  However, formation of several minor R-roscovitine metabolites was enhanced with R-roscovitine-d9, suggesting that metabolic switching from the major carbinol oxidn. pathway had occurred.  Synthetic COOH-R-roscovitine and C8-oxo-R-roscovitine were tested in functional cyclin-dependent kinase assays and shown to be less active than R-roscovitine, confirming that these metabolic reactions are deactivation pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBj5J1kUae7Vg90H21EOLACvtfcHk0lgbtHjyLm9Gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFyqtA%253D%253D&md5=5607206b139c515dae5ec69729059af7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutley%26aufirst%3DB.%2BP.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWilson%26aufirst%3DS.%2BC.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DGoddard%26aufirst%3DP.%2BM.%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DMetabolism%2520and%2520pharmacokinetics%2520of%2520the%2520cyclin-dependent%2520kinase%2520inhibitor%2520R-roscovitine%2520in%2520the%2520mouse%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D125%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Vita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Rehim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, M.</span><span> </span><span class="NLM_article-title">Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.ejps.2005.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15854805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=91-103&author=M.+Vitaauthor=M.+Abdel-Rehimauthor=S.+Olofssonauthor=Z.+Hassanauthor=L.+Meurlingauthor=A.+Sidenauthor=M.+Sidenauthor=T.+Petterssonauthor=M.+Hassan&title=Tissue+distribution%2C+pharmacokinetics+and+identification+of+roscovitine+metabolites+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat</span></div><div class="casAuthors">Vita, Marina; Abdel-Rehim, Mohamed; Olofsson, Susanne; Hassan, Zuzana; Meurling, Lennart; Siden, Aake; Siden, Mabel; Pettersson, Tommy; Hassan, Moustapha</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-103</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacokinetics, biodistribution and the metabolic pathway of roscovitine were investigated in Sprague-Dawley rats after a single i.v. dose of 25 mg/kg.  Blood, lungs, kidney, liver, testis, adipose tissue, spleen and brain were removed at different time-points.  Plasma and tissue samples were analyzed using high performance liq. chromatog.  The metabolites were identified using liq. chromatog./tandem mass spectrometry and NMR spectroscopy.  Roscovitine (MW = 354) was cleared rapidly from circulation and highly distributed to the tissues.  The elimination half-life of roscovitine in plasma and tissues was short (<30 min).  A major metabolite (M1) was obsd. mainly in plasma and in lower levels in all other tissues.  M1 was identified as conversion of the hydroxyl-group at C2 to carboxylic acid (MW = 368).  A second metabolite (M2) was obsd. mainly in liver and kidney and identified as a hydroxylation product of the C8 of the purine-ring (MW = 370).  A third metabolite (M3) was found in several organs and corresponded to N-dealkylation of the N9-iso-Pr side-chain (MW = 312).  Roscovitine concns. in the brain were 30% of that obsd. in plasma, however no metabolites were detected in brain.  In this investigation, three major metabolites of roscovitine were isolated and identified.  Also, it was shown that roscovitine eliminates rapidly from both blood and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCxxGyXcWbLVg90H21EOLACvtfcHk0lgbtHjyLm9Gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Kmsro%253D&md5=c4b7c6c0f7876cb67fb7ee6c91326262</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DVita%26aufirst%3DM.%26aulast%3DAbdel-Rehim%26aufirst%3DM.%26aulast%3DOlofsson%26aufirst%3DS.%26aulast%3DHassan%26aufirst%3DZ.%26aulast%3DMeurling%26aufirst%3DL.%26aulast%3DSiden%26aufirst%3DA.%26aulast%3DSiden%26aufirst%3DM.%26aulast%3DPettersson%26aufirst%3DT.%26aulast%3DHassan%26aufirst%3DM.%26atitle%3DTissue%2520distribution%252C%2520pharmacokinetics%2520and%2520identification%2520of%2520roscovitine%2520metabolites%2520in%2520rat%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D25%26spage%3D91%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lgbtHjyLm9Gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule−kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%88%92kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2588%2592kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierick, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaechtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Roscovitine targets, protein kinases and pyridoxal kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31208</span><span class="NLM_x">–</span> <span class="NLM_lpage">31219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31208-31219&author=S.+Bachauthor=M.+Knockaertauthor=J.+Reinhardtauthor=O.+Lozachauthor=S.+Schmittauthor=B.+Baratteauthor=M.+Kokenauthor=S.+P.+Coburnauthor=L.+Tangauthor=T.+Jiangauthor=D.-C.+Liangauthor=H.+Galonsauthor=J.-F.+Dierickauthor=L.+A.+Pinnaauthor=F.+Meggioauthor=F.+Totzkeauthor=C.+Schaechteleauthor=A.+S.+Lermanauthor=A.+Carneroauthor=Y.+Wanauthor=N.+Grayauthor=L.+Meijer&title=Roscovitine+targets%2C+protein+kinases+and+pyridoxal+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DS.%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DSchmitt%26aufirst%3DS.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DKoken%26aufirst%3DM.%26aulast%3DCoburn%26aufirst%3DS.%2BP.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DD.-C.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DDierick%26aufirst%3DJ.-F.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSchaechtele%26aufirst%3DC.%26aulast%3DLerman%26aufirst%3DA.%2BS.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520targets%252C%2520protein%2520kinases%2520and%2520pyridoxal%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31208%26epage%3D31219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0liYDskwCC2mdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1111%2Fj.1460-9568.2006.05226.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17241267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=59-68&author=J.+Z.+Wangauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Kinases+and+phosphatases+and+tau+sites+involved+in+Alzheimer+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span></div><div class="casAuthors">Wang Jian-Zhi; Grundke-Iqbal Inge; Iqbal Khalid</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Microtubule associated protein (MAP) tau is abnormally hyperphosphorylated in Alzheimer's disease (AD) and related tauopathies; in this form it is the major protein subunit of paired helical filaments (PHF)/neurofibrillary tangles.  However, the nature of protein kinases and phosphatases and tau sites involved in this lesion has been elusive.  We investigated self-assembly and microtubule assembly promoting activities of hyperphosphorylated tau isolated from Alzheimer disease brain cytosol, the AD abnormally hyperphosphorylated tau (AD P-tau) before and after dephosphorylation by phosphoseryl/phosphothreonyl protein phosphatase-2A (PP-2A), and then rephosphorylation by cyclic AMP-dependent protein kinase (PKA), calcium, calmodulin-dependent protein kinase II (CaMKII), glycogen synthase kinase-3beta (GSK-3beta) and cyclin-dependent protein kinase 5 (cdk5) in different kinase combinations.  We found that (i) dephosphorylation of AD P-tau by PP-2A inhibits its polymerization into PHF/straight filaments (SF) and restores its binding and ability to promote assembly of tubulin into microtubules; (ii) rephosphorylation of PP-2A-dephosphorylated AD P-tau by sequential phosphorylation by PKA, CaMKII and GSK-3beta or cdk5, and as well as by cdk5 and GSK-3beta, promotes its self-assembly into tangles of PHF similar to those seen in Alzheimer brain, and (iii) phosphorylation of tau sites required for this pathology are Thr231 and Ser262, along with several sites flanking the microtubule binding repeat region.  Phosphorylation of recombinant human brain tau(441) yielded similar results as the PP-2A dephosphorylated AD P-tau, except that mostly SF were formed.  The conditions for the abnormal hyperphosphorylation of tau that promoted its self-assembly also induced the microtubule assembly inhibitory activity.  These findings suggest that activation of PP-2A or inhibition of either both GSK-3beta and cdk5 or one of these two kinases plus PKA or CaMKII might be required to inhibit Alzheimer neurofibrillary degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI9DB-4K5ZmF1C8OJBvdfbfW6udTcc2eZJSRrvbCBTuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D&md5=b8f8ba0a76085995f6c652cc737c55b2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2006.05226.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2006.05226.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DKinases%2520and%2520phosphatases%2520and%2520tau%2520sites%2520involved%2520in%2520Alzheimer%2520neurofibrillary%2520degeneration%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Mi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">The role of tau phosphorylation in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.2174%2F156720506779025279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17168644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=449-463&author=K.+Miauthor=G.+V.+Johnson&title=The+role+of+tau+phosphorylation+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tau phosphorylation in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Mi, Kaihong; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau, which is abundantly expressed in neurons, is deposited in cells in an abnormally phosphorylated state as fibrillar lesions in numerous neurodegenerative diseases, with the most notable being Alzheimer's disease.  Tau plays a crucial role in the neuron as it binds and stabilizes microtubules, and can regulate axonal transport; functions that are regulated by site-specific phosphorylation events.  In pathol. conditions such as Alzheimer's disease and other tauopathies, tau is abnormally phosphorylated, and that this contributes to its dysfunction.  Given the increasing evidence that a disruption in the normal phosphorylation state of tau followed by conformational changes plays a key role in the pathogenic events that occur in Alzheimer's disease and other tauopathies; it is crit. to elucidate the regulation of tau phosphorylation.  This review focuses on recent literature pertaining to the regulation of tau phosphorylation and function, and the role that a dysregulation of tau phosphorylation may play in the neuronal dysfunction in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9dvtaMDpfbVg90H21EOLACvtfcHk0lgKqTeSV9KK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM&md5=1e0ea8f6bceba1b430a44392ceb34181</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F156720506779025279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025279%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DThe%2520role%2520of%2520tau%2520phosphorylation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">Cdk5 deregulation in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=452-8&author=J.+C.+Cruzauthor=L.+H.+Tsai&title=Cdk5+deregulation+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DCdk5%2520deregulation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D452%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">GSK-3 is essential in the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16914869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=309-17&author=A.+Takashima&title=GSK-3+is+essential+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 is essential in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">309-317</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) is a pivotal mol. in the development of Alzheimer's disease (AD).  GSK-3β is involved in the formation of paired helical filament (PHF)-tau, which is an integral component of the neurofibrillary tangle (NFT) deposits that disrupt neuronal function, and a marker of neurodegeneration in AD.  GSK-3β has exactly the same oligonucleotide sequence as tau-protein kinase I (TPKI), which was first purified from the microtubule fraction of bovine brain.  Initially, we discovered that GSK-3β was involved in amyloid-β (Aβ)-induced neuronal death in rat hippocampal cultures.  In the present review, we discuss our initial in vitro results and addnl. investigations showing that Aβ activates GSK-3β through impairment of phosphatidylinositol-3 (PI3)/Akt signaling; that Aβ-activated GSK-3β induces hyperphosphorylation of tau, NFT formation, neuronal death, and synaptic loss (all found in the AD brain); that GSK-3β can induce memory deficits in vivo; and that inhibition of GSK-3α (an isoform of GSK-3β) reduces Aβ prodn.  These combined results strongly suggest that GSK-3 activation is a crit. step in brain aging and the cascade of detrimental events in AD, preceding both the NFT and neuronal death pathways.  Therefore, therapeutics targeted to inhibiting GSK-3 may be beneficial in the treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4pguAPgiQLVg90H21EOLACvtfcHk0lgKqTeSV9KK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKktLo%253D&md5=d7157eb2d6a985a3489bb143113d7500</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DGSK-3%2520is%2520essential%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D309%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Phiel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=435-439&author=C.+J.+Phielauthor=C.+A.+Wilsonauthor=V.+M.+Leeauthor=P.+S.+Klein&title=GSK-3alpha+regulates+production+of+Alzheimer%E2%80%99s+disease+amyloid-beta+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DWilson%26aufirst%3DC.%2BA.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DGSK-3alpha%2520regulates%2520production%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-beta%2520peptides%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-beta formation by casein kinase I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-64&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-beta+formation+by+casein+kinase+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-beta%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Aulia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B. L.</span><span> </span><span class="NLM_article-title">Cdh1-APC/C, cyclin B-Cdc2, and Alzheimer’s disease pathology</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2006&pages=1-6&author=S.+Auliaauthor=B.+L.+Tang&title=Cdh1-APC%2FC%2C+cyclin+B-Cdc2%2C+and+Alzheimer%E2%80%99s+disease+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAulia%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DB.%2BL.%26atitle%3DCdh1-APC%252FC%252C%2520cyclin%2520B-Cdc2%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathology%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D339%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlund, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer’s disease</span> <span class="citation_source-journal">Dementia Geriatr. Cognit. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1159%2F000088634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=16192727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1aiurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=367-374&author=A.+Johanssonauthor=H.+Zetterbergauthor=H.+Hampelauthor=K.+Buergerauthor=J.+A.+Princeauthor=L.+Minthonauthor=L.+O.+Wahlundauthor=K.+Blennow&title=Genetic+association+of+CDC2+with+cerebrospinal+fluid+tau+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease</span></div><div class="casAuthors">Johansson, Annica; Zetterberg, Henrik; Hampel, Harald; Buerger, Katharina; Prince, Jonathan A.; Minthon, Lennart; Wahlund, Lars-Olof; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Dementia and Geriatric Cognitive Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">DGCDFX</span>;
        ISSN:<span class="NLM_cas:issn">1420-8008</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have recently reported that a polymorphism in the cell division cycle (CDC2)gene, designated Ex6 + 7I/D, is assocd. with Alzheimer's disease (AD).  The CDC2 gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD.  Active cdc2 accumulates in neurons contg. neurofibrillary tangles (NFT), a process that can precede the formation of NFT.  Therefore, CDC2is a promising candidate susceptibility gene for AD.  We investigated the possible effects of the CDC2 polymorphism on cerebrospinal fluid (CSF) biomarkers in AD patients.  CDC2 genotypes were evaluated in relation to CSF protein levels of total tau, phospho-tau and β-amyloid(1-42) in AD patients and control individuals, and in relation to the amt. of senile plaques and NFT in the frontal cortex and in the hippocampus in patients with autopsy-proven AD and controls.  The CDC2 Ex6 + 7I allele was assocd. with a gene dose-dependent increase of CSF total tau levels (F2, 626 = 7.0, p = 0.001) and the homozygous CDC2 Ex6 + 7II genotype was significantly more frequent among AD patients compared to controls (p = 0.006, OR = 1.57, 95% CI 1.13-2.17).  Our results provide further evidence for an involvement of cdc2 in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0nJEP6Okt67Vg90H21EOLACvtfcHk0liBCsmVasnVtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1aiurvO&md5=bf664d515fa435d51be5c746ce4fe14f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000088634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000088634%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBuerger%26aufirst%3DK.%26aulast%3DPrince%26aufirst%3DJ.%2BA.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DWahlund%26aufirst%3DL.%2BO.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DGenetic%2520association%2520of%2520CDC2%2520with%2520cerebrospinal%2520fluid%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2005%26volume%3D20%26spage%3D367%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer’s disease neurofibrillary degeneration</span> <span class="citation_source-journal">Acta Neuropathol. (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=12200623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFGrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2002&pages=369-376&author=J.+J.+Peiauthor=H.+Braakauthor=C.+X.+Gongauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=B+Winbladauthor=R.+F.+Cowburn&title=Up-regulation+of+cell+division+cycle+%28cdc%29+2+kinase+in+neurons+with+early+stage+Alzheimer%E2%80%99s+disease+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration</span></div><div class="casAuthors">Pei, Jin-Jing; Braak, Heiko; Gong, Cheng-Xin; Grundke-Iqbal, Inge; Iqbal, Khalid; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">369-376</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The major component of Alzheimer's disease (AD) neurofibrillary tangles (NFTs) is abnormally hyperphosphorylated tau aggregated as paired helical filaments (PHFs).  Cell division cycle (cdc) 2 kinase is one of the main candidate kinases that phosphorylates normal tau in vitro at several sites seen in PHF-tau.  Using brains staged according to Braak and Braak criteria, we investigated the role of cdc2 in neurofibrillary changes in the hippocampal formation, and the entorhinal and temporal cortices.  Neurons with tangle-like inclusions pos. for active cdc2 were found to appear first in the Pre-α layer of the entorhinal cortex, and then extend to other brain regions co-incident with the progressive sequence of neurofibrillary changes.  This predictable progressive pattern is not assocd. with amyloid.  The intraneuronal accumulation of active cdc2 appeared to precede the deposition of PHF-tau phosphorylated at Ser 202/Thr 205 sites.  These data are consistent with the notion that cdc2 might be involved in the abnormal hyperphosphorylation of tau and consequently aggregation of tau into PHF at an early stage and that increased cdc2 activity is not consequent to the deposition of β-amyloid in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB91vksOg9VbVg90H21EOLACvtfcHk0ljiuYAMfmbmFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFGrtro%253D&md5=1dfee72e3e3eee6cec11f7186a0dc50d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DWinblad%26aufirst%3DB%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DUp-regulation%2520of%2520cell%2520division%2520cycle%2520%2528cdc%2529%25202%2520kinase%2520in%2520neurons%2520with%2520early%2520stage%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520degeneration%26jtitle%3DActa%2520Neuropathol.%2520%2528Berlin%2529%26date%3D2002%26volume%3D104%26spage%3D369%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canudas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span> </span><span class="NLM_article-title">The role of CDK5/P25 formation/inhibition in neurodegeneration</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1358%2Fdnp.2006.19.8.1043961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17160145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=453-460&author=A.+Caminsauthor=E.+Verdaguerauthor=J.+Folchauthor=A.+M.+Canudasauthor=M.+Pallas&title=The+role+of+CDK5%2FP25+formation%2Finhibition+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CDK5/P25 formation/inhibition in neurodegeneration</span></div><div class="casAuthors">Camins, Antoni; Verdaguer, Ester; Folch, Jaume; Canudas, Anna Maria; Pallas, Merce</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cdk5 is an atypical cyclin-dependent kinase localized in the brain, and its activity is dependent upon binding to p35/p39.  In addn., while cdk5 has important physiol. functions related to brain development, the breakdown of cdk5/p35 into cdk5/p25 increases its kinase activity and neurotoxicity.  Interestingly, in recent years increased cdk5/p25 expression has been demonstrated in the brains of patients with Alzheimer's and Parkinson's diseases.  Exptl. studies performed in neuronal cell cultures indicate that cdk5/p25 plays a prominent role in apoptosis.  Moreover, an apoptotic pathway, via an intracellular calcium increase following calpain activation and cdk5/p25 formation, has been postulated.  Cdk5/p25 subsequently phosphorylates the nuclear transcription factor myocyte enhancer factor (MEF2), thereby inhibiting its prosurvival activity.  However, cdk5/p25 could phosphorylate other substrates such as tau and p53, as well as the retinoblastoma protein pRb.  All these data lend credence to the hypothesis that cdk5/p25 acts as a master regulator of neuronal cell death.  In addn., cdk5/p25 might also interact with other pathways such as glycogen synthetase kinase 3β (GSK3β) and c-JUN kinase.  Drugs like roscovitine, flavopiridol, calpain inhibitors, kenpaullone and induribins, which inhibit cdk5/p25 formation, constitute potential drugs for the treatment of neurol. disorders.  Furthermore, the dual inhibitory effect of some of these drugs on cdk5 and GSK3β could be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOxQ0IEe0BrVg90H21EOLACvtfcHk0ljiuYAMfmbmFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Cktw%253D%253D&md5=7cc22392cdc933c8aac503cbb8a0cede</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2006.19.8.1043961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2006.19.8.1043961%26sid%3Dliteratum%253Aachs%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DCanudas%26aufirst%3DA.%2BM.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520CDK5%252FP25%2520formation%252Finhibition%2520in%2520neurodegeneration%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2006%26volume%3D19%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">10536</span><span class="NLM_x">–</span> <span class="NLM_lpage">10541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.3133-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17035538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFegurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10536-10541&author=J.+C.+Cruzauthor=D.+Kimauthor=L.+Y.+Moyauthor=M.+M.+Dobbinauthor=X.+Sunauthor=R.+T.+Bronsonauthor=L.+H.+Tsai&title=p25%2Fcyclin-dependent+kinase+5+induces+production+and+intraneuronal+accumulation+of+amyloid+beta+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo</span></div><div class="casAuthors">Cruz, Jonathan C.; Kim, Dohoon; Moy, Lily Y.; Dobbin, Matthew M.; Sun, Xiaoyan; Bronson, Roderick T.; Tsai, Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10536-10541</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Aberrant processing of the amyloid precursor protein (APP) and the subsequent accumulation of amyloid β (Aβ) peptide has been widely established as a central event in Alzheimer's disease (AD) pathogenesis.  The sequential cleavage steps required for the generation of Aβ are well outlined; however, there is a relative dearth of knowledge pertaining to signaling pathways and mol. mechanisms that can modulate this process.  Here, we demonstrate a novel role for p25/cyclin-dependent kinase 5 (Cdk5) in regulating APP processing, Aβ peptide generation, and intraneuronal Aβ accumulation in inducible p25 transgenic and compd. PD-APP transgenic mouse models that demonstrate deregulated Cdk5 activity and a neurodegenerative phenotype.  Induction of p25 resulted in enhanced forebrain Aβ levels before any evidence of neuropathol. in these mice.  Intracellular Aβ accumulated in perinuclear regions and distended axons within the forebrains of these mice.  Evidence for modulations in axonal transport or β-site APP cleaving enzyme 1 protein levels and activity are presented as mechanisms that may account for the Aβ accumulation caused by p25/Cdk5 deregulation.  Collectively, these findings delineate a novel pathol. mechanism involving aberrant APP processing by p25/Cdk5 and have important implications in AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVz0iGp5L1DrVg90H21EOLACvtfcHk0ljiuYAMfmbmFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFegurzJ&md5=de2f38810b69f4c3dc6a8108cf2baaa1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3133-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3133-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DDobbin%26aufirst%3DM.%2BM.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3Dp25%252Fcyclin-dependent%2520kinase%25205%2520induces%2520production%2520and%2520intraneuronal%2520accumulation%2520of%2520amyloid%2520beta%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10536%26epage%3D10541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17100579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1389-1397&author=H.+C.+Huangauthor=P.+S.+Klein&title=Multiple+roles+for+glycogen+synthase+kinase-3+as+a+drug+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple roles for glycogen synthase kinase-3 as a drug target in alzheimer's disease</span></div><div class="casAuthors">Huang, Hui-Chuan; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1389-1397</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder that presents clin. as inexorable cognitive impairment and decline in performance of activities of daily living.  AD is characterized pathol. by neuronal depopulation, extracellular amyloid plaques, and intraneuronal accumulation of neurofibrillary tangles (NFTs).  Accumulation of these polypeptide aggregates is generally believed to be integral to the pathogenesis of AD.  Recent evidence implicates the protein kinase glycogen synthase kinase 3 (GSK-3) in the regulation of both of these processes.  GSK-3 has long been studied as one of several tau protein kinases, and has more recently been shown to be involved in the generation of Aβ peptides.  GSK-3 activity may also promote cell death and conversely, inhibition of GSK-3 has been assocd. with increased cell survival under a variety of cytotoxic conditions.  Thus drugs that target GSK-3 could attack AD pathogenesis on multiple fronts simultaneously.  Here we will briefly review the mol. understanding of AD pathogenesis as it stands at this point, and then discuss the emerging role of GSK-3 in regulating these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpauigv98zKTLVg90H21EOLACvtfcHk0lgf-LLBb5sOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FE&md5=78732ad65a149a092327eb614acad091</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DMultiple%2520roles%2520for%2520glycogen%2520synthase%2520kinase-3%2520as%2520a%2520drug%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D1389%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rockenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-on, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.4321-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17314294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1981-1991&author=E.+Rockensteinauthor=M.+Torranceauthor=A.+Adameauthor=M.+Manteauthor=P.+Bar-onauthor=J.+B.+Roseauthor=L.+Crewsauthor=E.+Masliah&title=Neuroprotective+effects+of+regulators+of+the+glycogen+synthase+kinase-3beta+signaling+pathway+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease+are+associated+with+reduced+amyloid+precursor+protein+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation</span></div><div class="casAuthors">Rockenstein, Edward; Torrance, Magdalena; Adame, Anthony; Mante, Michael; Bar-on, Pazit; Rose, John B.; Crews, Leslie; Masliah, Eliezer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1981-1991</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The glycogen synthase kinase-3β (GSK3β) pathway plays an important role in mediating neuronal fate and synaptic plasticity.  In Alzheimer's disease (AD), abnormal activation of this pathway might play an important role in neurodegeneration, and compds. such as lithium that modulate GSK3β activity have been shown to reduce amyloid prodn. and tau phosphorylation in amyloid precursor protein (APP) transgenic (tg) mice.  However, it is unclear whether regulation of GSK3β is neuroprotective in APP tg mice.  In this context, the main objective of the present study was to det. whether pharmacol. or genetic manipulations that block the GSK3β pathway might ameliorate the neurodegenerative alterations in APP tg mice and to better understand the mechanisms involved.  For this purpose, two sets of expts. were performed.  First, tg mice expressing mutant human APP under the Thy1 promoter (hAPP tg) were treated with either lithium chloride or saline alone.  Second, hAPP tg mice were crossed with GSK3β tg mice, in which overexpression of this signaling mol. results in a dominant-neg. (DN) effect with inhibition of activity.  HAPP tg mice that were treated with lithium or that were crossed with DN-GSK3β tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation.  Moreover, reduced activation of GSK3β was assocd. with decreased levels of APP phosphorylation that resulted in decreased amyloid-β prodn.  In conclusion, the present study showed that modulation of the GSK3β signaling pathway might also have neuroprotective effects in tg mice by regulating APP maturation and processing and further supports the notion that GSK3β might be a suitable target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUuW0UdsjNrVg90H21EOLACvtfcHk0lgf-LLBb5sOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D&md5=a94686f980fa6039d682ce16759f838c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4321-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4321-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRockenstein%26aufirst%3DE.%26aulast%3DTorrance%26aufirst%3DM.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DMante%26aufirst%3DM.%26aulast%3DBar-on%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DL.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DNeuroprotective%2520effects%2520of%2520regulators%2520of%2520the%2520glycogen%2520synthase%2520kinase-3beta%2520signaling%2520pathway%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520are%2520associated%2520with%2520reduced%2520amyloid%2520precursor%2520protein%2520phosphorylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Rockenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-on, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1523%2FJNEUROSCI.4321-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=17314294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1981-1991&author=E.+Rockensteinauthor=M.+Torranceauthor=A.+Adameauthor=M.+Manteauthor=P.+Bar-onauthor=J.+B.+Roseauthor=L.+Crewsauthor=E.+Masliah&title=Neuroprotective+effects+of+regulators+of+the+glycogen+synthase+kinase-3beta+signaling+pathway+in+a+transgenic+model+of+Alzheimer%E2%80%99s+disease+are+associated+with+reduced+amyloid+precursor+protein+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation</span></div><div class="casAuthors">Rockenstein, Edward; Torrance, Magdalena; Adame, Anthony; Mante, Michael; Bar-on, Pazit; Rose, John B.; Crews, Leslie; Masliah, Eliezer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1981-1991</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The glycogen synthase kinase-3β (GSK3β) pathway plays an important role in mediating neuronal fate and synaptic plasticity.  In Alzheimer's disease (AD), abnormal activation of this pathway might play an important role in neurodegeneration, and compds. such as lithium that modulate GSK3β activity have been shown to reduce amyloid prodn. and tau phosphorylation in amyloid precursor protein (APP) transgenic (tg) mice.  However, it is unclear whether regulation of GSK3β is neuroprotective in APP tg mice.  In this context, the main objective of the present study was to det. whether pharmacol. or genetic manipulations that block the GSK3β pathway might ameliorate the neurodegenerative alterations in APP tg mice and to better understand the mechanisms involved.  For this purpose, two sets of expts. were performed.  First, tg mice expressing mutant human APP under the Thy1 promoter (hAPP tg) were treated with either lithium chloride or saline alone.  Second, hAPP tg mice were crossed with GSK3β tg mice, in which overexpression of this signaling mol. results in a dominant-neg. (DN) effect with inhibition of activity.  HAPP tg mice that were treated with lithium or that were crossed with DN-GSK3β tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation.  Moreover, reduced activation of GSK3β was assocd. with decreased levels of APP phosphorylation that resulted in decreased amyloid-β prodn.  In conclusion, the present study showed that modulation of the GSK3β signaling pathway might also have neuroprotective effects in tg mice by regulating APP maturation and processing and further supports the notion that GSK3β might be a suitable target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUuW0UdsjNrVg90H21EOLACvtfcHk0lgf-LLBb5sOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2jur8%253D&md5=a94686f980fa6039d682ce16759f838c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4321-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4321-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRockenstein%26aufirst%3DE.%26aulast%3DTorrance%26aufirst%3DM.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DMante%26aufirst%3DM.%26aulast%3DBar-on%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DL.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DNeuroprotective%2520effects%2520of%2520regulators%2520of%2520the%2520glycogen%2520synthase%2520kinase-3beta%2520signaling%2520pathway%2520in%2520a%2520transgenic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520are%2520associated%2520with%2520reduced%2520amyloid%2520precursor%2520protein%2520phosphorylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seereeram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span> </span><span class="NLM_article-title">Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">23645</span><span class="NLM_x">–</span> <span class="NLM_lpage">23654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=23645-23654&author=D.+P.+Hangerauthor=H.+L.+Byersauthor=S.+Wrayauthor=K.+Y.+Leungauthor=M.+J.+Saxtonauthor=A.+Seereeramauthor=C.+H.+Reynoldsauthor=M.+A.+Wardauthor=B.+H.+Anderton&title=Novel+phosphorylation+sites+in+tau+from+Alzheimer+brain+support+a+role+for+casein+kinase+1+in+disease+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DByers%26aufirst%3DH.%2BL.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DK.%2BY.%26aulast%3DSaxton%26aufirst%3DM.%2BJ.%26aulast%3DSeereeram%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DWard%26aufirst%3DM.%2BA.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520phosphorylation%2520sites%2520in%2520tau%2520from%2520Alzheimer%2520brain%2520support%2520a%2520role%2520for%2520casein%2520kinase%25201%2520in%2520disease%2520pathogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D23645%26epage%3D23654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15938</span><span class="NLM_x">–</span> <span class="NLM_lpage">15945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15938-15945&author=G.+Liauthor=H.+Yinauthor=J.+Kuret&title=Casein+kinase+1+delta+phosphorylates+tau+and+disrupts+its+binding+to+microtubules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCasein%2520kinase%25201%2520delta%2520phosphorylates%2520tau%2520and%2520disrupts%2520its%2520binding%2520to%2520microtubules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15938%26epage%3D15945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Singh, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1046%2Fj.1471-4159.1995.64031420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=7532213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=1420-1423&author=T.+J.+Singhauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Phosphorylation+of+tau+protein+by+casein+kinase-1+converts+it+to+an+abnormal+Alzheimer-like+state"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of τ protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span></div><div class="casAuthors">Singh, Toolsee; Grundke-Iqbal, Inge; Iqbal, Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1420-3</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Microtubule-assocd. protein τ is abnormally hyperphosphorylated in Alzheimer's disease.  Both proline-dependent protein kinases (PDPKs) and non-PDPKs are involved in this hyperphosphorylation of τ.  Several PDPKs can phosphorylate τ in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies.  A similar induction has not been reported with non-PDPKs.  Here, the authors evaluated 6 non-PDPKs [cAMP-dependent (A-kinase), Ca2+/phospholipid-dependent (C-kinase), casein kinase-1 (CK-1), casein kinase-2 (CK-2), Ca2+/calmodulin-dependent protein kinase II, and Ca2+/calmodulin-dependent protein kinase from rat cerebellum] for their abilities to induce Alzheimer-like epitopes on τ.  Such epitopes were induced by A-kinase, C-kinase, CK-1, and CK-2, but the degree of induction achieved by CK-1 was much greater than with the other kinases.  These results suggest that CK-1 may play an important role in the conversion of τ from the normal to the abnormal phosphorylation state in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaaD_uS92HrVg90H21EOLACvtfcHk0lh7V87jFFTKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D&md5=3827ab9e85b4dc25ab1e3e02dd614a4d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64031420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64031420.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BJ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DPhosphorylation%2520of%2520tau%2520protein%2520by%2520casein%2520kinase-1%2520converts%2520it%2520to%2520an%2520abnormal%2520Alzheimer-like%2520state%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D1420%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Chang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.+T.+Changauthor=N.+G.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0lh7V87jFFTKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.%2BT.%26aulast%3DGray%26aufirst%3DN.%2BG.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, A. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeClerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1126%2Fscience.281.5376.533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=9677190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFCltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=533-538&author=N.+S.+Grayauthor=L.+Wodickaauthor=A.+W.+H.+Thunnissenauthor=T.+C.+Normanauthor=S.+Kwonauthor=F.+H.+Espinozaauthor=D.+O.+Morganauthor=G.+Barnesauthor=S.+LeClercauthor=L.+Meijerauthor=S-H.+Kimauthor=D.+J.+Lockhartauthor=P.+G.+Schultz&title=Exploiting+chemical+libraries%2C+structure%2C+and+genomics+in+the+search+for+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors</span></div><div class="casAuthors">Gray, Nathanael S.; Wodicka, Lisa; Thunnissen, Andy-Mark W. H.; Norman, Thea C.; Kwon, Soojin; Espinoza, F. Hernan; Morgan, David O.; Barnes, Georjana; LeClerc, Sophie; Meijer, Laurent; Kim, Sung-Hou; Lockhart, David J.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5376</span>),
    <span class="NLM_cas:pages">533-538</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Selective protein kinase inhibitors were developed on the basis of the unexpected binding mode of 2,6,9-trisubstituted purines to the ATP-binding site of the human cyclin-dependent kinase 2 (CDK2).  By iterating chem. library synthesis and biol. screening, potent inhibitors of the human CDK2-cyclin A kinase complex and of Saccharomyces cerevisiae Cdc28p were identified.  The structural basis for the binding affinity and selectivity was detd. by anal. of a three-dimensional crystal structure of a CDK2-inhibitor complex.  The cellular effects of these compds. were characterized in mammalian cells and yeast.  In the latter case the effects were characterized on a genome-wide scale by monitoring changes in mRNA levels in treated cells with high-d. oligonucleotide probe arrays.  Purine libraries could provide useful tools for analyzing a variety of signaling and regulatory pathways and may led to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRTOOPjk16tbVg90H21EOLACvtfcHk0lhUAauwwvZKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFCltr8%253D&md5=08b8debe4d05c1169c152ccd6676def8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5376.533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5376.533%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWodicka%26aufirst%3DL.%26aulast%3DThunnissen%26aufirst%3DA.%2BW.%2BH.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DEspinoza%26aufirst%3DF.%2BH.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3DLeClerc%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS-H.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DExploiting%2520chemical%2520libraries%252C%2520structure%252C%2520and%2520genomics%2520in%2520the%2520search%2520for%2520kinase%2520inhibitors%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D533%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A Concise and Traceless Linker Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8273</span><span class="NLM_x">–</span> <span class="NLM_lpage">8276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo016010f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8273-8276&author=S.+Dingauthor=N.+S.+Grayauthor=Q.+Dingauthor=P.+G.+Schultz&title=A+Concise+and+Traceless+Linker+Strategy+toward+Combinatorial+Libraries+of+2%2C6%2C9-Substituted+Purines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo016010f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016010f%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520Concise%2520and%2520Traceless%2520Linker%2520Strategy%2520toward%2520Combinatorial%2520Libraries%2520of%25202%252C6%252C9-Substituted%2520Purines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8273%26epage%3D8276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, Nathanael, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. and</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Resin-capture and release strategy toward combinatorial libraries of 2,6,9-substituted purines</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc010080i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=183-186&author=S.+Dingauthor=S.+Gray%2C+Nathanaelauthor=Q.+Dingauthor=X.+and+Wuauthor=P.+G.+Schultz&title=Resin-capture+and+release+strategy+toward+combinatorial+libraries+of+2%2C6%2C9-substituted+purines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Resin-Capture and Release Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines</span></div><div class="casAuthors">Ding, Sheng; Gray, Nathanael S.; Ding, Qiang; Wu, Xu; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-186</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A resin-capture and release strategy for making combinatorial 2,6,9-trisubstituted purine libraries is demonstrated by capturing N9-derivatized purines at the C6 position with a thio-modified polymer.  The C2 fluoro group is subsequently substituted with primary and secondary amines followed by thioether oxidn. and release by C6 substitution with amines and anilines.  This approach complements a previously reported strategy where a 6-phenylsulfenylpurine scaffold was captured at the C2 position with a resin-bound amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3l9Kkqq10p7Vg90H21EOLACvtfcHk0lhUAauwwvZKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlOitg%253D%253D&md5=7a864bd42a6d2e288d0c413aceaf25b0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcc010080i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc010080i%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%252C%2BNathanael%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DX.%2Band%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DResin-capture%2520and%2520release%2520strategy%2520toward%2520combinatorial%2520libraries%2520of%25202%252C6%252C9-substituted%2520purines%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2002%26volume%3D4%26spage%3D183%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Brun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legraverend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D. S.</span><span> </span><span class="NLM_article-title">Traceless solid-phase synthesis of 2,6,9- trisubstituted purines from resin bound 6-thiopurines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7911</span><span class="NLM_x">–</span> <span class="NLM_lpage">7923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=7911-7923&author=V.+Brunauthor=M.+Legraverendauthor=D.+S.+Grierson&title=Traceless+solid-phase+synthesis+of+2%2C6%2C9-+trisubstituted+purines+from+resin+bound+6-thiopurines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrun%26aufirst%3DV.%26aulast%3DLegraverend%26aufirst%3DM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26atitle%3DTraceless%2520solid-phase%2520synthesis%2520of%25202%252C6%252C9-%2520trisubstituted%2520purines%2520from%2520resin%2520bound%25206-thiopurines%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D7911%26epage%3D7923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Abraham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, L.</span><span> </span><span class="NLM_article-title">NMR Method for the determination of solute hydrogen bond acidity</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052631n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3389-3394&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=J.+Byrneauthor=L.+Griffiths&title=NMR+Method+for+the+determination+of+solute+hydrogen+bond+acidity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Byrne, Jonathan; Griffiths, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is shown that the difference in the 1H NMR chem. shift of a protic hydrogen in DMSO and CDCl3 solvents is directly related to the overall, or summation, hydrogen bond acidity for a wide range of solutes.  This provides a new and direct method of measuring the hydrogen bond acidity.  For 54 compds., the obsd. shifts for 72 protic hydrogens could be correlated to the Abraham solute hydrogen bond acidity parameter, A, with a correlation coeff. squared, R2, of 0.938 and a std. deviation, SD, of 0.054 units in A.  A training equation that used half the data could predict A values for the remaining data with an av. error of 0.001 and a std. deviation, SD, of 0.053 units, thus demonstrating the predictive power of the method.  Unlike any previous method for the detn. of solute hydrogen bond acidities, the NMR method allows the detn. of A values for individual protic hydrogens in multifunctional solutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjlb-QytDX37Vg90H21EOLACvtfcHk0lhKOKme0vPfzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D&md5=6c74f59a2aba5d0ac75d2bbb842c97ea</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo052631n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052631n%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DGriffiths%26aufirst%3DL.%26atitle%3DNMR%2520Method%2520for%2520the%2520determination%2520of%2520solute%2520hydrogen%2520bond%2520acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3389%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, D. C.</span><span> </span><span class="NLM_article-title">Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31220</span><span class="NLM_x">–</span> <span class="NLM_lpage">31229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31220-31229&author=L.+Tangauthor=M.+H.+Liauthor=P.+Caoauthor=F.+Wangauthor=W.+R.+Changauthor=S.+Bachauthor=J.+Reinhardtauthor=Y.+Ferandinauthor=H.+Galonsauthor=Y.+Wanauthor=N.+Grayauthor=L.+Meijerauthor=T.+Jiangauthor=D.+C.+Liang&title=Crystal+structure+of+pyridoxal+kinase+in+complex+with+roscovitine+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DW.%2BR.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DD.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520pyridoxal%2520kinase%2520in%2520complex%2520with%2520roscovitine%2520and%2520derivatives%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31220%26epage%3D31229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer’s disease; A property common to most CDK inhibitors?</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=251-260&author=S.+Leclercauthor=M.+Garnierauthor=R.+Hoesselauthor=D.+Markoauthor=J.+A.+Bibbauthor=G.+L.+Snyderauthor=P.+Greengardauthor=J.+Biernatauthor=Y.+Z.+Wuauthor=E.-M.+Mandelkowauthor=G.+Eisenbrandauthor=L.+Meijer&title=Indirubins+inhibit+glycogen+synthase+kinase-3%CE%B2+and+CDK5%2Fp25%2C+two+protein+kinases+involved+in+abnormal+tau+phosphorylation+in+Alzheimer%E2%80%99s+disease%3B+A+property+common+to+most+CDK+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DHoessel%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DIndirubins%2520inhibit%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520and%2520CDK5%252Fp25%252C%2520two%2520protein%2520kinases%2520involved%2520in%2520abnormal%2520tau%2520phosphorylation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520A%2520property%2520common%2520to%2520most%2520CDK%2520inhibitors%253F%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J.; Galons, H.; Meijer, L.</span><span> </span><span class="NLM_article-title">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><span class="refDoi"> DOI: in press</span> .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+Bettayeb&author=N.+Oumata&author=A.+Echalier&author=Y.+Ferandin&author=J.+Endicott&author=H.+Galons&author=L.+Meijer&title=CR8%2C+a+potent+and+selective%2C+roscovitine-derived+inhibitor+of+cyclin-dependent+kinases&doi=in+press"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26atitle%3DCR8%252C%2520a%2520potent%2520and%2520selective%252C%2520roscovitine-derived%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DOncogene%26date%3D2008%26doi%3Din+press" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span> </span><span class="NLM_article-title">An integrated computational approach to the phenomenon of potent and selective inhibition of Aurora kinases B and C by a series of 7-substituted indirubins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4027</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4027-4037&author=V.+Myrianthopoulosauthor=P.+Magiatisauthor=Y.+Ferandinauthor=A.-L.+Skaltsounisauthor=L.+Meijerauthor=E.+Mikros&title=An+integrated+computational+approach+to+the+phenomenon+of+potent+and+selective+inhibition+of+Aurora+kinases+B+and+C+by+a+series+of+7-substituted+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm070077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070077z%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26atitle%3DAn%2520integrated%2520computational%2520approach%2520to%2520the%2520phenomenon%2520of%2520potent%2520and%2520selective%2520inhibition%2520of%2520Aurora%2520kinases%2520B%2520and%2520C%2520by%2520a%2520series%2520of%25207-substituted%2520indirubins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4027%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">Macromodel: an intergrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=Macromodel%3A+an+intergrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacromodel%253A%2520an%2520intergrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Gouet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courcelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metoz, F.</span><span> </span><span class="NLM_article-title">ESPript: analysis of multiple sequence alignments in PostScript</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1093%2Fbioinformatics%2F15.4.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=10320398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADyaK1MXjslCmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=305-308&author=P.+Gouetauthor=E.+Courcelleauthor=D.+I.+Stuartauthor=F.+Metoz&title=ESPript%3A+analysis+of+multiple+sequence+alignments+in+PostScript"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ESPript: analysis of multiple sequence alignments in PostScript</span></div><div class="casAuthors">Gouet, Patrice; Courcelle, Emmanuel; Stuart, David I.; Metoz, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-308</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The program ESPript (Easy Sequencing in PostScript) allows the rapid visualization, via PostScript output, of sequences aligned with popular programs such as CLUSTAL-W or GCG PILEUP.  It can read secondary structure files (such as that created by the program DSSP) to produce a synthesis of both sequence and structural information.  ESPript can be run via a command file or a friendly html-based user interface.  The program calcs. an homol. score by columns of residues and can sort this calcn. by groups of sequences.  It offers a palette of markers to highlight important regions in the alignment.  ESPript can also paste information on residue conservation into coordinate files, for subsequent visualization with a graphics program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf-fAq5SJgT7Vg90H21EOLACvtfcHk0ljVpPPQigw_Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslCmtrY%253D&md5=6829ce0fbc54c94d93bc9d5fc8fd8f40</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2F15.4.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252F15.4.305%26sid%3Dliteratum%253Aachs%26aulast%3DGouet%26aufirst%3DP.%26aulast%3DCourcelle%26aufirst%3DE.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DMetoz%26aufirst%3DF.%26atitle%3DESPript%253A%2520analysis%2520of%2520multiple%2520sequence%2520alignments%2520in%2520PostScript%26jtitle%3DBioinformatics%26date%3D1999%26volume%3D15%26spage%3D305%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span>JAGUAR 4.2; <span class="NLM_publisher-name">Schrödinger, Inc.</span>, <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">1991−2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JAGUAR+4.2%3B+Schr%C3%B6dinger%2C+Inc.%2C+Portland%2C+OR%2C+1991%E2%88%922000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJAGUAR%25204.2%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D1991%25E2%2588%25922000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Boys, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, F.</span><span> </span><span class="NLM_article-title">Calculation of small molecular interactions by differences of separate total energies. Some procedures with reduced errors</span> <span class="citation_source-journal">Mol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1970&pages=553-566&author=S.+F.+Boysauthor=F.+Bernardi&title=Calculation+of+small+molecular+interactions+by+differences+of+separate+total+energies.+Some+procedures+with+reduced+errors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DS.%2BF.%26aulast%3DBernardi%26aufirst%3DF.%26atitle%3DCalculation%2520of%2520small%2520molecular%2520interactions%2520by%2520differences%2520of%2520separate%2520total%2520energies.%2520Some%2520procedures%2520with%2520reduced%2520errors%26jtitle%3DMol.%2520Phys.%26date%3D1970%26volume%3D19%26spage%3D553%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Ribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boix, J.</span><span> </span><span class="NLM_article-title">Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm800109e&amp;key=10.1016%2Fj.yexcr.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm800109e&amp;key=15051486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm800109e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Whu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2004&pages=9-24&author=J.+Ribasauthor=J.+Boix&title=Cell+differentiation%2C+caspase+inhibition%2C+and+macromolecular+synthesis+blockage%2C+but+not+BCL-2+or+BCL-XL+proteins%2C+protect+SH-SY5Y+cells+from+apoptosis+triggered+by+two+CDK+inhibitory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs</span></div><div class="casAuthors">Ribas, Judit; Boix, Jacint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-24</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Olomoucine and roscovitine are two ATP-competing compds. described as specific inhibitors of cyclin-dependent kinases (CDK).  Both drugs showed to induce apoptosis in SH-SY5Y, a neuroblastoma-derived cell line.  In these cells, neither Bcl-2 nor Bcl-XL overexpression conferred any resistance to both drugs.  However, a partial protective effect was detected when cells were treated with a general inhibitor of caspases (zVADfmk), cycloheximide (CHX), or actinomycin D (DAct).  Interestingly, a synergism in cell protection was obsd. between zVADfmk and macromol. synthesis inhibitors, thus suggesting different apoptotic pathways in distinct subpopulations of the cell culture.  On the other hand, no lethality was found when cells were treated with either PD98059 or UO126.  This discarded Erk1/Erk2 inhibition as the cause of apoptosis.  Furthermore, SH-SY5Y cells became resistant to either Olomoucine or Roscovitine upon the induction of differentiation.  This resistance correlated with the extent of differentiation and, therefore, the no. of cells entering a quiescent state.  In conclusion, the results seem to support a role for CDK inhibition as the cause of the apoptotic process triggered by olomoucine and roscovitine.  Both compds. are promising anticancer drugs., at least for the treatment of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvNQ_XHcCZ7Vg90H21EOLACvtfcHk0ljWuSlfLyI1Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Whu78%253D&md5=e196d961db076496865e8b68e06b31cd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DJ.%26aulast%3DBoix%26aufirst%3DJ.%26atitle%3DCell%2520differentiation%252C%2520caspase%2520inhibition%252C%2520and%2520macromolecular%2520synthesis%2520blockage%252C%2520but%2520not%2520BCL-2%2520or%2520BCL-XL%2520proteins%252C%2520protect%2520SH-SY5Y%2520cells%2520from%2520apoptosis%2520triggered%2520by%2520two%2520CDK%2520inhibitory%2520drugs%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2004%26volume%3D295%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1B38" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1B38','PDB','1B38'); return false;">PDB: 1B38</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNL','PDB','1UNL'); return false;">PDB: 1UNL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKJ','PDB','1CKJ'); return false;">PDB: 1CKJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i96"><a href="/doi/suppl/10.1021/jm800109e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50747"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800109e/suppl_file/jm800109e-file006.pdf">jm800109e-file006.pdf (46.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800109e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm800109e%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800109e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679914455d883c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
